<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31977</article-id><article-id pub-id-type="doi">10.7554/eLife.31977</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-96695"><name><surname>Thurner</surname><given-names>Matthias</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7329-9769</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-34508"><name><surname>van de Bunt</surname><given-names>Martijn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6744-6125</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98096"><name><surname>Torres</surname><given-names>Jason M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-93617"><name><surname>Mahajan</surname><given-names>Anubha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98092"><name><surname>Nylander</surname><given-names>Vibe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98090"><name><surname>Bennett</surname><given-names>Amanda J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98089"><name><surname>Gaulton</surname><given-names>Kyle J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98091"><name><surname>Barrett</surname><given-names>Amy</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-106209"><name><surname>Burrows</surname><given-names>Carla</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98093"><name><surname>Bell</surname><given-names>Christopher G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98094"><name><surname>Lowe</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-7472"><name><surname>Beck</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-98095"><name><surname>Rakyan</surname><given-names>Vardhman K</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-35326"><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1205-1844</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1138"><name><surname>McCarthy</surname><given-names>Mark I</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4393-0510</contrib-id><email>mark.mccarthy@drl.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund16"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">The Wellcome Centre for Human Genetics</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Oxford Centre for Diabetes, Endocrinology and Metabolism</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Pediatrics</institution><institution>University of California, San Diego</institution><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Twin Research and Genetic Epidemiology</institution><institution>Kings College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">MRC Lifecourse Epidemiology Unit</institution><institution>University of Southampton</institution><addr-line><named-content content-type="city">Southampton</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Centre for Genomics and Child Health, Blizard Institute</institution><institution>Barts and The London School of Medicine and Dentistry</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Cancer Biology, UCL Cancer Institute</institution><institution>University College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Oxford NIHR Biomedical Research Centre</institution><institution>Churchill Hospital</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-98063"><name><surname>Nobrega</surname><given-names>Marcelo</given-names></name><role>Reviewing Editor</role><aff id="aff9"><institution>University of Chicago</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>07</day><month>02</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e31977</elocation-id><history><date date-type="received" iso-8601-date="2017-09-13"><day>13</day><month>09</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2018-02-06"><day>06</day><month>02</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Thurner et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Thurner et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-31977-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.31977.001</object-id><p>Human genetic studies have emphasised the dominant contribution of pancreatic islet dysfunction to development of Type 2 Diabetes (T2D). However, limited annotation of the islet epigenome has constrained efforts to define the molecular mechanisms mediating the, largely regulatory, signals revealed by Genome-Wide Association Studies (GWAS). We characterised patterns of chromatin accessibility (ATAC-seq, n = 17) and DNA methylation (whole-genome bisulphite sequencing, n = 10) in human islets, generating high-resolution chromatin state maps through integration with established ChIP-seq marks. We found enrichment of GWAS signals for T2D and fasting glucose was concentrated in subsets of islet enhancers characterised by open chromatin and hypomethylation, with the former annotation predominant. At several loci (including <italic>CDC123, ADCY5, KLHDC5</italic>) the combination of fine-mapping genetic data and chromatin state enrichment maps, supplemented by allelic imbalance in chromatin accessibility pinpointed likely causal variants. The combination of increasingly-precise genetic and islet epigenomic information accelerates definition of causal mechanisms implicated in T2D pathogenesis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Type 2 Diabetes</kwd><kwd>human pancreatic islets</kwd><kwd>GWAS</kwd><kwd>epigenetics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004191</institution-id><institution>Novo Nordisk</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>van de Bunt</surname><given-names>Martijn</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>HEALTH-F4-2007-201413</award-id><principal-award-recipient><name><surname>Nylander</surname><given-names>Vibe</given-names></name><name><surname>Gloyn</surname><given-names>Anna L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Beck</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01-DK105535</award-id><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>099673/Z/12/Z</award-id><principal-award-recipient><name><surname>Thurner</surname><given-names>Matthias</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-DK098032</award-id><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>106130</award-id><principal-award-recipient><name><surname>Torres</surname><given-names>Jason M</given-names></name><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-MH090941</award-id><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>095101/Z/10/Z</award-id><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>200837/Z/16/Z</award-id><principal-award-recipient><name><surname>Gloyn</surname><given-names>Anna L</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>090532</award-id><principal-award-recipient><name><surname>McCarthy</surname><given-names>Mark I</given-names></name><name><surname>Gloyn</surname><given-names>Anna L</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>098381</award-id><principal-award-recipient><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01-DK085545</award-id><principal-award-recipient><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>090367</award-id><principal-award-recipient><name><surname>McCarthy</surname><given-names>Mark I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Human pancreatic islet high-resolution chromatin state maps generated from DNA methylation, open chromatin and ChIP-seq mark data facilitate the characterisation of regulatory mechanisms at type 2 diabetes genome-wide association study loci.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>T2D is a complex disease characterised by insulin resistance and reduced beta cell function. Recent GWAS have identified a large number of T2D susceptibility loci (<xref ref-type="bibr" rid="bib54">Scott et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Mahajan et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Wellcome Trust Case Control Consortium et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Voight et al., 2010</xref>), the majority of which affect insulin secretion and beta cell function (<xref ref-type="bibr" rid="bib10">Dimas et al., 2014</xref>; <xref ref-type="bibr" rid="bib64">Wood et al., 2017</xref>). However, most GWAS signals map to the non-coding genome and identification of the molecular mechanisms through which non-coding variants exert their effect has proven challenging. Several studies have demonstrated that T2D-associated variants map disproportionately to regulatory elements, particularly those which influence RNA expression and cellular function of human pancreatic islets. (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Olsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Dayeh et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Volkov et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Gaulton et al., 2015</xref>, <xref ref-type="bibr" rid="bib20">2010</xref>).</p><p>Characterisation of the islet regulome has until now been limited in scope. The use of DNA methylation and open chromatin data to further annotate ChIP-seq derived chromatin states has successfully uncovered novel biology for other diseases (<xref ref-type="bibr" rid="bib62">Wang et al., 2016</xref>). Existing methylation studies in islets, however, have either profiled a very small proportion of methylation sites using methylation arrays (<xref ref-type="bibr" rid="bib45">Olsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Dayeh et al., 2014</xref>) or focused on T2D-associated disease differentially methylated regions (dDMRs) rather than the integration of DNA methylation status with T2D-relevant GWAS data (<xref ref-type="bibr" rid="bib61">Volkov et al., 2017</xref>). At the same time, assays of open chromatin in human islets have been restricted to small sample numbers (limiting the potential to capture allelic imbalance in chromatin accessibility for example): these have focussed predominantly on the impact of clustered or ‘stretch’ enhancers (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Gaulton et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>).</p><p>Most importantly, in part due to historical challenges in accessing human islet material or authentic human cellular models, reference annotations of the islet epigenome and transcriptome (in the context of projects such as GTEx, ENCODE and Epigenome Roadmap) have been largely absent. It is worth noting that islets constitute only ~1% of the pancreas, and islet epigenomes and transcriptomes cannot therefore be reliably assayed in analyses involving the entire organ. Previous islet epigenome studies have, therefore, had only limited ability to directly relate genetic variation to regulatory performance or to broadly characterise the role of DNA methylation in these processes.</p><p>In this study, we set out to expand upon previous studies of the islet regulome in several ways. First, we explored the human islet methylome in unprecedented depth using Whole-Genome Bisulphite Sequencing (WGBS) applied to a set of 10 human islet preparations. Second, we explored both basal and genotype-dependent variation in chromatin accessibility through ATAC-seq in 17 human islet samples. Third, we integrated these genome-wide data with existing islet regulatory annotations to generate a high-resolution, epigenome map of this key tissue. Finally, we used this detailed map to interpret GWAS signals for T2D (and the related trait of fasting glucose) and deduce the molecular mechanisms through which some of these loci operate.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characterising the DNA methylation landscape of human pancreatic islets</title><p>To characterise the human islet methylome and characterise the role of DNA methylation with respect to T2D genetic risk, we performed WGBS (mean coverage 13X) in human pancreatic islet DNA samples isolated from 10 non-diabetic cadaveric donors of European descent. Methylation levels across the genome were highly correlated across individual donors (mean CpG methylation Spearman’s rho across 10 individual WGBS donors = 0.71, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>): we pooled the WGBS results to generate a single high-pass (mean coverage 85X) set of pooled human pancreatic islet methylation data covering 23.3 million CpG sites (minimum pooled coverage 10X).</p><p>Most previous studies of the relationship between GWAS data and tissue-specific methylation patterns (including those interrogating the relationship between islet methylation and T2D predisposition [<xref ref-type="bibr" rid="bib8">Dayeh et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Olsson et al., 2014</xref>]) had used data generated on the Illumina 450 k methylation array (<xref ref-type="bibr" rid="bib24">Hannon et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Mitchell et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Kato et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Ventham et al., 2016</xref>). For comparative purposes, we generated 450 k array methylation data from 32 islet samples ascertained from non-diabetic donors of European descent (five overlapping with those from whom WGBS data were generated). As with the WGBS data, methylation levels were highly correlated across individuals (mean CpG methylation Spearman’s rho across 32 individual 450 k donor = 0.98, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). After pooling 450 k array data across samples, methylation profiles generated from the 450 k array and WGBS were highly correlated at the small subset of total CpG sites for which they overlap: this was observed across pooled samples (pooled WGBS vs. 450 k Spearman’s rho = 0.89, <xref ref-type="fig" rid="fig1">Figure 1A</xref>) and across the five donors analysed by both methods (mean Spearman’s rho = 0.80, not shown).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.002</object-id><label>Figure 1.</label><caption><title>Comparison of human pancreatic islet WGBS and 450 k methylation data across the genome.</title><p>(<bold>A</bold>) Smooth Scatter plot shows Spearman’s rho correlation between the 450 k array (y-axis) and WGBS (x-axis) at overlapping sites. Darker colour indicates higher density of sites. (<bold>B</bold>) Comparison of the 450 k array (orange) and WGBS (yellow) methylation levels (x-axis) of all CpGs genome-wide assayed by either method (y-axis shows density). The P-value shown is derived using a Kolmogorov-Smirnov (KS) test. (<bold>C</bold>) For each chromatin state from <xref ref-type="bibr" rid="bib46">Parker et al. (2013)</xref> the methylation levels of all CpG sites independent of overlap (diamond indicates the median) are shown as violin plots (left y-axis) and the CpG probe percentage per state for the 450 k array (orange) and WGBS (yellow) are shown as bar-plot (right y-axis). The 450 k probes represent the percentage of the total number of CpG sites which is determined by the number of WGBS CpG sites detected (WGBS = 100%). (<bold>D</bold>) Distribution of GWAS Posterior Probabilities (Type 2 Diabetes and Fasting Glucose) captured by CpG sites on the 450 k array (orange), 850 k array (green) and WGBS (yellow/black line). (<bold>E</bold>) Locuszoom plot showing CpG density and credible set SNPs. SNPs are shown with P-values (dots, y-axis left), recombination rate (line, y-axis right) and chromosome positions (x-axis) while CpG and gene annotations are shown below. These annotations include CpGs identified from WGBS (yellow stripes), 450 k CpG probes (orange stripes), 850 k CpG probes (green stripes) and gene overlap (<italic>DGKB</italic> label). The highlighted region in blue captures the 99% credible set region plus additional 1000 bp on either side. At the very bottom the position on chromosome seven is shown in Megabases (Mb).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Correlation of DNA methylation across WGBS and 450 k sites and comparison of WGBS and 450 k methylation levels across chromatin states.</title><p>(<bold>A-B</bold>) Spearman’s rho correlation of DNA methylation across 10 individual (A) WGBS and (B) 10 selected (out of 32) 450 k samples on the x-axis and y-axis. (<bold>C</bold>) Islet chromatin state definitions based on ChIP-seq data reproduced from <xref ref-type="bibr" rid="bib46">Parker et al. (2013)</xref>. TSS: Transcription Start Site (<bold>D</bold>) The differences in the 450 k and WGBS methylation level distribution measured as D statistic, which represents the difference in the cumulative distributions and is derived from the Kolmogorov-Smirnov test, are shown for each chromatin state separately.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>PC analysis of 450 k DNA methylation samples.</title><p>(<bold>A-B</bold>) PC analysis of 450 k DNA methylation data of 32 human islet samples coloured according to the location of origin and processing (<bold>A</bold>) before correction for Sample-location and (<bold>B</bold>) after correction for Sample-location using the ComBat function included in the sva package. The shape indicates sex. Sample location EDM_OX: samples obtained from the Alberta Diabetes Institute in Edmonton (Canada) and processed at the University of Oxford. OX_OX: samples obtained from Oxford DRWF Human Islet Isolation Facility and processed at the University of Oxford. OX_UCL: samples obtained from Oxford DRWF Human Islet Isolation Facility and processed at University College London.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig1-figsupp2-v2"/></fig></fig-group><p>WGBS and 450 k array data differed substantially in terms of genome-wide coverage. The 450 k array was designed to interrogate with high precision and coverage ~480 k CpG sites (approximately 2% of all sites in the genome), selected primarily because they are located near gene promoters and CpG-island regions. The focus of the 450 k array on these regions, which tend to be less variable in terms of methylation, explains the high 450 k array correlation levels between donors. In addition, this selective design results in marked differences in the distributions of genome-wide methylation values between WGBS and the 450 k array. Whilst the WGBS data revealed the expected pattern of widespread high methylation levels with hypomethylation (&lt;50%) restricted to 11.2% (2.6M/23.3M CpG sites) of the genome, the array disproportionately interrogated those hypomethylated sites (218 k [46%] of all 450 k CpG probes) (Kolmogorov–Smirnov (KS) test for difference, D = 0.40, p&lt;2.2×10<sup>−16</sup>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These differences in methylation distribution were also evident within specific islet regulatory elements from previously defined standard chromatin state maps (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–D</xref>). We found significant (FDR &lt; 0.05) differences between the methylation levels of CpG sites accessed on the array, and those interrogated by WGBS, across most islet chromatin states: the largest differences were observed for weak promoters (median WGBS = 0.71 vs. median 450k = 0.11, KS test D = 0.51, p&lt;2.2×10<sup>−16</sup>,) and weak enhancers (WGBS = 0.87 vs. 450 k median = 0.76, D = 0.39, p&lt;2.2×10<sup>−16</sup>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>).</p><p>In terms of coverage, most chromatin states, apart from promoters, were poorly represented by CpG sites directly interrogated by the array: for example the array assayed only ~2.9% of CpG sites in strong enhancer states (2.7–3.8% depending on strong enhancer subtype, <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Although methylation levels were previously reported to be highly correlated across short (0.1–2 kb) genomic distances (<xref ref-type="bibr" rid="bib65">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib2">Bell et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Eckhardt et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Guo et al., 2017</xref>), the observed significant differences in the methylation distribution (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>) across chromatin states including weak promoter (median size 600 bp) and enhancer subtypes (median size ranges from 200 to 1200 bp) indicate that these correlative effects are not strong enough to counterbalance the low coverage of the 450 k array. These findings are consistent with 450 k array content being focused towards CpG-dense hypomethylated and permissive promoter regions. This highlights the limited capacity of the array to comprehensively interrogate the global DNA methylome, in particular at distal regulatory states such as enhancers.</p><p>To understand the value of these data to reveal molecular mechanisms at GWAS loci, where we and others had shown enrichment for islet enhancer states (<xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Gaulton et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>), we were interested to see how the selective coverage of the array might impact on its ability to interrogate methylation in GWAS-identified regions. We used the largest currently available T2D DIAGRAM GWAS data set (involving 26.7 k cases and 132.5 k controls of predominantly European origin, see dataset section for details) to identify the ‘credible sets’ of variants at each locus which collectively account for 99% of the posterior probability of association (PPA) (<xref ref-type="bibr" rid="bib54">Scott et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Maller et al., 2012</xref>).</p><p>To estimate the respective proportions of these T2D-associated variants captured by CpG sites assayed by the 450 k array and WGBS, we determined, for each locus, the combined PPA of all 99% credible set variants mapping within 1000 bp of any CpG site captured. This is based on evidence that across short distances CpG methylation is highly correlated (<xref ref-type="bibr" rid="bib65">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib2">Bell et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Eckhardt et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Guo et al., 2017</xref>) and may be influenced by genetic variants associated with altered transcription factor binding (<xref ref-type="bibr" rid="bib11">Do et al., 2016</xref>). We found that coverage of this space of putative T2D GWAS variants by the 450 k array is low: across GWAS loci, the combined PPA attributable to variants within regions assayed by the array ranged from 0–99% with a median PPA per locus of 16% (compared to a WGBS median PPA per locus = 99%, KS-test p&lt;2.2×10<sup>−16</sup>, <xref ref-type="fig" rid="fig1">Figure 1D</xref>, top). We estimated that the equivalent figure for a recently developed upgrade of the 450 k array, which captures ~850 k CpG sites and aims to provide better coverage of enhancer regions, would be ~39% (range 0%–99% <xref ref-type="fig" rid="fig1">Figure 1D</xref>, top). For instance, at the <italic>DGKB</italic> T2D locus (centred on rs10276674), CpG sites covered by the 450 k array interrogated less than 1% of the PPA of associated variants (vs. 99% captured by WGBS); the figure for the 850 k array would be 23% (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). We obtained similar results when we performed equivalent analyses using GWAS data for fasting glucose (FG, from the ENGAGE consortium [<xref ref-type="bibr" rid="bib27">Horikoshi et al., 2015</xref>]), another phenotype dominated by islet dysfunction (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, bottom).</p><p>These data indicate that available methylation arrays provide poor genome-wide coverage of methylation status and are notably deficient in capturing methylation status around the distal regulatory enhancer regions most relevant to T2D predisposition. For this reason, we focused subsequent analyses on the WGBS data.</p></sec><sec id="s2-2"><title>Integration islet methylation and other epigenomic annotations</title><p>Studies in a variety of other tissues have shown that hypomethylation is a strong indicator of regulatory function (<xref ref-type="bibr" rid="bib55">Stadler et al., 2011</xref>). More specifically, continuous stretches of CpG-poor Low-Methylated Regions (LMRs, with methylation ranging from 10–50% and containing fewer than 30 CpG sites) denote potential distal regulatory elements such as enhancers, while stretches of CpG-rich UnMethylated Regions (UMRs, containing more than 30 CpG sites) are more likely to represent proximal regulatory elements including promoters (<xref ref-type="bibr" rid="bib4">Burger et al., 2013</xref>). We detected 37.1 k LMRs, 13.6 k UMRs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and 10.7 k Partially Methylated Domains (PMDs) (Materials and methods and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). PMDs represent large regions of unordered methylation states associated with DNA sequence features (<xref ref-type="bibr" rid="bib18">Gaidatzis et al., 2014</xref>). As anticipated, we found significant enrichment of LMRs with weak and strong enhancer states as defined by islet chromatin state maps derived from existing ChIP-seq data (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>) (69.2% of islet LMRs overlapped islet strong and weak enhancer states, log<sub>2</sub>FE = 2.2–2.9, Bonferroni p&lt;0.05, <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Similarly, UMRs were enriched for islet active promoter chromatin states (90.8% of UMRs overlapped islet active promoters, log<sub>2</sub>FE = 3.9, Bonferroni p &lt; 0.05, <xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.005</object-id><label>Figure 2.</label><caption><title>Overlap of WGBS hypomethylation and ATAC-seq open chromatin peaks with regulatory annotation.</title><p>(<bold>A</bold>) Methylation levels in percent (y-axis) and log<sub>2</sub> CpG density (x-axis) of UMR and LMR regulatory regions with the dashed line indicating the CpG-number (30 CpGs) that distinguishes LMRs and UMRs. (<bold>B</bold>) Log<sub>2</sub> Fold Enrichment (log<sub>2</sub>FE) of LMRs (green shape), UMRs (blue shape) in various islet annotations is shown. These annotations include islet chromatin states, islet relevant TFBS (FOXA2, MAFB, NKX2.2, NKX6.1, PDX1), islet eQTLs, WGBS derived T2D-associated islet disease DMRs (dDMRs) and ATAC-seq open chromatin peaks. The dDMRs were derived from 6 T2D and eight non-diabetic individuals by <xref ref-type="bibr" rid="bib61">Volkov et al. (2017)</xref> and dDMRs (orange shape) were also tested for enrichment in the aforementioned islet regulatory annotations. For all annotations, the empirically determined Bonferroni adjusted P-value is ≤0.00032 unless otherwise indicated by the shape: a dot corresponds to an Bonferroni adjusted p-value&lt;0.00032 while the three triangles indicates Bonferroni adjusted p-values&gt;0.00032: UMR enrichment adjusted P-value for weak enhancers = 1; dDMR enrichment adjusted P-value for MAFB = 0.006 and dDMR enrichment adjusted P-value for islet eQTLs = 0.01.</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.31977.007</object-id><label>Figure 2—source data 1.</label><caption><title>LMR_UMR_source_MThurner_Oct_2017.tds is associated with primary <xref ref-type="fig" rid="fig2">Figure 2</xref> Bed file providing coordinates of WGBS hypomethylated regulatory regions defined as UMRs and LMRs.</title></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-31977-fig2-data1-v2.tds"/></supplementary-material> </p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Identification and removal of Partially Methylated Domains (PMDs) and additional characterisation of regulatory regions.</title><p>(<bold>A-B</bold>) Density distribution of the alpha value (<bold>A</bold>) before and (<bold>B</bold>) after removing PMDs (green curve in (<bold>A</bold>)) on chromosome 22. Alpha values represent a summary statistic derived from DNA methylation of windows of 100 CpGs and represents an indication of the polarisation status of methylation values in the genome which is expected to contain either highly methylated or unmethylated regions. Distributions with alpha &lt;1 indicate methylation levels that are bimodal with either 0 or one methylation. Alpha = 1 corresponds to a uniform distribution of methylation; and distributions with alpha &gt;1 tend to have primarily intermediate methylation levels. The red and green curve in (A) represent the non-PMD (red) and PMD regions (green) in the genome. (<bold>C</bold>) Number of peaks (x-axis) and mapped and filtered reads (y-axis) per ATAC-seq islet preparation. The dashed line indicates the mean read number. (<bold>D</bold>) Log<sub>2</sub> Fold Enrichment (log<sub>2</sub>FE, x-axis) and associated -log10 Bonferroni adjusted P-values (y-axis) of LMRs (circle), UMRs (triangle) in various islet annotations (colours) is shown. These annotations include islet chromatin states, islet relevant TFBS (FOXA2, MAFB, NKX2.2, NKX6.1, PDX1), islet eQTLs, WGBS derived T2D-associated islet disease DMRs (dDMRs) and ATAC-seq open chromatin peaks. dDMRs (square) were also tested for enrichment in the aforementioned islet regulatory annotations. The results cluster near -log10 P-value of 3.5 since most Bonferroni adjusted P-values were more extreme than 0.00032.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig2-figsupp1-v2"/></fig></fig-group><p>To further characterise these hypomethylation domains, we overlapped information from analyses of islet cis-expression QTLs (eQTLs) (<xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>) and islet ChIP-seq transcription factor binding sites (TFBS) (<xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>). We observed marked enrichment for eQTLs (LMR log<sub>2</sub>FE = 1.1, UMR log<sub>2</sub>FE = 2.7, Bonferroni p&lt;0.05) and TFBS (LMR log<sub>2</sub>FE = 4.1–4.6; UMR log<sub>2</sub>FE = 2.4–3.9, Bonferroni p&lt;0.05, <xref ref-type="fig" rid="fig2">Figure 2B</xref>). These observations confirm that islet LMRs and UMRs correspond to important tissue-specific regulatory regions, overlapping cis-regulatory annotations known to be enriched for T2D GWAS signals (<xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Gaulton et al., 2015</xref>).</p><p>We also considered the relationship between LMR and UMR regions defined in our non-diabetic islet WGBS, and a complementary set of methylation-based annotations previously derived from WGBS of islets from 6 T2D and 8 control individuals (<xref ref-type="bibr" rid="bib61">Volkov et al., 2017</xref>). In that study, comparisons between diabetic and non-diabetic islets had been used to define a set of 25,820 ‘disease differentially methylated regions’ (dDMRs, minimum absolute methylation difference 5% and p&lt;0.02). We found only limited overlap between these dDMRs and the UMRs and LMRs from our data: of the 25,820 dDMRs, 2.2% overlapped LMRs and 2.4% UMRs. This overlap was slightly greater than expected by chance (Bonferroni p&lt;0.05, LMR log<sub>2</sub>FE = 1.0 and promoter-like UMRs log<sub>2</sub>FE = 1.1, <xref ref-type="fig" rid="fig2">Figure 2B</xref>) but more modest than seen for the other regulatory annotations. Similarly, we also observed that dDMRs showed more modest (log<sub>2</sub>FE = 0.4–1.0), but still significant (Bonferroni p&lt;0.05) levels of enrichment with respect to all other islet regulatory annotations (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The modest enrichment of dDMRs indicates that only a fraction of these regions correspond to islet genomic regulatory sites. Given that T2D risk variants preferentially map in islet regulatory sites, the corollary is that most dDMRs are unlikely to directly contribute to the mediation of genetic T2D risk.</p></sec><sec id="s2-3"><title>Refining islet enhancer function using methylation and open chromatin data</title><p>To further characterise the regulatory potential of hypomethylated regions, including LMRs and UMRs, we combined the islet WGBS methylation data with chromatin accessibility data generated from ATAC-seq assays of 17 human islet samples (from non-diabetic donors of European descent; mean read count after filtering = 130M, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). We identified a total of 141 k open chromatin regions based on read depth, peak width and signal-to-noise ratio (see Materials and methods). These regions of islet open chromatin showed substantial overlap (78%) with equivalent regions described in a recent study of two human islets (<xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>) (log<sub>2</sub>FE = 2.8 compared to random sites, not shown). In addition, our islet ATAC-Seq sites demonstrated substantial overlap with LMRs: 53% of LMRs overlapped 16% of all ATAC-seq peaks (LMR log<sub>2</sub>FE = 3.8 compared to randomised sites, <xref ref-type="fig" rid="fig2">Figure 2B</xref>). Almost all UMRs (98%) were contained within regions overlapping (13% of) ATAC-seq peaks (UMR log<sub>2</sub>FE = 3.4 compared to randomised sites, <xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>To fully leverage information across multiple overlapping islet epigenome assays, we generated augmented chromatin state maps, using chromHMM (<xref ref-type="bibr" rid="bib14">Ernst and Kellis, 2012</xref>). These maps combined the WGBS methylation and ATAC-Seq open chromatin data with previously generated ChIP-seq marks (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). For these analyses, we initially used a single definition for hypomethylated regions (methylation &lt;60%) that captured both UMRs and LMRs (see Materials and methods).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.008</object-id><label>Figure 3.</label><caption><title>Integration of islet epigenetic data to refine chromatin regulatory states and enrichment of these states in T2D GWAS data.</title><p>(<bold>A</bold>) 15 chromatin states (y-axis) were derived from ChIP histone marks, DNA methylation and ATAC-seq open chromatin annotations (x-axis) using chromHMM. For each state the relevant marks characterising the state are shown. The colour is based on the chromHMM emission parameters and a darker colour indicates a higher frequency of a mark at a given state. Weak enhancers (marked by H3K4me1 alone, red) and strong enhancers (marked by H3K27ac and H3K4me1, green) were subdivided by the chromHMM analysis according to methylation and ATAC-seq status (highlighted in red and green box). The black bar at the x-axis highlights the most important marks for characterising enhancer subtypes. (<bold>B-C</bold>) FGWAS Log<sub>2</sub> Fold Enrichment including 95% CI (log<sub>2</sub>FE, x-axis) of all chromatin states (y-axis) in T2D GWAS regions is shown which demonstrate differential enrichment amongst enhancer subclasses in single-feature enrichment analysis. In addition, log2FE of Coding Sequence (CDS) and Conserved Sequence (CONS) annotations are shown to include the effect of protein-coding and conserved regions. Significantly enriched annotations are shown in black while non-siginificant annotations are shown in grey. (<bold>C</bold>) T2D FGWAS maximum likelihood model determined through cross-validation. Log<sub>2</sub>FE and 95% CI (x-axis) of annotations included in the maximum likelihood model (y-axis) also demonstrate differential enrichment amongst enhancer subclasses. *Analysis for Genic Enhancers (state 10) did not converge and hence, only a point log2FE estimate is provided. (<bold>D</bold>) Single feature log2FE including 95% CI (x-axis) results are shown highlighting the differences in T2D GWAS enrichment of various annotations. These include ATAC-seq open chromatin peaks (red), WGBS methylation regions (including enhancer-like LMRs, promoter-like UMRs and Partially Methylated Domains, blue), ChIP-seq chromatin states (orange) and CDS and CONS (green) annotations. (<bold>E</bold>) Chi-square distribution (curved black line) with the indicated results of a maximum likelihood ratio test based on the maximum likelihood difference between a model including LMRs or ATAC-seq peaks compared to the ChIP-only model. The dashed red line indicates significance (p-value&lt;0.05). For all FGWAS enrichment plots the axis has been truncated at −6 to facilitate visualisation and accurate values are provided in the supplementary tables.</p><p><supplementary-material id="fig3sdata1"><object-id pub-id-type="doi">10.7554/eLife.31977.011</object-id><label>Figure 3—source data 1.</label><caption><title>Annotation enrichment in T2D GWAS data.</title><p>For each annotation the data source and the log2 Fold Enrichment (log<sub>2</sub>FE) in T2D is shown. 95% Confidence Intervals (CI) for log<sub>2</sub>FE are shown in brackets and significantly enriched states are highlighted in bold (lower CI limit &gt;0).</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31977-fig3-data1-v2.docx"/></supplementary-material> </p><p><supplementary-material id="fig3sdata2"><object-id pub-id-type="doi">10.7554/eLife.31977.012</object-id><label>Figure 3—source data 2.</label><caption><title>Evaluating enrichment in T2D GWAS data.</title><p>For each annotation the single feature and joint-model log2 Fold Enrichment (log<sub>2</sub>FE) in T2D is shown. 95% Confidence Intervals (CI) for log<sub>2</sub>FE are shown in brackets. In addition, the LRT statistic and P-value of a nested joint-model excluding a given annotation is shown.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31977-fig3-data2-v2.docx"/></supplementary-material> </p><p><supplementary-material id="fig3sdata3"><object-id pub-id-type="doi">10.7554/eLife.31977.013</object-id><label>Figure 3—source data 3.</label><caption><title>Evaluating enrichment in FG GWAS data.</title><p>For each annotation the single feature and joint-model log2 Fold enrichment (log<sub>2</sub>FE) in FG is shown. 95% Confidence Intervals (CI) for log<sub>2</sub>FE are shown in brackets. In addition, the LRT statistic and P-value of a nested joint-model excluding a given annotation is shown.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31977-fig3-data3-v2.docx"/></supplementary-material> </p><p><supplementary-material id="fig3sdata4"><object-id pub-id-type="doi">10.7554/eLife.31977.014</object-id><label>Figure 3—source data 4.</label><caption><title>Merged_ATAC_seq_peaks_MThurner_Oct_2017.tds is associated with primary <xref ref-type="fig" rid="fig3">Figure 3</xref></title><p>Bed file providing coordinates of ATAC-seq open chromatin peaks merged across all samples.</p></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-31977-fig3-data4-v2.tds"/></supplementary-material> </p><p><supplementary-material id="fig3sdata5"><object-id pub-id-type="doi">10.7554/eLife.31977.015</object-id><label>Figure 3—source data 5.</label><caption><title>Pancreatic_islet_15_chromatin_states_MThurner_Oct_2017.tds.zip is associated with primary <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p>Zipped bed file providing coordinates of human pancreatic islet chromatin states.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-31977-fig3-data5-v2.zip"/></supplementary-material> </p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31977-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.009</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Prediction of regulatory regions using WGBS and ATAC-seq data and testing these regions for enrichment in T2D GWAS regions.</title><p>(<bold>A</bold>) Different combinations of epigenomic data (top) were combined to generate different sets of refined chromatin states (middle, 11 ChIP-only and 15 ChIP + Meth, ChIP + ATAC and ChIP + ATAC+Meth states, see figure <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref> and <xref ref-type="fig" rid="fig3">Figure 3A-B</xref> for actual states) using chromHMM. These sets of chromatin states were then tested for enrichment in T2D-related GWAS traits using FGWAS to compare enrichment across states (bottom). (<bold>B</bold>) ChromHMM (I) 11 ChIP-only and 15 state (II) ChIP + ATAC state and (III) ChIP + Meth models. (<bold>C</bold>) Single feature log2FE (x-axis) for different enhancer states (grey panels) defined from different combinations of epigenetic marks (y-axis) including ChIP+ ATAC+ Meth, ChIP+ ATAC, ChIP + Meth and ChIP-only. Enhancers are defined as follows: Strong enhancers are marked by both H3K4me1 and H3K27ac, weak Enhancers are defined by H3K4me1 only, gene enhancers are marked by H3K4me1 and H3K36me3, other enhancers are marked by H3K4me1, H3K4me3 and H3K27ac and are often referred to as TSS upstream regions (only included in the FGWAS T2D model for ChIP-only and ChIP + Meth chromatin states). (<bold>D</bold>) Since chromatin states defined from a different set of epigenomic marks (ChIP-only, ChIP + Meth, ChIP + ATAC and ChIP + ATAC+ Meth), as described in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A-B</xref>, are not equivalent and the enrichment can not be easily compared across models, a nested model approach was applied. That is, ChIP-only chromatin states were generated and after evaluating the individual enrichment of each annotation (see <xref ref-type="fig" rid="fig3">Figure 3D</xref>), FGWAS maximum likelihood models were defined using ChIP-only, hypomethylated and/or ATAC-seq peak regulatory regions. The combination of all these annotations represented a nested linear model and the changes in maximum likelihood by adding/removing hypomethylated regulatory and ATAC-seq states could be statistically evaluated using a Loglikelihood Ratio Test (LRT) as shown in <xref ref-type="fig" rid="fig3">Figure 3E</xref>. (<bold>E</bold>) Maximum likelihood FGWAS nested model combining ChIP-only, ATAC-peaks and LMR states (y-axis) showing log<sub>2</sub>FE enrichment (x-axis) which was used for the LRT in <xref ref-type="fig" rid="fig3">Figure 3E</xref>. For all FGWAS enrichment plots the axis has been truncated at −6 to facilitate visualisation and accurate values are provided in the supplementary tables.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.010</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Enrichment of refined islet regulatory states in FG GWAS data.</title><p>(<bold>A</bold>) FGWAS Log2 Fold Enrichment including 95% CI (log2FE, x-axis) of all chromatin states (y-axis) in FG GWAS regions. In addition, log2FE of CDS and CONS annotations are shown to also include the effect of protein-coding and conserved regions. Significantly enriched annotations are shown in black. (<bold>B</bold>) FG FGWAS maximum likelihood model determined through cross-validation. log<sub>2</sub>FE and 95% CI (x-axis) of annotations included in the maximum likelihood model (y-axis) are shown. (<bold>C</bold>) Single feature log<sub>2</sub>FE (x-axis) for different enhancer states (grey panels) defined from different combinations of epigenetic marks (y-axis) including ChIP + ATAC + Meth, ChIP + ATAC, ChIP + Meth and ChIP-only. Enhancers are defined as follows: Strong enhancers are marked by both H3K4me1 and H3K27ac, weak Enhancers are defined by H3K4me1 only, gene enhancers are marked by H3K4me1 and H3K36me3, other enhancers are marked by H3K4me1, H3K4me3 and H3K27ac and are often referred to as TSS upstream regions (only included in the FGWAS T2D model for ChIP-only and ChIP + Meth chromatin states). (<bold>D</bold>) Single feature log<sub>2</sub>FE including 95% CI (x-axis) results of various annotations derived from ChiP-seq (ChIP-only), ATAC-seq, WGBS methylation status and CDS and CONS are shown. (<bold>E</bold>) Maximum likelihood FGWAS nested model combining ChIP-only, ATAC-peaks and LMR states (y-axis) showing log2FE enrichment (x-axis) which was used for the LRT in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2F</xref>. (<bold>F</bold>) Chi-square distribution (black curved line) with the indicated results of a maximum likelihood ratio test based on the maximum likelihood difference between a model including LMRs or ATAC-seq peaks compared to the ChIP-only model. The dashed line indicates significance (p-value&lt;0.05). For all FGWAS enrichment plots the axis has been truncated at −6 to facilitate visualisation and accurate values are provided in the supplementary tables.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig3-figsupp2-v2"/></fig></fig-group><p>This augmented and larger set of 15 islet chromatin states retained the broad classification of regulatory elements that included promoters (positive for H3K4me3), transcribed and genic regions (H3K36me3), strong enhancers (H3K4me1; H3K27ac), weak enhancers (H3K4me1), insulators (CTCF) and repressed elements (H3K27me) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The addition of islet methylation and open chromatin data expanded existing chromatin state definitions to provide new subclasses, particularly amongst enhancer elements. Here, we observed two subclasses of strong enhancers and three of weak enhancers (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We denote the strong enhancer subtypes as ‘open’ (n = 32 k genome-wide), characterised by open chromatin and hypomethylation, and ‘closed’ (n = 110 k) with closed chromatin and hypermethylation (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The three weak enhancer states we denote as ‘open’ (n = 38k: open chromatin, hypomethylation), ‘lowly-methylated’ (n = 78 k; closed chromatin, hypomethylation) and ‘closed’ (n = 206k: closed chromatin, hypermethylation). No equivalent class of ‘lowly-methylated’ strong enhancers was observed in the 15-state model. When comparing these chromatin states to those identified using only ChIP-seq marks ([<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>], <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), the two strong enhancer subclasses we identified subdivided the ‘strong enhancer 1’ state as described by Parker (defined by H3K27ac and H3K4me1). Additional comparison to ‘stretch’ enhancer clusters (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>), showed that there was considerable overlap between the ‘open’ strong and weak enhancer states we identify here and previously-described ‘stretch’ enhancer states (16.1 k out of 23 k stretch enhancer overlapped 32 k out of 70.1 k ‘open’ enhancers). Even so, most (55%) ‘open’ enhancer states, and in particular ‘open weak enhancers’ (70%), were not captured within ‘stretch’ enhancer intervals, and we regard these as distinct islet enhancer subclasses.</p><p>To understand the relationship of these various state definitions to genetic variants influencing T2D risk, we applied the hierarchical modelling approach FGWAS (<xref ref-type="bibr" rid="bib48">Pickrell, 2014</xref>) to the same sets of large-scale GWAS data for T2D (from DIAGRAM [<xref ref-type="bibr" rid="bib54">Scott et al., 2017</xref>]) and FG (ENGAGE [<xref ref-type="bibr" rid="bib27">Horikoshi et al., 2015</xref>]) described in section 2.1. FGWAS allowed us to combine GWAS and genomic data to determine the genome-wide enrichment within islet regulatory features for variants associated with T2D risk. These enrichment priors were then used to generate credible variant sets that are informed by both GWAS and genomic data, as described in section 2.4.</p><p>In single-feature analyses, we found significant enrichment (lower limit of Confidence Interval (CI) &gt;0) limited to four enhancer states (open weak enhancers, both types of strong enhancer and H3K36me3 marked genic enhancers) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). To take into account protein-coding variant and conserved sequence effects, we also included CoDing exon Sequence (CDS) (<xref ref-type="bibr" rid="bib5">Carlson and Maintainer, 2015</xref>) and CONServed sequence (CONS) (<xref ref-type="bibr" rid="bib37">Lindblad-Toh et al., 2011</xref>) as additional annotations which were previously found to be strongly enriched for T2D GWAS signal (<xref ref-type="bibr" rid="bib16">Finucane et al., 2015</xref>). We observed significant enrichment for CDS and CONS sequence in the single state results (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). FGWAS multi-feature analyses for T2D, incorporating all annotations positive in single-element analyses, retained both subclasses of strong enhancer, the subclass of open weak enhancers, genic enhancers and CDS in the joint model (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and Materials and methods). Conserved sequence annotations were not retained in the joint model.</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.016</object-id><label>Table 1.</label><caption><title>Single FGWAS annotation enrichment in T2D and FG GWAS data.</title><p>For each chromatin state annotation the total number of sites and the single state FGWAS log2 Fold Enrichment (log2FE) in T2D and FG is shown. In addition, log2FE enrichment is also shown for CDS and CONS annotation. 95% Confidence Intervals (CI) for log2FE are shown in brackets and significantly enriched states are highlighted in bold (lower CI limit &gt;0). Parker enhancer states refer to enhancer states defined by <xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chromatin <break/>States</th><th>Total number of states</th><th>T2D log2FE <break/>(CI)</th><th>FG log2FE <break/>(CI)</th></tr></thead><tbody><tr><td>1. Active Promoter</td><td>20 k</td><td> 1.6 (-0.8 to 2.7)</td><td> 2.7 (0 to 4.1)</td></tr><tr><td>2. Weak Promoter</td><td>33 k</td><td> 1.7 (-4.8 to 2.9)</td><td> 2.7 (-0.1 to 4.2)</td></tr><tr><td>3.Transcriptional Elongation</td><td>71 k</td><td>-0.4 (-20 to 1.1)</td><td>-26.1 (-46.1 to 1.0)</td></tr><tr><td>4. Low Methylation</td><td>73 k</td><td>-1.5 (-3.1 to -0.6)</td><td>-1.7 (-4.2 to -0.3)</td></tr><tr><td>5. Closed Weak Enhancer</td><td>206 k</td><td> 1.2 (-0.1 to 2)</td><td> 1.7 (0 to 2.9)</td></tr><tr><td>6. Lowly-methylated Weak Enhancer</td><td>78 k</td><td>-0.5 (-20 to 1.6)</td><td>-26.7 (-46.7 to 1.6)</td></tr><tr><td>7. Open Weak Enhancer</td><td>38 k</td><td> <bold>3.4 (2.5 to 4.2)</bold></td><td> 3.1 (-0.6 to 4.6)</td></tr><tr><td>8. Closed Strong Enhancer</td><td>110 k</td><td> <bold>2.7 (1.8 to 3.4)</bold></td><td> <bold>3.3 (2 to 4.4)</bold></td></tr><tr><td>9. Open Strong Enhancer</td><td>32 k</td><td> <bold>3.8 (3.1 to 4.5)</bold></td><td> <bold>4.3 (2.8 to 5.5)</bold></td></tr><tr><td>10. Genic Enhancer</td><td>39 k</td><td> <bold>2.5 (1.3 to 3.4)</bold></td><td> <bold>2.9 (0.8 to 4.3)</bold></td></tr><tr><td>11. Accessible chromatin</td><td>14 k</td><td>-25.2 (-45.2 to 2.5)</td><td>-28.4 (-48.4 to 3.7)</td></tr><tr><td>12. Insulator</td><td>31 k</td><td> 0.9 (-20 to 2.6)</td><td>-0.6 (-20 to 3.6)</td></tr><tr><td>13. Heterochromatin</td><td>216 k</td><td> 2.3 (-20 to 3.9)</td><td> 1.8 (-1.5 to 4.0)</td></tr><tr><td>14. Polycomb Repressed</td><td>71 k</td><td>-25.5 (-45.5 to 0.9)</td><td>-33.2 (-53.2 to 1.5)</td></tr><tr><td>15. Quiescent State</td><td>1.7 k</td><td>-1.0 (-2.2 to -0.1)</td><td>-28.6 (-48.6 to -0.6)</td></tr><tr><td>CDS</td><td>NA</td><td> <bold>2.6 (1.2 to 3.5)</bold></td><td> 2.7 (-0.2 to 4.3)</td></tr><tr><td>CONS</td><td>NA</td><td> <bold>2.1 (1.1 to 2.9)</bold></td><td> <bold>1.9 (0.2 to 3.2)</bold></td></tr><tr><td>Parker Weak Enhancer</td><td>119 k</td><td> 0.9 (-2.5 to 2.0)</td><td>-2.0 (-20.0 to 2.4)</td></tr><tr><td>Parker Strong Enhancer (all)</td><td>123 k</td><td> <bold>2.7 (2.0 to 3.3)</bold></td><td> <bold>3.1 (2.0 to 4.4)</bold></td></tr><tr><td>Parker Strong Enhancer (open)</td><td>64 k</td><td> <bold>3.1 (2.4 to 3.7)</bold></td><td> <bold>3.6 (2.3 to 4.8)</bold></td></tr><tr><td>Parker Strong Enhancer (closed)</td><td>59 k</td><td> <bold>1.9 (0.8 to 2.7)</bold></td><td> <bold>2.3 (0.5 to 3.5)</bold></td></tr></tbody></table></table-wrap><p>We observed markedly different levels of enrichment for T2D association between and within open and closed enhancer states (<xref ref-type="fig" rid="fig3">Figure 3B–3C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Using these augmented chromatin state maps, we demonstrated clear enrichment for T2D association for the subset of ‘open’ weak enhancers (12% of all weak enhancer sites) with no evidence of enrichment in the remaining subclasses (‘closed’ and ‘lowly-methylated’) (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). This concentration of enrichment amongst a relatively small subset of the weak enhancers was consistent with the lack of enrichment across all weak enhancers defined solely on the basis of H3K4me1 signal ([<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>], single state log<sub>2</sub>FE = 0.9, CI = −2.5 to 2.0, <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). We also saw differences in enrichment signal between open and closed strong enhancers, with the most marked enrichment amongst open strong enhancers (22% of the total, <xref ref-type="fig" rid="fig3">Figure 3B–C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). This effect was particularly obvious in the joint-analysis (open strong enhancer joint log<sub>2</sub>FE = 4.1, CI = 3.3 to 4.8 vs. closed strong enhancer joint log<sub>2</sub>FE = 2.4, CI = 0.5 to 3.3, <xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>Hypomethylation and open chromatin are highly correlated, but the observed difference in T2D enrichment between the weak enhancer states (particularly between ‘lowly-methylated’ and ‘open’ which differ markedly with respect to chromatin status) points to a primary role for open chromatin. To test this further, we regenerated chromatin state maps using different subsets of the data (ChIP-only, with optional addition of methylation and/or open chromatin information, see Materials and methods and <xref ref-type="fig" rid="fig3s1">Figure 3-figure supplement 1A-B</xref>). These analyses confirmed that the T2D GWAS enrichment signal was predominantly driven by the distribution of islet open chromatin (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>).</p><p>We further evaluated the role of subclasses of DNA methylation regulatory region with respect to T2D GWAS enrichment. We divided hypomethylated (&lt;60% methylated) sequence into enhancer-like LMRs (6.5% of all hypomethylated sequence), promoter-like UMRs (7.5% of hypomethylated sequence), as well as PMDs (61% of hypomethylated sequence). The remaining 25% of hypomethylated sequence did not fit any category. LMRs were significantly (lower CI limit &gt;0) enriched (log<sub>2</sub>FE = 3.2, CI = 2.3 to 3.9) for T2D association signals consistent with their co-localisation with distal regulatory elements, and displayed modestly increased enrichment compared to enhancer states derived from ChIP-seq alone (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). In contrast, no significant enrichment was found for human islet (promoter-like) UMRs (log<sub>2</sub>FE = 1.4, CI = −0.6 to 2.5) or PMDs (log<sub>2</sub>FE = −0.8, CI = −1.7 to −0.1). We also found no evidence that recently-described regions of T2D-associated differential methylation (dDMRs: derived from comparison of WGBS data from islets of diabetic and non-diabetic individuals) were enriched for genome-wide T2D association signals (log<sub>2</sub>FE = −24.6, CI = −44.6 to 3.7) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>).</p><p>Finally, since the hypomethylation signal for T2D enrichment was concentrated in LMRs (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>), we reran a FGWAS joint-analysis combining open chromatin peaks, LMRs and ChIP-only states using a nested model (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D–E</xref>, see Materials and methods). This confirmed that the improvement in enrichment was mainly driven by open chromatin but showed that LMRs also contributed significantly and independently to the enrichment (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>).</p><p>FGWAS analysis for FG corroborated the observations from T2D analysis. Despite reduced power of the FG GWAS data due to a lower number of significantly associated FG GWAS loci, both single feature and joint-model analyses of human islet epigenome data found significant enrichment in strong enhancer states with the strongest enrichment in enhancers with open chromatin and hypomethylation (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–B</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). In addition, evaluation of the relative contributions of ATAC-seq open chromatin and DNA methylation to FG GWAS enrichment across both single-feature (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C–D</xref>) and joint-model analysis (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E–F</xref> and <xref ref-type="supplementary-material" rid="fig3sdata3">Figure 3—source data 3</xref>) indicated that open chromatin was primarily responsible for the enhanced enrichment.</p><p>Overall, these analyses demonstrate that the addition of open chromatin and DNA methylation data to ChIP-seq marks enhances the resolution of regulatory annotation for human islets. In particular, it defines subsets of weak and strong enhancers that differ markedly with respect to the impact of genetic variation on T2D risk. Although DNA accessibility and hypomethylation status are strongly correlated and provide broadly similar enrichments, the effects of the former predominate. In line with the dominance of open chromatin status for T2D GWAS enrichment, we observed that T2D risk in relation to methylation status is primarily invested in hypomethylated LMRs (i.e. enhancers) rather than UMRs, dDMRs or PMDs.</p></sec><sec id="s2-4"><title>Augmented chromatin maps and open chromatin allelic imbalance refine likely causal variants at <italic>ADCY5, CDC123,</italic> and <italic>KLHDC5</italic></title><p>We next deployed the insights from the global FGWAS enrichment analyses to define the molecular mechanisms at individual T2D susceptibility loci, refining T2D causal variant localisation using the combination of genetic data (from fine-mapping) and the genome-wide patterns of epigenomic enrichment.</p><p>Specifically, we applied FGWAS to the T2D DIAGRAM GWAS data (<xref ref-type="bibr" rid="bib54">Scott et al., 2017</xref>) under the joint model (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) derived from the augmented chromatin state maps. We divided the genome into 2327 segments (average size 5004 SNPs or 1.2 Mb) and identified 52 segments significantly associated with T2D genome-wide (segmental FGWAS PPA &gt;= 0.9 or single variant GWAS p&lt;5×10<sup>−8</sup>, see Materials and methods for details). These corresponded to 49 known T2D associated regions representing that subset of the ~120 known T2D GWAS loci which passed those significance/filtering criteria in this European-only dataset. We then calculated reweighted PPAs for each variant within each segment and generated reweighted 99% credible sets. (Of note, in line with traditional GWAS nomenclature, locus names were defined based on proximity between the lead variant and the closest gene and does not, of itself, indicate any causal role for the gene in T2D susceptibility).</p><p>Consistent with the increased T2D GWAS enrichment of states including open chromatin and DNA methylation information, we found that analyses using enrichments from the augmented chromatin state model (combining ChIP-seq, ATAC-seq and WGBS data) were associated with smaller 99% credible sets (median of 17 SNPs) than those derived from FGWAS enrichment derived from ChIP-seq data alone (median 23). In parallel, the PPA for the best variant per locus increased (median 0.39 vs 0.31). Individual T2D GWAS locus results are shown in <xref ref-type="fig" rid="fig4">Figure 4A–B</xref>. We also expanded the FGWAS PPA analysis to investigate open chromatin and DNA methylation effects on fine-mapping and found that the reduction in 99% credible set size and increase in maximum variant PPA was driven predominantly by open chromatin (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). This demonstrates that the inclusion of open chromatin maps helps to improve prioritisation of causal variants at many T2D GWAS loci.</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.017</object-id><label>Figure 4.</label><caption><title>Evaluating Posterior Probabilities (PPA) derived from the FGWAS maximum likelihood model at significant T2D GWAS loci.</title><p>(<bold>A</bold>) Per locus the difference in the number of 99% credible set variants between ChIP +ATAC + Meth and ChIP-only model is shown (positive values indicate a reduction in the number of 99% credible set variants in the ChIP+ATAC+Meth model). (<bold>B</bold>) Per locus the difference in the maximum single variant PPA between the ChIP +ATAC + Meth and ChIP-only model is shown (positive values indicate an increase in the maximum single variant PPA in the ChIP +ATAC + Meth model). (<bold>C</bold>) T2D GWAS loci were classified into insulin secretion (ISR), insulin resistance (IR) or unclassified loci based on genetic association with physiological traits derived from <xref ref-type="bibr" rid="bib10">Dimas et al. (2014)</xref> and <xref ref-type="bibr" rid="bib64">Wood et al. (2017)</xref>. In addition, loci with known role in islet genomic regulation or function are highlighted in bold. These include loci with islet eQTLs (<italic>ZMIZ1, CDC123</italic>) and mQTLs (<italic>WFS1, KCNJ11</italic>). (<bold>D</bold>) Identification of T2D GWAS loci and variants enriched for enhancer chromatin states using FGWAS PPA. Per locus the highest PPA variant is shown (y-axis) and the number of variants with PPA &gt;0.01 (x-axis). Loci with high PPA variants (min PPA &gt;0.1, dashed horizontal line) that overlap one of the enhancer states (green) are highlighted and the high PPA variants (PPA &gt;0.1) were tested for allelic imbalance in open chromatin.</p><p><supplementary-material id="fig4sdata1"><object-id pub-id-type="doi">10.7554/eLife.31977.019</object-id><label>Figure 4—source data 1.</label><caption><title>Comparison of variant variant PPA and 99% credible set size across annotations.</title><p>For each set of annotations used the median segment top variant PPA (thigher values indicate better performance), the median segment 99% credible set size (lower values indicate better performance) and the number of significant segments (higher number indicates better performance) is shown. Significant loci were defined solely on a combined segmental PPA of at least 0.90.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31977-fig4-data1-v2.docx"/></supplementary-material> </p><p><supplementary-material id="fig4sdata2"><object-id pub-id-type="doi">10.7554/eLife.31977.020</object-id><label>Figure 4—source data 2.</label><caption><title>Information for variants overlapping a genomic annotation included in the FGWAS T2D-joint model.</title><p>For each variant that overlaps a genomic annotation included in FGWAS T2D-joint model the following information is provided: rsID; FGWAS PPA; T2D GWAS P-value; FGWAS segment number; T2D locus name; tested for allelic imbalance (Yes/No). If available, the following eQTL information from <xref ref-type="bibr" rid="bib58">Varshney et al. (2017)</xref> is shown as well: eQTL allele1 (effector), eQTL allele 2, eQTL q-value, eQTL effect and eQTL gene.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-31977-fig4-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.018</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Evaluating annotation effect on Posterior Probabilities (PPA) derived from the FGWAS maximum likelihood model at significant T2D GWAS loci.</title><p>(<bold>A</bold>) Violin plot showing the distribution of 99% credible set variant size (y-axis, log10 scale) of different annotation types used (x-axis, ChIP-only, ChIP + Meth, ChIP + ATAC, ChIP +ATAC + Meth, ATAC-only and LMR-only model). (<bold>B</bold>) Violin plot showing the distribution in the maximum single variant PPA (y-axis) of different annotation types used (x-axis, ChIP-only, ChIP + Meth, ChIP + ATAC, ChIP +ATAC + Meth, ATAC-only and LMR-only model). Dots indicate mean value. (<bold>C</bold>) Median 99% credible set variant size (x-axis) and median top variant PPA (y-axis) information for ChIP-only, ChIP + Meth, ChIP + ATAC, ChIP + ATAC + Meth, ATAC-only and LMR-only models.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig4-figsupp1-v2"/></fig></fig-group><p>A subset of T2D GWAS signals are known to influence T2D risk through a primary effect on insulin secretion, whilst others act primarily through insulin resistance. We used previous categorisations of T2D GWAS loci based on the patterns of association with quantitative measurements of metabolic function and anthropometry (<xref ref-type="bibr" rid="bib64">Wood et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Dimas et al., 2014</xref>), to define a set of 15/48 loci most clearly associated with deficient insulin secretion (and therefore most likely to involve islet dysfunction). At 11 of these 15 loci, we found that islet ‘open strong enhancer’ states, and to a lesser extent ‘open weak enhancer’ and ‘closed strong enhancer’, captured more than 60% of the PPA (median 92%, <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Variants in these islet enhancer subclasses also captured at least 95% of the PPA at 4 T2D GWAS loci that could not be classified according to physiological association data but which have been previously implicated in human islet genome or functional regulation based on islet eQTL (<xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>) or mQTL (<xref ref-type="bibr" rid="bib45">Olsson et al., 2014</xref>) data (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, genes highlighted in bold). In contrast, at 3/6 of the insulin resistance and all but five unclassified loci, the PPA was mostly (&gt;50%) attributable to other non-islet enhancer states (across all insulin resistance and unclassified loci, DNA not overlapping islet enhancers and defined as ‘Other’ capture a median PPA of 64%). Thus, islet regulatory annotations are particularly useful for fine-mapping T2D GWAS loci that affect insulin secretion and beta-cell function.</p><p>To obtain additional evidence to support the localisation of causal variants, we tested for allelic imbalance in ATAC-seq open chromatin data. We selected 54 variants within 33 T2D-associated GWAS segments for testing of allelic imbalance on the basis of (a) a reweighted variant PPA &gt;= 10% and (b) overlap with an enriched regulatory state within the FGWAS T2D joint-model (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>). Of these, 20 variants (at 16 loci) had sufficient numbers of heterozygous samples (&gt;2) and ATAC-seq read depth (depth &gt;9 and at least five reads for each allele). After correcting for mapping bias using WASP, we observed the strongest evidence for allelic imbalance (FDR &lt; 0.05) at 3 out of the 20 variants (rs11257655 near <italic>CDC123</italic> and <italic>CAMK1D</italic>, rs10842991 near <italic>KLHDC5</italic> and rs11708067 at <italic>ADCY5</italic>) (<xref ref-type="table" rid="table2">Table 2</xref>). All three overlapped refined islet open strong or open weak enhancer regions characterised by open chromatin and hypomethylation.</p><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.021</object-id><label>Table 2.</label><caption><title>T2D-associated variants with allelic imbalance in open chromatin.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Variant</th><th>Locus</th><th>DIAGRAM <break/>P-value</th><th>Fgwas <break/> T2D PPA</th><th>Allelic imbalance <break/>Allele Ratio (Allele #)</th><th>Allelic imbalance WASP P-value</th><th>Direction of effect (T2D)</th></tr></thead><tbody><tr><td> rs11708067</td><td>ADCY5</td><td>8.8E-13</td><td>0.92</td><td>0.29 <break/>(38 A VS 94 G alleles)</td><td>1.2E-06</td><td>risk allele A closed</td></tr><tr><td> rs11257655</td><td>CDC123</td><td>4.0E-08</td><td>0.95</td><td>0.39 <break/>(278 C VS 435 T alleles)</td><td>4.5E-09</td><td>risk allele T open</td></tr><tr><td> rs10842991</td><td>KLHDC5</td><td>7.3E-07</td><td>0.13</td><td>0.64 <break/>(75 C VS 43 T alleles)</td><td>4.1E-03</td><td>risk C allele open</td></tr></tbody></table></table-wrap><p>Variant rs11257655 accounts for 95% of the reweighted PPA (compared to a PPA of 20% from genetic data alone) at the <italic>CDC123/CAMK1D</italic> locus, overlaps an ‘open strong enhancer’ region (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and the risk allele correlates with increased chromatin accessibility. The same variant is in high LD (r2 = 0.82) with the lead variant for a cis-eQTL for <italic>CAMK1D</italic> in islets (<xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>). In experimental assays (<xref ref-type="bibr" rid="bib17">Fogarty et al., 2014</xref>), the T2D-risk allele has been shown to be associated with increased <italic>CAMK1D</italic> gene expression and enhanced binding of the FOXA1 and FOXA2 transcription factors. These data all point to rs11257655 as the causal variant at this locus.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.022</object-id><label>Figure 5.</label><caption><title>Epigenome Landscape of selected loci with allelic imbalance.</title><p>For each locus (<bold>A</bold>) <italic>CDC123</italic>, (<bold>B</bold>) <italic>KLHDC5</italic> and C) <italic>ADCY5</italic> the following information is shown: Variant level information (depending on the region GWAS lead SNP red, credible set black, eQTL blue and high LD SNPs with r2 &gt;0.8 black), WGBS methylation data (black, middle), four human islet ATAC-seq tracks (green, middle), islet chromatin states (from this study as well as <xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>) and <xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>) and Encode chromatin states from 9 cell types (bottom). For <italic>ADCY5</italic> 3 ATAC-seq Endoß tracks (top green) and the Capture C results in the Endoß cell line are shown as well (middle blue). Abbreviation for cell types: B-lymphoblastoid cells (GM12878), embryonic stem cells (H1 ES), erythrocytic leukaemia cells (K562), hepatocellular carcinoma cells (HepG2), umbilical vein endothelial cells (HUVEC), mammary epithelial cells (HMEC), skeletal muscle myoblasts (HSMM),normal epidermal keratinocytes (NHEK) and normal lung fibroblasts (NHLF).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31977-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31977.023</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Characterisation of likely causal mechanisms at selected loci with allelic imbalance.</title><p>(<bold>A</bold>) Predicted <italic>PAX6</italic> Transcription factor binding motif likely affected by allelic imbalance of the variant rs10842991 (highlighted in purple). (<bold>B</bold>) The <italic>ADCY5</italic> rs11708067 risk A allele was associated with increased methylation levels (y-axis, while genotypes are shown on the x-axis). (<bold>C</bold>) Chromatin Capture (Capture C) in the human beta-cell line EndoßH1 showed interactions between the <italic>ADCY5</italic> promoter (peak) and the flanking regions of the promoter. The x-axis shows the position on the chromosome in Mb while the y-axis indicates mapped reads per fragment. (<bold>D</bold>) Chromatin Capture (Capture C) in the human beta-cell line EndoßH1 focussed at the genomic region (~47 kb) near the variant rs11708067 (highlighted) and variants in high LD (r2 &gt;0.8) with it (variants are depicted as black dots). Fragments containing rs11708067 (red) or other high LD variants (dark grey) are highlighted. The x-axis shows the position on the chromosome in bp while the y-axis indicates normalised mapped reads per fragment. The two fragments with P-values have a significant (FDR &lt; 0.05) number of normalised read counts over background: The fragment with the P-value on the left (in red) contains rs11708067 while the fragment with the P-value on the right harbours rs2877716, rs6798189, rs56371916.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31977-fig5-figsupp1-v2"/></fig></fig-group><p>At <italic>KLHDC5</italic>, no clear causal variant emerged based on genetic fine-mapping data alone as the credible set contained 23 variants in high mutual LD (r<sup>2</sup> &gt;0.8, top variant PPA &lt;5%, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Of these, variants rs10771372 (genetic fine-mapping PPA = 5%), rs10842992 (genetic fine mapping PPA = 5%) and rs10842991 (genetic fine-mapping PPA = 3%) overlapped ‘open strong enhancer’ regions (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), such that their reweighted PPAs rose to 21% (rs10771372), 21% (rs10842992) and 13% (rs10842991), respectively. We observed allelic imbalance only at rs10842991 with the T2D-risk C allele showing greater chromatin accessibility (binomial p=4.1×10<sup>−3</sup>, <xref ref-type="table" rid="table2">Table 2</xref>). This variant further overlapped a predicted TFBS motif for PAX6 as determined by the software tool FIMO (<xref ref-type="bibr" rid="bib21">Grant et al., 2011</xref>): the T2D-risk allele was predicted to enhance PAX6 transcription factor binding consistent with the allelic effects on increasing chromatin accessibility (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). This strong enhancer region is almost exclusively found in islets, with strong enhancer H3K27ac states overlapping rs10842991 in only two non-islet (heart and smooth muscle) Epigenome Roadmap tissues (out of 99 tissues with 18-state chromatin state information, <xref ref-type="fig" rid="fig5">Figure 5B</xref>)(<xref ref-type="bibr" rid="bib32">Kundaje et al., 2015</xref>). Islet eQTL data (<xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>) also links rs10842991 and close proxy SNPs (including rs7960190) to islet transcription with the risk allele increasing <italic>KLHDC5</italic> expression. These data prioritise rs10842991 as the likely causal variant at the <italic>KLHDC5</italic> T2D GWAS locus, and indicate a likely molecular mechanism involving modified PAX6 transcription factor binding and an impact on <italic>KLHDC5</italic> expression and islet function.</p><p>The third example of allelic imbalance mapped to the <italic>ADCY5</italic> locus. Fine-mapping based solely on genetic data could not prioritise a distinct causal variant due to multiple variants in high LD (range for top five variants = 12–26%, <xref ref-type="fig" rid="fig5">Figure 5C</xref>). However, reweighting of variants based on epigenomic annotation clearly prioritised variant rs11708067: this SNP overlapped an ‘open weak enhancer’ and captured most of the reweighted PPA (PPA = 92%). Allelic imbalance analysis also showed that the T2D-risk A allele was associated with decreased chromatin accessibility (binomial p=1.2×10<sup>−6</sup>, <xref ref-type="table" rid="table2">Table 2</xref>). The same lead variant maps to an islet cis-eQTL and methylation QTL (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>) at which the T2D-risk allele is associated with reduced <italic>ADCY5</italic> expression and increased <italic>ADCY5</italic> gene body DNA methylation.</p><p>To further understand the role of the rs11708067 variant, we performed ATAC-seq and Next Generation Capture-C, in the glucose-responsive human beta-cell line EndoC-βH1 (n = 3). We targeted the <italic>ADCY5</italic> promoter to define distal regions interacting with the promoter, and confirmed physical contact with the hypomethylated open chromatin enhancer region harbouring rs11708067 (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). To resolve the significance of the interaction between the restriction fragment encompassing rs11708067 and the <italic>ADCY5</italic> promoter, we used the programme peakC (<xref ref-type="bibr" rid="bib9">de Wit and Geeven, 2017</xref>) (<ext-link ext-link-type="uri" xlink:href="https://github.com/deWitLab/peakC">https://github.com/deWitLab/peakC</ext-link>) to evaluate the interactions of 12 fragments covering the lead SNP rs11708067 and 15 SNPs in high LD (r2 &gt;0.8) across a region of 47 kb. After adjusting for multiple testing using FDR correction, only two fragments yielded a significant normalised read number over background. This included the open-chromatin overlapping fragment containing rs11708067 and another fragment harbouring rs2877716, rs6798189, rs56371916 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). These SNPs fall into a region that did not show evidence of open chromatin.</p><p>These findings support rs11708067 as the likely causal variant affecting islet accessible chromatin (in line with another recent study [<xref ref-type="bibr" rid="bib53">Roman et al., 2017</xref>]), and link the open and hypomethylated enhancer element in which it sits to regulation of <italic>ADCY5</italic> expression in islets.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>A key challenge in the quest to describe the molecular mechanisms through which GWAS signals influence traits of interest, involves the identification of the causal variants responsible and, given that most lie in non-coding sequence, the characterisation of the regulatory elements which they perturb. This underpins efforts to define the effector genes through which these variants operate and to reconstruct the biological networks that are central to disease pathogenesis.</p><p>Genetic and physiological studies have highlighted the singular importance of pancreatic islet dysfunction in type 2 diabetes, but epigenomic characterisation of this tissue has been limited in large-scale community projects such as ENCODE and GTEx. The present study seeks to address this deficit by describing, in unprecedented detail, genome-wide patterns of methylation and chromatin accessibility in human islet material. We have combined these data with existing islet epigenomic marks to generate a refined regulatory map which, based on the evidence of improved enrichment for T2D association signals, offers more granular annotation of functional impact.</p><p>Our data show that, for DNA methylation, the signal of T2D predisposition is primarily associated with enhancer-like LMRs rather than other categories of methylation elements including UMRs, dDMRs or PMDs. We highlight the strong correlation between islet methylation status and chromatin accessibility but demonstrate that open chromatin predominantly contributes to defining the regulatory impact associated with genetic T2D risk. Finally, we demonstrate how these enhanced epigenomic annotations, when analysed in concert with genetic fine-mapping data and information from allelic imbalance in chromatin accessibility allow us to home in on likely causal variants at T2D association signals such as those near <italic>ADCY5, CDC123</italic> and <italic>KLHDC5</italic>.</p><p>While previous studies had explored the candidacy of selected variants at the <italic>CDC123</italic> (<xref ref-type="bibr" rid="bib17">Fogarty et al., 2014</xref>) and <italic>ADCY5</italic> (<xref ref-type="bibr" rid="bib45">Olsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib26">Hodson et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>) loci with respect to islet regulation and T2D predisposition, our integrative analysis of T2D GWAS and epigenetic data has enabled a detailed and comprehensive analysis that considers the regulatory impact of all variants at these loci across multiple islet samples. Our analysis implicates the rs11257655 and rs11708067 variants as the most likely causal variants at the <italic>CDC123</italic> and <italic>ADCY5</italic> loci respectively and highlights their relationship to islet enhancer activity. The findings at <italic>ADCY5</italic> are supported by a recent paper that found allelic imbalance in H3K27 acetylation involving the rs11708067 variant in a single human islet sample, and which observed that deletion of the relevant enhancer element led to reduction in both <italic>ADCY5</italic> gene expression and insulin secretion (<xref ref-type="bibr" rid="bib53">Roman et al., 2017</xref>).</p><p>At the <italic>KLHDC5</italic> locus, local LD frustrated efforts to define the causal variant using genetic data alone, but the integration of genetic and epigenetic data pinpointed rs10842991 as the likely culprit based on its impact on chromatin accessibility in an open enhancer region. Evidence that this variant co-localises with an islet cis-eQTL signal points to <italic>KLHDC5</italic> as the likely downstream target (<xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>). Overall, our integrative approach provides useful insights into the functional mechanisms through which T2D GWAS signals operate. Our findings mirror those from other studies, which have, in various ways, and for other complex traits, combined diverse epigenomic annotations to explore the basis of genetic risk (<xref ref-type="bibr" rid="bib62">Wang et al., 2016</xref>).</p><p>The whole genome methylation data generated in the present study also allowed us to evaluate the likely contribution of previously identified T2D-associated dDMRs (<xref ref-type="bibr" rid="bib61">Volkov et al., 2017</xref>) with respect to T2D predisposition. These dDMRs, defined on the basis of observed differences in methylation between islets recovered from diabetic and non-diabetic donors, cover a substantial part of the genome, but we were able to show that only a small minority of these overlap functional islet regulatory regions. As a consequence, dDMR regions as a whole had no significant enrichment for T2D association signals. This suggests that most of the dDMR signal involves stochastic effects and/or the secondary consequences on methylation of the diabetic state. However, we cannot exclude that some of the dDMR signals are causal contributors to the diabetic phenotype either because they reflect environmental rather than genetic predisposition, or because they accelerate further perturbation of islet dysfunction as diabetes develops.</p><p>Although we provide highly detailed functional fine-mapping of T2D genetic variants to uncover causal variants, the FGWAS approach applied in this study is limited in its ability to determine the effect of multiple variants at individual loci. Specifically, FGWAS relies on the assumption of a single causal variant within each region, which may not necessarily be true for all loci. This assumption could be violated where there are multiple independent signals at a given locus, or where there are multiple (small effect size) variants on a single risk haplotype which jointly impact the phenotype. Analysis methods that combine functional fine-mapping with conditional analysis and consider LD and haplotype patterns are likely to provide a more complete overview of the causal interactions at T2D GWAS loci.</p><p>In addition, while the present study characterises islet epigenome status and variability in chromatin accessibility in substantially larger numbers of islet samples than those previously reported (<xref ref-type="bibr" rid="bib19">Gaulton et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>), the number of islet preparations for which these data were available was still limited. As a result, our power to detect allelic imbalance in chromatin accessibility was restricted to sites with common variants and relatively large effects. We anticipate that expansion of these sample numbers will extend our capacity to detect such allelic imbalance, and offer more granular insights into the relationships between genetic variation and methylation status. A further limitation is that the genomic data we analysed was generated only from islet samples from non-diabetic donors. Whilst causal inference is possible through the integration of basal epigenomic annotations with genetic data, addition of epigenomic data from islets recovered from diabetic donors has the potential to add a further dimension to such analyses, and to unravel what are likely to be complex causal relationships between genetic variants, epigenomic phenotypes and disease states (<xref ref-type="bibr" rid="bib23">Gutierrez-Arcelus et al., 2013</xref>). Finally, future work should also focus on experimental validation of likely causal variants and mechanisms e.g. differential binding of the TF PAX6 could be tested at the <italic>KLHDC5</italic> rs10842991 variant through electrophoretic mobility shift assays. Our ongoing research efforts are now concentrated on improving the fine-mapping analysis and expanding these genomic enrichment analyses in larger numbers of human islet samples from healthy and diabetic islets. By coupling the integration of these data with empirical functional studies, we expect to provide an increasingly complete description of the causal interactions between DNA methylation, chromatin state, RNA expression and T2D susceptibility.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Human pancreatic islet samples</title><sec id="s4-1-1"><title>WGBS and 450 k array human pancreatic islet sample collection</title><p>Human islets were retrieved from deceased Caucasian non-diabetic donors from the Oxford DRWF Human Islet Isolation Facility (n = 34) and at the Alberta Diabetes Institute in Edmonton in Canada (n = 10). For the analysis only samples with a purity &gt;70% were used as determined by dithizone labeling. The Human Research Ethics Board at the University of Alberta (Pro00001754), the University of Oxford's Oxford Tropical Research Ethics Committee (OxTREC Reference: 2–15), or the Oxfordshire Regional Ethics Committee B (REC reference: 09/H0605/2) approved the studies. All organ donors provided informed consent for use of pancreatic tissue in research.</p><p>For all WGBS (n = 10) and a subset of 450 k array samples (n = 18) human pancreatic islet DNA was extracted from 100,000 to 150,000 islet cells using Trizol-(Ambion from Thermo Fisher Scientific, Waltham, MA was used for islets processed in Oxford, UK while Trizol from Sigma Aldrich, St. Louis, MO was used for islets processed in Edmonton, Canada) as described previously (<xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>). For the remaining 23 samples islet DNA was extracted using the ReliaPrep gDNA Tissue Miniprep system (Promega, Madison, WI). Extracted DNA was stored at −80°C before further use.</p></sec><sec id="s4-1-2"><title>ATAC-seq human pancreatic islet sample collection</title><p>Human pancreatic islets preparations (n = 18) were retrieved from 17 deceased non-diabetic donors of European descent from the Oxford DRWF Human Islet Isolation Facility and stored for 1–3 days in CMRL or UW media. The latter were reactivated in CMRL for 1 hr before processing them further. Approximately 50,000 islet cells per sample were hand-picked and immediately processed for ATAC-seq as described previously (<xref ref-type="bibr" rid="bib3">Buenrostro et al., 2013</xref>), however, an additional round of purification was performed using Agencourt AMPure XP magnetic beads (Beckman Coulter, Brea, CA).</p></sec></sec><sec id="s4-2"><title>WGBS data generation</title><sec id="s4-2-1"><title>Bisulphite conversion</title><p>400 ng of DNA per human islet samples (n = 10) were sent as part of a collaborative effort to the Blizard Institute, Queen Mary University, London, UK and bisulphite- converted using the Ovation Ultralow Methyl-Seq DR Multiplex System 1–8 (Nugen, Manchester, UK) and purified using Agencourt AMPure beads (Beckman Coulter) as described previously (<xref ref-type="bibr" rid="bib38">Lowe et al., 2013</xref>).</p></sec><sec id="s4-2-2"><title>Library generation and processing of reads</title><p>The libraries were sequenced by members of the High-Throughput Genomics group at the Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. Samples were sequenced as multiplex libraries across 3 HiSeq2000 lanes with 100 bp paired-end read length (including a PhIX spike-in of 5%) to obtain high-coverage read data. The obtained reads were trimmed using a customized python3 script (10 bp at the start and 15 bp at the end) and aligned to hg19 using the software Bismark (settings: L,0,–0.6, version 0.12.5, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_005604">SCR_005604</ext-link>)(<xref ref-type="bibr" rid="bib31">Krueger and Andrews, 2011</xref>). Specifically, paired-end alignment of trimmed reads was performed and unmapped reads from read one were realigned using Bismark and merged with the paired-end alignment using samtools (<xref ref-type="bibr" rid="bib36">Li et al., 2009</xref>) (version 0.1.19, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002105">SCR_002105</ext-link>) in order to increase mapping efficiency. Coverage for the merged paired-end and realigned HiSeq read alignments was estimated for the human mappable genome (NCBI hg19 2.8 billion base pairs excluding gaps and unmappable and blacklisted regions according to UCSC and Encode [<xref ref-type="bibr" rid="bib13">ENCODE Project Consortium, 2012</xref>]) using bedtools (version v2.21.0) (<xref ref-type="bibr" rid="bib50">Quinlan, 2014</xref>).</p></sec><sec id="s4-2-3"><title>WGBS DNA methylation quantification and prediction of hypomethylated regulatory regions</title><p>CpG methylation levels were determined for each sample by calculating the ratio of unmodified C (methylated) and bisulphite converted T (unmethylated) alleles using BiFAST (first described here [<xref ref-type="bibr" rid="bib38">Lowe et al., 2013</xref>]). High-pass pooled WGBS data was generated by adding methylated and unmethylated read counts across individual low-pass samples to then estimate the average beta methylation levels.</p><p>Regulatory regions were identified using the R package methylseek (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006513">SCR_006513</ext-link>) (<xref ref-type="bibr" rid="bib4">Burger et al., 2013</xref>). After removing PMDs, which represent highly heterogenous methylation states determined by DNA sequence features (<xref ref-type="bibr" rid="bib18">Gaidatzis et al., 2014</xref>), LMRs (&lt;30 CpGs) and UMRs (&gt;30 CpGs) were predicted in hypomethylated regions (&lt;50%) at an FDR of 0.05. The methylation level and FDR parameter was inferred from the data as suggested by the methylseek workflow (<xref ref-type="bibr" rid="bib4">Burger et al., 2013</xref>).</p></sec></sec><sec id="s4-3"><title>450 k DNA methylation array data generation</title><p>In total, 41 samples were processed for the Illumina Infinium HumanMethylation450 BeadChip (Illumina, San Diego, CA). Of these 18 samples were bisulphite-converted and processed as part of a collaboration at the UCL Cancer Institute, University College London, London, UK while the remaining 23 samples were processed in OCDEM, University of Oxford, Oxford, UK. The DNA was bisulphite converted using the EZ DNA Methylation<sup>TM</sup> Kit ( Zymogen Research Corp, Irvine, CA) and hybridised to the Illumina 450 k array and scanned with iScan (Illumina) according to the manufacturer’s protocol.</p><p>The resulting data was analysed using the Package minfi (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_012830">SCR_012830</ext-link>) (<xref ref-type="bibr" rid="bib1">Aryee et al., 2014</xref>) and custom R scripts ([<xref ref-type="bibr" rid="bib51">R Development Core Team, 2011</xref>], R version 3.0.2, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link>). Specifically, CpG sites with a detection p-value&gt;0.01 were removed from the analysis and samples with &gt;5% of CpG sites failing this threshold (n = 9) were also removed from the analysis.</p><p>Following separate quantile normalisation of signal intensities derived from methylated and unmethylated Type I probes and Type II probes, methylation levels (ß) were estimated, based on the intensities of the methylated (M) and unmethylated (U) signal in the following way: β = M/(M + U + 100). To correct for batch effects the ComBat function implemented in the sva (<xref ref-type="bibr" rid="bib28">Johnson et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Leek et al., 2007</xref>) package was used (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p></sec><sec id="s4-4"><title>ATAC-seq data generation</title><sec id="s4-4-1"><title>Sequencing of ATAC-seq reads</title><p>ATAC-seq libraries were sequenced at the High-Throughput Genomics group which is part of the Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. Samples were sequenced as 4-6plex libraries across 1–3 Hiseq2500 lanes with 50 bp paired-end read length.</p></sec><sec id="s4-4-2"><title>Processing of ATAC-seq reads</title><p>Raw FASTQ reads were processed with an in-house pipeline (first described in (<xref ref-type="bibr" rid="bib25">Hay et al., 2016</xref>) and on the website <ext-link ext-link-type="uri" xlink:href="http://userweb.molbiol.ox.ac.uk/public/telenius/PipeSite.html">http://userweb.molbiol.ox.ac.uk/public/telenius/PipeSite.html</ext-link>). Specifically, library and sequencing quality was checked with FASTQC (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014583">SCR_014583</ext-link>) (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link>) and reads were mapped to the human genome (hg19) via bowtie (<xref ref-type="bibr" rid="bib33">Langmead et al., 2009</xref>) (version 1.1.0, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_005476">SCR_005476</ext-link>) with default settings but -m 2, and maxins 2000 which allows mapping of reads with a maximum number of 2 alignments and a maximum insert size of 2000 bp. For reads that could not be aligned the first time, adapters were removed with Trim Galore at the three prime end (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_011847">SCR_011847</ext-link>, settings -length 10, -qualFilter 20, <ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/">http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>) to enhance the chance of mapping. The resulting trimmed reads were then mapped again with bowtie. Any remaining unmapped and trimmed reads were processed with FLASH (<xref ref-type="bibr" rid="bib39">Magoč and Salzberg, 2011</xref>) (version 1.2.8, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_005531">SCR_005531</ext-link>, settings -m 9 -x 0.125) which combines overlapping read pairs and reconstructs read pairs without overlap. These are then realigned a third time using bowtie. PCR duplicates are then removed from the mapped bam files using samtools rmdup function (<xref ref-type="bibr" rid="bib36">Li et al., 2009</xref>). Additionally, all reads overlapping any of the ‘unmappable’ UCSC Duke blacklisted hg19 regions (<xref ref-type="bibr" rid="bib13">ENCODE Project Consortium, 2012</xref>) are also removed from the final bam file.</p><p>Open chromatin peaks were called through the aforementioned in-house pipeline by applying sample-specific read depth and width parameters, which were chosen based on the signal to noise ratio of a given sample.</p></sec></sec><sec id="s4-5"><title>ChIP-seq data and identification of chromatin states</title><sec id="s4-5-1"><title>Processing of available ChIP-seq data</title><p>Human islet ChIP-seq histone mark and TFBS data were obtained from various sources: H3K4me1, <italic>CTCF</italic> and H3K27ac (<xref ref-type="bibr" rid="bib47">Pasquali et al., 2014</xref>), H3K36me3 and H3K4me3 (<xref ref-type="bibr" rid="bib43">Morán et al., 2012</xref>) and H3K27me3 (<xref ref-type="bibr" rid="bib32">Kundaje et al., 2015</xref>). Available raw fastq files were aligned to hg19 using bowtie1 (version 1.1.1) with modified default settings (-m 1 which removes reads with more than one valid alignment and -n 1 which defines the maximum number of mismatches in seed) and PCR duplicates were removed from the aligned bam files with Picard tools (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006525">SCR_006525</ext-link>, v1.119, <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>). The resulting reads were converted into bed format using the bedtools bamToBed function (<xref ref-type="bibr" rid="bib50">Quinlan, 2014</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006646">SCR_006646</ext-link>, version v2.21.0) and extended by 200 bp towards the 3’ end to account for fragment size.</p></sec><sec id="s4-5-2"><title>Identification of chromatin states using chromHMM</title><p>Binarised 200 bp density maps from the bed files of the 6 ChIP-seq marks were created using a Poisson distribution implemented in the BinaryBed function of the ChromHMM software as described in (<xref ref-type="bibr" rid="bib14">Ernst and Kellis, 2012</xref>; <xref ref-type="bibr" rid="bib15">Ernst et al., 2011</xref>). From these epigenomic density maps, 11 ChIP-only chromatin states were derived using a multivariate Hidden Markov Model implemented in the Learnmodel function (standard settings, h19 genome) of the software ChromHMM (<xref ref-type="bibr" rid="bib14">Ernst and Kellis, 2012</xref>).</p><p>To generate additional sets of chromatin states based on ChIP-seq, ATAC-seq and DNA methylation data, ATAC-seq open chromatin and DNA methylation status were binarised. Specifically, ATAC-seq peaks (presence/absence) and whole-genome CpG methylation status (hypermethylation/hypomethylation based on a threshold of 60% methylation) were binarised across 200 bp windows of the genome.</p><p>These binarised 200 bp ChIP-seq, ATAC-seq and DNA methylation maps were combined and used to generate 3 sets of chromatin states derived from ChIP and DNA methylation data (ChIP +Meth), ChIP and ATAC-seq data (ChIP +ATAC) or ChIP, ATAC-seq and DNA methylation data (ChIP +ATAC + Meth) using the Learnmodel ChromHMM function (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–B</xref>). As suggested by (<xref ref-type="bibr" rid="bib15">Ernst et al., 2011</xref>), after evaluating models with up to 20 chromatin states, a 15 state model was chosen based on the resolution provided by identified states</p></sec></sec><sec id="s4-6"><title><italic>ADCY5</italic> capture C analysis and ATAC-seq in EndoC-ßH1</title><p>Next-generation Capture-C was performed in order to map physical chromatin interactions with the <italic>ADCY5</italic> promoter in EndoC-ßH1 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_L909">CVCL_L909</ext-link>) cell lines (n = 3) (see protocol in Materials and methods in [<xref ref-type="bibr" rid="bib6">Davies et al., 2016</xref>]).</p><p>In brief, chromatin conformation capture (3C) libraries were generated by formaldehyde fixation prior to DpnII restriction enzyme digestion and subsequent DNA ligation. Following cross-link reversal, DNA extraction and sonication, sequencing adapters were added to sonicated fragments (~200 bp). Library fragments were subjected to a double capture through hybridisation with a biotinylated oligonucleotide probes encompassing the <italic>ADCY5</italic> promoter and enriched using streptavidin bead pulldown. PCR amplified fragments were then sequenced through paired-end sequencing (Illumina Next-Seq). An in silico restriction enzyme digestion was performed on the set of reconstructed fragments (from paired-end sequenced reads) using the DpnII2E.pl script (<xref ref-type="bibr" rid="bib7">Davies, 2015</xref>)(<ext-link ext-link-type="uri" xlink:href="https://github.com/Hughes-Genome-Group/captureC">https://github.com/Hughes-Genome-Group/captureC</ext-link>). Uncaptured reads and PCR duplicates were removed prior to mapping to the human genome (hg19) with Bowtie (<xref ref-type="bibr" rid="bib33">Langmead et al., 2009</xref>)(v 1.1.0). Removal of PCR duplicates and classification of fragments as ‘capture’ (i.e. including the <italic>ADCY5</italic> promoter) or ‘reporter’ (outside the capture fragment on exclusion region) was performed with the CCanalyser2.pl wrapper (<xref ref-type="bibr" rid="bib7">Davies, 2015</xref>)(<ext-link ext-link-type="uri" xlink:href="https://github.com/Hughes-Genome-Group/captureC">https://github.com/Hughes-Genome-Group/captureC</ext-link>). Unique mapped interactions were normalized to the total number of <italic>cis</italic> interactions (i.e. same chromosome) per 100,000 interactions. Significant chromatin interactions were determined from a rank-sum test implemented in the program peakC (<xref ref-type="bibr" rid="bib9">de Wit and Geeven, 2017</xref>)(<ext-link ext-link-type="uri" xlink:href="https://github.com/deWitLab/peakC">https://github.com/deWitLab/peakC</ext-link>). Specifically, we evaluated interactions involving all SNPs in high LD (r2 &gt;0.8) with the lead rs11708067. The lead variant (rs11708067) was in high LD with 15 SNPs (mapping to 12 DpnII fragments) that spanned a region of 47 kb. We applied the Benjamini-Hochberg correction to control the false discovery rate for the set of p-values corresponding to each restriction fragment within the 47 kb region at the ADCY5 locus.</p><p>In addition, ATAC-seq was performed in 50,000 cells of EndoC-ßH1 cell lines (n = 3) and the data was analysed in the same way as described above for human islet samples.</p><p>Endo-βH1 cells were obtained from Endocells and have been previously authenticated (<xref ref-type="bibr" rid="bib52">Ravassard et al., 2011</xref>). In addition, the cell line was tested and found negative for mycoplasma contamination.</p></sec><sec id="s4-7"><title>Overlaying generated epigenomic datasets generated here with other genomic regulatory regions</title><p>CpG sites and/or hypomethylated regulatory regions identified from the WGBS and/or 450 k array data were overlapped with existing islet chromatin state maps (<xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>), islet transcription factor binding sites (<italic>FOXA2, MAFB, NKX2.2, NKX6.1, PDX1</italic>), T2D-associated islet dDMRs (<xref ref-type="bibr" rid="bib8">Dayeh et al., 2014</xref>) and eQTLs (<xref ref-type="bibr" rid="bib56">van de Bunt et al., 2015</xref>). Similarly, ATAC-seq open chromatin peaks generated here were overlapped with publicly available ATAC-seq peaks (<xref ref-type="bibr" rid="bib58">Varshney et al., 2017</xref>).</p><p>In addition, we also obtained the 850 k array manifest file to determine overlap of 850 k array CpG sites with GWAS credible set regions (<ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/downloads/infinium-methylationepic-v1-0-product-files.html">https://support.illumina.com/downloads/infinium-methylationepic-v1-0-product-files.html</ext-link>).</p></sec><sec id="s4-8"><title>Genetic datasets used in this study</title><p>Credible sets from the DIAGRAM (<xref ref-type="bibr" rid="bib54">Scott et al., 2017</xref>)(involving 26.7 k cases and 132.5 k controls of predominantly European origin, imputed to the 1000G March 2012 reference panel) and ENGAGE (<xref ref-type="bibr" rid="bib27">Horikoshi et al., 2015</xref>)(including 46.7 k individuals, imputed to the 1000G March 2012 reference panel) consortium were used to compare the ability of the 450 k, 850 k and WGBS methylation array to interrogate T2D and FG GWAS regions.</p><p>The DIAGRAM and ENGAGE GWAS SNP summary level data was used for the FGWAS analysis to determine enrichment of regulatory annotations in T2D and FG GWAS signal.</p><p>Furthermore, data from (<xref ref-type="bibr" rid="bib64">Wood et al., 2017</xref>) and (<xref ref-type="bibr" rid="bib10">Dimas et al., 2014</xref>) were used to categories T2D GWAS loci into physiological groups of insulin secretion, insulin resistance or unclassified loci.</p></sec><sec id="s4-9"><title>Statistical and computational analysis</title><sec id="s4-9-1"><title>Enrichment analysis of identified regulatory annotations in other genomic annotations</title><p>Enrichment of hypomethylated regulatory regions (LMRs and UMRs, result section 2.2.) and ATAC-seq open chromatin peaks (result section 2.3) in the aforementioned genomic annotations (method section 4.6) was determined through 100,000 random permutations. P-values and fold enrichment was determined by comparing the true overlap results to the permuted overlap results. The resulting P-values were multiple testing corrected using Bonferroni correction (an adjusted p-value&lt;0.05 was considered significant).</p></sec><sec id="s4-9-2"><title>FGWAS enrichment analysis</title><p>FGWAS (<xref ref-type="bibr" rid="bib48">Pickrell, 2014</xref>) (version 0.3.6) applied a hierarchical model that determined shared properties of loci affecting a trait. The FGWAS model used SNP-based GWAS summary level data and divided the genome into windows (setting ‘k’=5000 which represents the number of SNPs per window), which are larger than the expected LD patterns in the population. The model assumed that each window either contained a single SNP that affected the trait or that there was no SNP in the window that influenced the trait. The model estimated the prior probability of a window to contain an association and the conditional prior probability that a SNP within the window was the causal variant. These prior probabilities were variable, dependent on regional annotations and estimated based on enrichment patterns of annotations across the genome using a Bayes approach.</p><sec id="s4-9-2-1"><title>FGWAS single state analysis</title><p>FGWAS was used with standard settings to determine enrichment of individual islet chromatin states, LMRs, UMRs, PMDS and ATAC-seq open chromatin peaks, CDS and CONS sequence in DIAGRAM (setting ‘cc’ was applied for use with T2D-case-control GWAS data) and ENGAGE GWAS SNP summary level data.</p><p>For each individual annotation, the model provided maximum likelihood enrichment parameters and annotations were considered as significantly enriched if the parameter estimate and 95% CI was above zero.</p></sec><sec id="s4-9-2-2"><title>FGWAS joint model analysis</title><p>To determine the maximum likelihood model the following approach suggested by (<xref ref-type="bibr" rid="bib48">Pickrell, 2014</xref>) was used for each set of chromatin states (ChIP-only, ChIP +ATAC, ChIP +Meth and ChIP +ATAC + Meth), separately. In addition, CDS and CONS sequenced were used as well for each set of chromatin states in the joint analysis. Firstly, a model was fitted for each annotation individually to identify all annotations that were significantly enriched with the trait. Secondly, the annotation with the highest increase (and enrichment) in the maximum log-likelihood was added to the model and the analysis was repeated with the additional annotation. Thirdly, annotations were added as long as they increase the maximum log-likelihood of the newly tested model. Fourthly, a 10-fold cross-validation approach was used after determining a penalty parameter based on the maximum likelihood of a penalised log-likelihood function to avoid overfitting. Fifthly, each annotation was dropped from the model and the maximum cross-validation likelihood was evaluated. If a reduced model has a higher cross-validation maximum likelihood, additional annotations are dropped until the model cannot be further improved. This model was described as the best fitted model and used for the remaining analysis. The maximum likelihood enrichment parameters and 95% CI for each annotation of the best model were reported (independent of significance).</p></sec><sec id="s4-9-2-3"><title>Comparing FGWAS enrichment parameter across chromatin states</title><p>Initially, similar enhancer chromatin states derived from the four different ChromHMM analyses (ChIP-only, ChIP + ATAC, ChIP + Meth, ChIP + ATAC + Meth) were compared. Similarity was determined based on shared histone chromatin marks according to the chromHMM emission parameters. Further comparisons between the ChIP-only and ChIP + ATAC + Meth model were performed based on the reweighted FGWAS maximum variant PPA and the number of reweighted 99% credible set variants per T2D locus (for details regarding FGWAS PPA see next section).</p><p>However, considering that the chromatin states were derived from distinct sets of annotations across different analyses of ChromHMM, a direct comparison was not fully possible. Hence, a nested model approach was used to further dissect the contribution of open chromatin and DNA methylation to the enrichment. Specifically, an FGWAS analysis was performed that combined the ChIP-only chromHMM states with raw LMRs (representing DNA methylation) and ATAC-seq peaks (representing open chromatin). After determining the best maximum-likelihood cross-validation model (combining ChIP-only, ATAC-seq and LMR states) a nested model and log-likelihood ratio test were used to determine the contribution of each annotation to the model (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>).</p></sec></sec><sec id="s4-9-3"><title>Reweighting of variant PPA and testing of allelic imbalance</title><p>The enrichment priors derived from the FGWAS maximum likelihood model were used as a basis for evaluating both the significance and functional impact of associated variants in GWAS regions; allowing variants that map into annotations that show global enrichment to be afforded extra weight.</p><p>Specifically, variants at significant GWAS regions with a high FGWAS PPA (PPA &gt;= 10%) and overlapping open enhancer states were prioritised for further follow-up. Genome-wide significance of loci was determined based on P-values (p&lt;5×10<sup>−8</sup>) or a regional FGWAS PPA &gt;= 90% (representing the sum of the PPAs of all SNPs in a given region). The latter threshold is based on a recommendation from (<xref ref-type="bibr" rid="bib48">Pickrell, 2014</xref>) who observed that a regional PPA of 90% or above can be used to identify sub-threshold GWAS loci.</p><p>Of the prioritised variants, only variants with at least two heterozygous samples and ATAC-seq read depth of at least nine reads (minimum five reads for each allele) were tested for allelic imbalance.</p><p>To avoid read-mapping and reference allele bias the software WASP (<xref ref-type="bibr" rid="bib57">van de Geijn et al., 2015</xref>)(Version 0.2261) was used to remove reads associated with mapping bias. In short, reads of the unfiltered bam file that overlapped the variant of interest were identified. For each read overlapping an SNP, the genotype of that SNP was changed to the alternative allele and the read was remapped using bwa (<xref ref-type="bibr" rid="bib35">Li and Durbin, 2009</xref>) (version 0.5.8 c). Any read that failed to realign in the same position in the genome was discarded. Ultimately, PCR duplicates were filtered using the WASP ‘rmdup_pe.py’ script, which removed duplicated reads randomly (independent of the mapping score) to avoid any bias.</p><p>Allelic imbalance was determined using a binomial test as implemented in R.</p></sec><sec id="s4-9-4"><title>Identification of TFBS at SNPs that display allelic imbalance</title><p>The tool ‘Fimo’(<xref ref-type="bibr" rid="bib21">Grant et al., 2011</xref>) implemented in the ‘meme’ software package (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001783">SCR_001783</ext-link>) was applied to identify TF motifs that significantly (FDR &lt; 0.05) matched the sequence overlapping a SNP variant showing allelic imbalance (20 bp up and downstream).</p></sec><sec id="s4-9-5"><title>Overlap of regulatory regions</title><p>Overlap between genomic regulatory regions was performed using bedtools intersectBed function (<xref ref-type="bibr" rid="bib50">Quinlan, 2014</xref>) (version 2.21.0). Summary statistics across 200 bp windows were determined using bedtools mapBed function. Random permutations of regulatory regions were performed by applying the bedtools shuffleBed function.</p></sec><sec id="s4-9-6"><title>Statistical analysis</title><p>All statistical analysis (unless otherwise stated) was performed using R (version 3.0.2) including Spearman’s correlation analysis to compare the 450 k and WGBS array, the KS-test to compare 450 k and WGBS DNA methylation distributions, the binomial test to evaluate allelic imbalance and principal component analysis to identify batch effects in the 450 k data. Significance is defined as p&lt;0.05 unless otherwise stated.</p></sec><sec id="s4-9-7"><title>Visualisation and figure generation</title><p>All figures unless otherwise stated were generated using R (version 3.0.2) and/or ggplot2(<xref ref-type="bibr" rid="bib63">Wickham, 2009</xref>). <xref ref-type="fig" rid="fig1">Figure 1E</xref> was generated using locuszoom (<xref ref-type="bibr" rid="bib49">Pruim et al., 2010</xref>). Chromatin state CHiP-seq enrichment maps (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–B</xref>) were generated using chromHMM (<xref ref-type="bibr" rid="bib14">Ernst and Kellis, 2012</xref>). The genome-browser views (<xref ref-type="fig" rid="fig5">Figure 5</xref>) were generated using the UCSC genome browser tool (<xref ref-type="bibr" rid="bib30">Kent et al., 2002</xref>).</p></sec></sec><sec id="s4-10"><title>Sequencing data</title><p>ATAC-seq and WGBS sequencing data has been deposited at the EBI hosted European Genome-phenome Archive (EGA, <ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/">https://ega-archive.org/</ext-link>) and is accessible via the EGA accession numbers: EGAS00001002592, EGAD00001003946 and EGAD00001003947.</p></sec></sec></body><back><ack id="ack"> <title>Acknowledgements</title> <p>We thank the High-Throughput Genomics Group at the Wellcome Centre for Human Genetics (funded by Wellcome grant reference 090532) for the generation of the Sequencing data. MT was supported by a Wellcome Doctoral Studentship. MvdB was supported by a Novo Nordisk postdoctoral fellowship run in partnership with the University of Oxford. JMT is supported by Wellcome Strategic Award. VN is funded by the European Union Horizon 2020 Programme (T2DSYSTEMS). SB was supported by a Royal Society Wolfson Research Merit Award (WM100023). ALG is a Wellcome Senior Fellow in Basic Biomedical Science (095101/Z/10/Z and 200837/Z/16/Z) and MIM is a Wellcome Senior Investigator. The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). This work was also supported by EU (HEALTH-F4-2007-201413), Wellcome (090367, 090532, 106130, 098381 and 099673/Z/12/Z) and NIH (U01-DK105535, U01-DK085545, R01-DK098032 and R01-MH090941) grants. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Formal analysis, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con9"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con10"><p>Data curation, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Data curation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Data curation, Writing—review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Data curation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The Human Research Ethics Board at the University of Alberta (Pro00001754), the University of Oxford's Oxford Tropical Research Ethics Committee (OxTREC Reference: 2-15), or the Oxfordshire Regional Ethics Committee B (REC reference: 09/H0605/2) approved the studies. All organ donors provided informed consent for use of pancreatic tissue in research.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.31977.024</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-31977-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="https://ega-archive.org/datasets/EGAD00001003947" source-id-type="uri"><collab collab-type="author">Matthias Thurner</collab><collab collab-type="author">Anna L Gloyn</collab><collab collab-type="author">Mark I McCarthy</collab><year>2017</year><source>Islet open chromatin data</source><ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/datasets/EGAD00001003947">https://ega-archive.org/datasets/EGAD00001003947</ext-link><comment>Available through controlled access at the EGA website (study accession: EGAS00001002592 and dataset accession: EGAD00001003947)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset2" source-id="https://ega-archive.org/datasets/EGAD00001003946" source-id-type="uri"><collab collab-type="author">Matthias Thurner</collab><collab collab-type="author">Anna L Gloyn</collab><collab collab-type="author">Mark I McCarthy</collab><year>2017</year><source>Islet DNA methylation data</source><ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/datasets/EGAD00001003946">https://ega-archive.org/datasets/EGAD00001003946</ext-link><comment>Available through controlled access at the EGA website (study accession: EGAS00001002592 and dataset accession: EGAD00001003946)</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataset3" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1294/" source-id-type="uri"><collab collab-type="author">Morán I</collab><collab collab-type="author">Akerman I</collab><collab collab-type="author">van de Bunt M</collab><collab collab-type="author">Xie R</collab><collab collab-type="author">Benazra M</collab><collab collab-type="author">Nammo T</collab><collab collab-type="author">Arnes L</collab><collab collab-type="author">Nakić N</collab><collab collab-type="author">García-Hurtado J</collab><collab collab-type="author">Rodríguez-Seguí S</collab><collab collab-type="author">Pasquali L</collab><collab collab-type="author">Sauty-Colace C</collab><collab collab-type="author">Beucher A</collab><collab collab-type="author">Scharfmann R</collab><collab collab-type="author">van Arensbergen J</collab><collab collab-type="author">Johnson PR</collab><collab collab-type="author">Berry A</collab><collab collab-type="author">Lee C</collab><collab collab-type="author">Harkins T</collab><collab collab-type="author">Gmyr V</collab><collab collab-type="author">Pattou F</collab><collab collab-type="author">Kerr-Conte J</collab><collab collab-type="author">Piemonti L</collab><collab collab-type="author">Berney T</collab><collab collab-type="author">Hanley N</collab><collab collab-type="author">Gloyn AL</collab><collab collab-type="author">Sussel L</collab><collab collab-type="author">Langman L</collab><collab collab-type="author">Brayman KL</collab><collab collab-type="author">Sander M</collab><collab collab-type="author">McCarthy MI</collab><collab collab-type="author">Ravassard P</collab><collab collab-type="author">Ferrer J</collab><year>2012</year><source>Transcription profiling by high throughput sequencing of human and mouse pancreatic islet-cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1294/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1294/</ext-link><comment>Available from Array Express (accession no: E-MTAB-1294)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset4" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312" source-id-type="uri"><collab collab-type="author">Parker SC</collab><collab collab-type="author">Stitzel ML</collab><collab collab-type="author">Taylor DL</collab><collab collab-type="author">Orozco JM</collab><collab collab-type="author">Erdos MR</collab><collab collab-type="author">Akiyama JA</collab><collab collab-type="author">van Bueren KL</collab><collab collab-type="author">Chines PS</collab><collab collab-type="author">Narisu N</collab><collab collab-type="author">NISC Comparative Sequencing Program</collab><collab collab-type="author">Black BL</collab><collab collab-type="author">Visel A</collab><collab collab-type="author">Pennacchio LA</collab><collab collab-type="author">Collins FS</collab><year>2013</year><source>Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312</ext-link><comment>Available from NCBI GEO (accession no: GSE51312)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset5" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1919/" source-id-type="uri"><collab collab-type="author">Pasquali L</collab><collab collab-type="author">Gaulton KJ</collab><collab collab-type="author">Rodríguez-Seguí SA</collab><collab collab-type="author">Mularoni L</collab><collab collab-type="author">Miguel-Escalada I</collab><collab collab-type="author">Akerman I</collab><collab collab-type="author">Tena JJ</collab><collab collab-type="author">Morán I</collab><collab collab-type="author">Gómez-Marín C</collab><collab collab-type="author">van de Bunt M</collab><collab collab-type="author">Ponsa-Cobas J</collab><collab collab-type="author">Castro N</collab><collab collab-type="author">Nammo T</collab><collab collab-type="author">Cebola I</collab><collab collab-type="author">García-Hurtado J</collab><collab collab-type="author">Maestro MA</collab><collab collab-type="author">Pattou F</collab><collab collab-type="author">Piemonti L</collab><collab collab-type="author">Berney T</collab><collab collab-type="author">Gloyn AL</collab><collab collab-type="author">Ravassard P</collab><collab collab-type="author">Gómez-Skarmeta JL</collab><collab collab-type="author">Müller F</collab><collab collab-type="author">McCarthy MI</collab><collab collab-type="author">Ferrer J</collab><year>2014</year><source>Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1919/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1919/</ext-link><comment>Available from Array Express (accession no: E-MTAB-1919)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset6" source-id="http://www.roadmapepigenomics.org/" source-id-type="uri"><collab collab-type="author">Roadmap Epigenomics Consortium</collab><collab collab-type="author">Kundaje A</collab><collab collab-type="author">Meuleman W</collab><collab collab-type="author">Ernst J</collab><collab collab-type="author">Bilenky M</collab><collab collab-type="author">Yen A</collab><collab collab-type="author">Heravi-Moussavi A</collab><collab collab-type="author">Kheradpour P</collab><collab collab-type="author">Zhang Z</collab><collab collab-type="author">Wang J</collab><collab collab-type="author">Ziller MJ</collab><collab collab-type="author">Amin V</collab><collab collab-type="author">Whitaker JW</collab><collab collab-type="author">Schultz MD</collab><collab collab-type="author">Ward LD</collab><year>2015</year><source>Integrative analysis of 111 reference human epigenomes</source><ext-link ext-link-type="uri" xlink:href="http://www.roadmapepigenomics.org/">http://www.roadmapepigenomics.org/</ext-link><comment>Available from Epigenome Roadmap website</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset7" source-id="http://diagram-consortium.org/2015_ENGAGE_1KG/" source-id-type="uri"><collab collab-type="author">Horikoshi M</collab><collab collab-type="author">Magi R</collab><collab collab-type="author">van de Bunt M</collab><collab collab-type="author">Surakka I</collab><collab collab-type="author">Sarin AP</collab><collab collab-type="author">Mahajan A</collab><collab collab-type="author">Marullo L</collab><collab collab-type="author">Thorleifsson G</collab><collab collab-type="author">Hagg S</collab><collab collab-type="author">Hottenga JJ</collab><collab collab-type="author">Ladenvall C</collab><collab collab-type="author">Ried JS</collab><collab collab-type="author">Winkler TW</collab><collab collab-type="author">Willems SM</collab><collab collab-type="author">Pervjakova N</collab><collab collab-type="author">Esko T</collab><collab collab-type="author">Beekman M</collab><collab collab-type="author">Nelson CP</collab><collab collab-type="author">Willenborg C</collab><collab collab-type="author">Wiltshire S</collab><collab collab-type="author">Ferreira T</collab><collab collab-type="author">Fernandez J</collab><collab collab-type="author">Gaulton KJ</collab><collab collab-type="author">Steinthorsdottir V</collab><collab collab-type="author">Hamsten A</collab><collab collab-type="author">Magnusson PK</collab><collab collab-type="author">Willemsen G</collab><collab collab-type="author">Milaneschi Y</collab><collab collab-type="author">Robertson NR</collab><collab collab-type="author">Groves CJ</collab><collab collab-type="author">Bennett AJ</collab><collab collab-type="author">Lehtimaki T</collab><collab collab-type="author">Viikari JS</collab><collab collab-type="author">Rung J</collab><collab collab-type="author">Lyssenko V</collab><collab collab-type="author">Perola M</collab><collab collab-type="author">Heid IM</collab><collab collab-type="author">Herder C</collab><collab collab-type="author">Grallert H</collab><collab collab-type="author">Muller-Nurasyid M</collab><collab collab-type="author">Roden M</collab><collab collab-type="author">Hypponen E</collab><collab collab-type="author">Isaacs A</collab><collab collab-type="author">van Leeuwen EM</collab><collab collab-type="author">Karssen LC</collab><collab collab-type="author">Mihailov E</collab><collab collab-type="author">Houwing-Duistermaat JJ</collab><collab collab-type="author">de Craen AJ</collab><collab collab-type="author">Deelen J</collab><collab collab-type="author">Havulinna AS</collab><collab collab-type="author">Blades M</collab><collab collab-type="author">Hengstenberg C</collab><collab collab-type="author">Erdmann J</collab><collab collab-type="author">Schunkert H</collab><collab collab-type="author">Kaprio J</collab><collab collab-type="author">Tobin MD</collab><collab collab-type="author">Samani NJ</collab><collab collab-type="author">Lind L</collab><collab collab-type="author">Salomaa V</collab><collab collab-type="author">Lindgren CM</collab><collab collab-type="author">Slagboom PE</collab><collab collab-type="author">Metspalu A</collab><collab collab-type="author">van Duijn CM</collab><collab collab-type="author">Eriksson JG</collab><collab collab-type="author">Peters A</collab><collab collab-type="author">Gieger C</collab><collab collab-type="author">Jula A</collab><collab collab-type="author">Groop L</collab><collab collab-type="author">Raitakari OT</collab><collab collab-type="author">Power C</collab><collab collab-type="author">Penninx BW</collab><collab collab-type="author">de Geus E</collab><collab collab-type="author">Smit JH</collab><collab collab-type="author">Boomsma DI</collab><collab collab-type="author">Pedersen NL</collab><collab collab-type="author">Ingelsson E</collab><collab collab-type="author">Thorsteinsdottir U</collab><collab collab-type="author">Stefansson K</collab><collab collab-type="author">Ripatti S</collab><collab collab-type="author">Prokopenko I</collab><collab collab-type="author">McCarthy MI</collab><collab collab-type="author">Morris AP</collab><collab collab-type="author">ENGAGE Consortium</collab><year>2015</year><source>Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation</source><ext-link ext-link-type="uri" xlink:href="http://diagram-consortium.org/2015_ENGAGE_1KG/">http://diagram-consortium.org/2015_ENGAGE_1KG/</ext-link><comment>Available from the ENGAGE Consortium website</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset8" source-id="https://www.ebi.ac.uk/ega/studies/EGAS00001001265" source-id-type="uri"><collab collab-type="author">van de Bunt M</collab><collab collab-type="author">Manning Fox JE</collab><collab collab-type="author">Dai X</collab><collab collab-type="author">Barrett A</collab><collab collab-type="author">Grey C</collab><collab collab-type="author">Li L</collab><collab collab-type="author">Bennett AJ</collab><collab collab-type="author">Johnson PR</collab><collab collab-type="author">Rajotte RV</collab><collab collab-type="author">Gaulton KJ</collab><collab collab-type="author">Dermitzakis ET</collab><collab collab-type="author">MacDonald PE</collab><collab collab-type="author">McCarthy MI</collab><collab collab-type="author">Gloyn AL</collab><year>2015</year><source>Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001001265">https://www.ebi.ac.uk/ega/studies/EGAS00001001265</ext-link><comment>Available from the EGA website (study accession no: EGAS00001002592)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset9" source-id="http://diagram-consortium.org/" source-id-type="uri"><collab collab-type="author">Scott RA</collab><collab collab-type="author">Scott LJ</collab><collab collab-type="author">Mägi R</collab><collab collab-type="author">Marullo L</collab><collab collab-type="author">Gaulton KJ</collab><collab collab-type="author">Kaakinen M</collab><collab collab-type="author">Pervjakova N</collab><collab collab-type="author">Pers TH</collab><collab collab-type="author">Johnson AD</collab><collab collab-type="author">Eicher JD</collab><collab collab-type="author">Jackson AU</collab><collab collab-type="author">Ferreira T</collab><collab collab-type="author">Lee Y</collab><collab collab-type="author">et al</collab><year>2017</year><source>An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans</source><ext-link ext-link-type="uri" xlink:href="http://diagram-consortium.org/">http://diagram-consortium.org/</ext-link><comment>Available from the Diagram Consortium website</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset10" source-id="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001188.v1.p1" source-id-type="uri"><collab collab-type="author">Varshney A</collab><collab collab-type="author">Scott LJ</collab><collab collab-type="author">Welch RP</collab><collab collab-type="author">Erdos MR</collab><collab collab-type="author">Chines PS</collab><collab collab-type="author">Narisu N</collab><collab collab-type="author">Albanus RD</collab><collab collab-type="author">Orchard P</collab><collab collab-type="author">Wolford BN</collab><collab collab-type="author">Kursawe R</collab><collab collab-type="author">Vadlamudi S</collab><collab collab-type="author">Cannon ME</collab><collab collab-type="author">Didion JP</collab><collab collab-type="author">Hensley J</collab><collab collab-type="author">Kirilusha A; NISC Comparative Sequencing Program</collab><collab collab-type="author">Bonnycastle LL</collab><collab collab-type="author">Taylor DL</collab><collab collab-type="author">Watanabe R</collab><collab collab-type="author">Mohlke KL</collab><collab collab-type="author">Boehnke M</collab><collab collab-type="author">Collins FS</collab><collab collab-type="author">Parker SC</collab><collab collab-type="author">Stitzel ML</collab><year>2017</year><source>Genetic regulatory signatures underlying islet gene expression and type 2 diabetes</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001188.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001188.v1.p1</ext-link><comment>Available through the dbGaP website (study accession no: phs001188.v1.p1)</comment></related-object></p></sec></sec><ref-list> <title>References</title> <ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryee</surname> <given-names>MJ</given-names></name><name><surname>Jaffe</surname> <given-names>AE</given-names></name><name><surname>Corrada-Bravo</surname> <given-names>H</given-names></name><name><surname>Ladd-Acosta</surname> <given-names>C</given-names></name><name><surname>Feinberg</surname> <given-names>AP</given-names></name><name><surname>Hansen</surname> <given-names>KD</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1363</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu049</pub-id><pub-id pub-id-type="pmid">24478339</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname> <given-names>JT</given-names></name><name><surname>Pai</surname> <given-names>AA</given-names></name><name><surname>Pickrell</surname> <given-names>JK</given-names></name><name><surname>Gaffney</surname> <given-names>DJ</given-names></name><name><surname>Pique-Regi</surname> <given-names>R</given-names></name><name><surname>Degner</surname> <given-names>JF</given-names></name><name><surname>Gilad</surname> <given-names>Y</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines</article-title><source>Genome Biology</source><volume>12</volume><elocation-id>R10</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2011-12-1-r10</pub-id><pub-id pub-id-type="pmid">21251332</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Zaba</surname> <given-names>LC</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title><source>Nature Methods</source><volume>10</volume><fpage>1213</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id><pub-id pub-id-type="pmid">24097267</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname> <given-names>L</given-names></name><name><surname>Gaidatzis</surname> <given-names>D</given-names></name><name><surname>Schübeler</surname> <given-names>D</given-names></name><name><surname>Stadler</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of active regulatory regions from DNA methylation data</article-title><source>Nucleic Acids Research</source><volume>41</volume><elocation-id>e155</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkt599</pub-id><pub-id pub-id-type="pmid">23828043</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Carlson</surname> <given-names>M</given-names></name><name><surname>Maintainer</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>TxDb.Hsapiens.UCSC.hg19.knownGene: Annotation Package for TxDb Object(s)</data-title><version designator="3.2.2">R package version 3.2.2</version></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JO</given-names></name><name><surname>Telenius</surname> <given-names>JM</given-names></name><name><surname>McGowan</surname> <given-names>SJ</given-names></name><name><surname>Roberts</surname> <given-names>NA</given-names></name><name><surname>Taylor</surname> <given-names>S</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name><name><surname>Hughes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiplexed analysis of chromosome conformation at vastly improved sensitivity</article-title><source>Nature Methods</source><volume>13</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3664</pub-id><pub-id pub-id-type="pmid">26595209</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JOJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>captureC</data-title><source>Github</source><version designator="aae8046">aae8046</version><ext-link ext-link-type="uri" xlink:href="https://github.com/Hughes-Genome-Group/captureC">https://github.com/Hughes-Genome-Group/captureC</ext-link></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayeh</surname> <given-names>T</given-names></name><name><surname>Volkov</surname> <given-names>P</given-names></name><name><surname>Salö</surname> <given-names>S</given-names></name><name><surname>Hall</surname> <given-names>E</given-names></name><name><surname>Nilsson</surname> <given-names>E</given-names></name><name><surname>Olsson</surname> <given-names>AH</given-names></name><name><surname>Kirkpatrick</surname> <given-names>CL</given-names></name><name><surname>Wollheim</surname> <given-names>CB</given-names></name><name><surname>Eliasson</surname> <given-names>L</given-names></name><name><surname>Rönn</surname> <given-names>T</given-names></name><name><surname>Bacos</surname> <given-names>K</given-names></name><name><surname>Ling</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004160</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004160</pub-id><pub-id pub-id-type="pmid">24603685</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>Geeven</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>peakC</data-title><source>Github</source><version designator="a2ac8c1">a2ac8c1</version><ext-link ext-link-type="uri" xlink:href="https://github.com/deWitLab/peakC">https://github.com/deWitLab/peakC</ext-link></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimas</surname> <given-names>AS</given-names></name><name><surname>Lagou</surname> <given-names>V</given-names></name><name><surname>Barker</surname> <given-names>A</given-names></name><name><surname>Knowles</surname> <given-names>JW</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Hivert</surname> <given-names>MF</given-names></name><name><surname>Benazzo</surname> <given-names>A</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Song</surname> <given-names>C</given-names></name><name><surname>Fischer-Rosinsky</surname> <given-names>A</given-names></name><name><surname>Boesgaard</surname> <given-names>TW</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Abbasi</surname> <given-names>FA</given-names></name><name><surname>Assimes</surname> <given-names>TL</given-names></name><name><surname>Hao</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Lecoeur</surname> <given-names>C</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Böttcher</surname> <given-names>Y</given-names></name><name><surname>Bumpstead</surname> <given-names>S</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Graessler</surname> <given-names>J</given-names></name><name><surname>Kovacs</surname> <given-names>P</given-names></name><name><surname>Morken</surname> <given-names>MA</given-names></name><name><surname>Narisu</surname> <given-names>N</given-names></name><name><surname>Payne</surname> <given-names>F</given-names></name><name><surname>Stancakova</surname> <given-names>A</given-names></name><name><surname>Swift</surname> <given-names>AJ</given-names></name><name><surname>Tönjes</surname> <given-names>A</given-names></name><name><surname>Bornstein</surname> <given-names>SR</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Meyre</surname> <given-names>D</given-names></name><name><surname>Schwarz</surname> <given-names>PE</given-names></name><name><surname>Häring</surname> <given-names>HU</given-names></name><name><surname>Smith</surname> <given-names>U</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Quertemous</surname> <given-names>T</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Walker</surname> <given-names>M</given-names></name><name><surname>Pfeiffer</surname> <given-names>AF</given-names></name><name><surname>Spranger</surname> <given-names>J</given-names></name><name><surname>Stumvoll</surname> <given-names>M</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Watanabe</surname> <given-names>RM</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Investigators</surname> <given-names>M</given-names></name><collab>MAGIC Investigators</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity</article-title><source>Diabetes</source><volume>63</volume><fpage>2158</fpage><lpage>2171</lpage><pub-id pub-id-type="doi">10.2337/db13-0949</pub-id><pub-id pub-id-type="pmid">24296717</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname> <given-names>C</given-names></name><name><surname>Lang</surname> <given-names>CF</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Darbary</surname> <given-names>H</given-names></name><name><surname>Krupska</surname> <given-names>I</given-names></name><name><surname>Gaba</surname> <given-names>A</given-names></name><name><surname>Petukhova</surname> <given-names>L</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Gallagher</surname> <given-names>MP</given-names></name><name><surname>Goland</surname> <given-names>RS</given-names></name><name><surname>Clynes</surname> <given-names>RA</given-names></name><name><surname>Dwork</surname> <given-names>A</given-names></name><name><surname>Kral</surname> <given-names>JG</given-names></name><name><surname>Monk</surname> <given-names>C</given-names></name><name><surname>Christiano</surname> <given-names>AM</given-names></name><name><surname>Tycko</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mechanisms and disease associations of haplotype-dependent allele-specific DNA methylation</article-title><source>The American Journal of Human Genetics</source><volume>98</volume><fpage>934</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.027</pub-id><pub-id pub-id-type="pmid">27153397</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckhardt</surname> <given-names>F</given-names></name><name><surname>Lewin</surname> <given-names>J</given-names></name><name><surname>Cortese</surname> <given-names>R</given-names></name><name><surname>Rakyan</surname> <given-names>VK</given-names></name><name><surname>Attwood</surname> <given-names>J</given-names></name><name><surname>Burger</surname> <given-names>M</given-names></name><name><surname>Burton</surname> <given-names>J</given-names></name><name><surname>Cox</surname> <given-names>TV</given-names></name><name><surname>Davies</surname> <given-names>R</given-names></name><name><surname>Down</surname> <given-names>TA</given-names></name><name><surname>Haefliger</surname> <given-names>C</given-names></name><name><surname>Horton</surname> <given-names>R</given-names></name><name><surname>Howe</surname> <given-names>K</given-names></name><name><surname>Jackson</surname> <given-names>DK</given-names></name><name><surname>Kunde</surname> <given-names>J</given-names></name><name><surname>Koenig</surname> <given-names>C</given-names></name><name><surname>Liddle</surname> <given-names>J</given-names></name><name><surname>Niblett</surname> <given-names>D</given-names></name><name><surname>Otto</surname> <given-names>T</given-names></name><name><surname>Pettett</surname> <given-names>R</given-names></name><name><surname>Seemann</surname> <given-names>S</given-names></name><name><surname>Thompson</surname> <given-names>C</given-names></name><name><surname>West</surname> <given-names>T</given-names></name><name><surname>Rogers</surname> <given-names>J</given-names></name><name><surname>Olek</surname> <given-names>A</given-names></name><name><surname>Berlin</surname> <given-names>K</given-names></name><name><surname>Beck</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>DNA methylation profiling of human chromosomes 6, 20 and 22</article-title><source>Nature Genetics</source><volume>38</volume><fpage>1378</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1038/ng1909</pub-id><pub-id pub-id-type="pmid">17072317</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ENCODE Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname> <given-names>J</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ChromHMM: automating chromatin-state discovery and characterization</article-title><source>Nature Methods</source><volume>9</volume><fpage>215</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1906</pub-id><pub-id pub-id-type="pmid">22373907</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname> <given-names>J</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Mikkelsen</surname> <given-names>TS</given-names></name><name><surname>Shoresh</surname> <given-names>N</given-names></name><name><surname>Ward</surname> <given-names>LD</given-names></name><name><surname>Epstein</surname> <given-names>CB</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Issner</surname> <given-names>R</given-names></name><name><surname>Coyne</surname> <given-names>M</given-names></name><name><surname>Ku</surname> <given-names>M</given-names></name><name><surname>Durham</surname> <given-names>T</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mapping and analysis of chromatin state dynamics in nine human cell types</article-title><source>Nature</source><volume>473</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/nature09906</pub-id><pub-id pub-id-type="pmid">21441907</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finucane</surname> <given-names>HK</given-names></name><name><surname>Bulik-Sullivan</surname> <given-names>B</given-names></name><name><surname>Gusev</surname> <given-names>A</given-names></name><name><surname>Trynka</surname> <given-names>G</given-names></name><name><surname>Reshef</surname> <given-names>Y</given-names></name><name><surname>Loh</surname> <given-names>PR</given-names></name><name><surname>Anttila</surname> <given-names>V</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Zang</surname> <given-names>C</given-names></name><name><surname>Farh</surname> <given-names>K</given-names></name><name><surname>Ripke</surname> <given-names>S</given-names></name><name><surname>Day</surname> <given-names>FR</given-names></name><name><surname>Purcell</surname> <given-names>S</given-names></name><name><surname>Stahl</surname> <given-names>E</given-names></name><name><surname>Lindstrom</surname> <given-names>S</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Okada</surname> <given-names>Y</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Patterson</surname> <given-names>N</given-names></name><name><surname>Neale</surname> <given-names>BM</given-names></name><name><surname>Price</surname> <given-names>AL</given-names></name><name><surname>Reprogen</surname> <given-names>C</given-names></name><collab>ReproGen Consortium</collab><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><collab>RACI Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1228</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1038/ng.3404</pub-id><pub-id pub-id-type="pmid">26414678</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>MP</given-names></name><name><surname>Cannon</surname> <given-names>ME</given-names></name><name><surname>Vadlamudi</surname> <given-names>S</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004633</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004633</pub-id><pub-id pub-id-type="pmid">25211022</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaidatzis</surname> <given-names>D</given-names></name><name><surname>Burger</surname> <given-names>L</given-names></name><name><surname>Murr</surname> <given-names>R</given-names></name><name><surname>Lerch</surname> <given-names>A</given-names></name><name><surname>Dessus-Babus</surname> <given-names>S</given-names></name><name><surname>Schübeler</surname> <given-names>D</given-names></name><name><surname>Stadler</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>DNA sequence explains seemingly disordered methylation levels in partially methylated domains of Mammalian genomes</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004143</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004143</pub-id><pub-id pub-id-type="pmid">24550741</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Raimondo</surname> <given-names>A</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Reschen</surname> <given-names>ME</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Locke</surname> <given-names>A</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Green</surname> <given-names>T</given-names></name><name><surname>Sparso</surname> <given-names>T</given-names></name><name><surname>Thuillier</surname> <given-names>D</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Wahl</surname> <given-names>S</given-names></name><name><surname>Frånberg</surname> <given-names>M</given-names></name><name><surname>Strawbridge</surname> <given-names>RJ</given-names></name><name><surname>Kestler</surname> <given-names>H</given-names></name><name><surname>Chheda</surname> <given-names>H</given-names></name><name><surname>Eisele</surname> <given-names>L</given-names></name><name><surname>Gustafsson</surname> <given-names>S</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Karssen</surname> <given-names>LC</given-names></name><name><surname>van Leeuwen</surname> <given-names>EM</given-names></name><name><surname>Willems</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Fuchsberger</surname> <given-names>C</given-names></name><name><surname>Kwan</surname> <given-names>P</given-names></name><name><surname>Ma</surname> <given-names>C</given-names></name><name><surname>Linderman</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Thomsen</surname> <given-names>SK</given-names></name><name><surname>Rundle</surname> <given-names>JK</given-names></name><name><surname>Beer</surname> <given-names>NL</given-names></name><name><surname>van de Bunt</surname> <given-names>M</given-names></name><name><surname>Chalisey</surname> <given-names>A</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Baldassarre</surname> <given-names>D</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Blüher</surname> <given-names>M</given-names></name><name><surname>Boeing</surname> <given-names>H</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Bottinger</surname> <given-names>EP</given-names></name><name><surname>Burtt</surname> <given-names>NP</given-names></name><name><surname>Carey</surname> <given-names>J</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Cornelis</surname> <given-names>MC</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Crenshaw</surname> <given-names>AT</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>Doney</surname> <given-names>AS</given-names></name><name><surname>Dorkhan</surname> <given-names>M</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Eury</surname> <given-names>E</given-names></name><name><surname>Fadista</surname> <given-names>J</given-names></name><name><surname>Flannick</surname> <given-names>J</given-names></name><name><surname>Fontanillas</surname> <given-names>P</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Franks</surname> <given-names>PW</given-names></name><name><surname>Gertow</surname> <given-names>K</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Gigante</surname> <given-names>B</given-names></name><name><surname>Gottesman</surname> <given-names>O</given-names></name><name><surname>Grant</surname> <given-names>GB</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Hassinen</surname> <given-names>M</given-names></name><name><surname>Have</surname> <given-names>CT</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Holmen</surname> <given-names>OL</given-names></name><name><surname>Hreidarsson</surname> <given-names>AB</given-names></name><name><surname>Humphries</surname> <given-names>SE</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Jonsson</surname> <given-names>A</given-names></name><name><surname>Jørgensen</surname> <given-names>ME</given-names></name><name><surname>Jørgensen</surname> <given-names>T</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Kerrison</surname> <given-names>ND</given-names></name><name><surname>Kinnunen</surname> <given-names>L</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Kovacs</surname> <given-names>P</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Kravic</surname> <given-names>J</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Leander</surname> <given-names>K</given-names></name><name><surname>Liang</surname> <given-names>L</given-names></name><name><surname>Lichtner</surname> <given-names>P</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Lindholm</surname> <given-names>E</given-names></name><name><surname>Linneberg</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>CT</given-names></name><name><surname>Lobbens</surname> <given-names>S</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Männistö</surname> <given-names>S</given-names></name><name><surname>McLeod</surname> <given-names>O</given-names></name><name><surname>Meyer</surname> <given-names>J</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Mirza</surname> <given-names>G</given-names></name><name><surname>Mühleisen</surname> <given-names>TW</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Navarro</surname> <given-names>C</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Oskolkov</surname> <given-names>NN</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Palli</surname> <given-names>D</given-names></name><name><surname>Pechlivanis</surname> <given-names>S</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Platou</surname> <given-names>CG</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Ruderfer</surname> <given-names>D</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>van der Schouw</surname> <given-names>YT</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Sigurðsson</surname> <given-names>G</given-names></name><name><surname>Stančáková</surname> <given-names>A</given-names></name><name><surname>Steinbach</surname> <given-names>G</given-names></name><name><surname>Storm</surname> <given-names>P</given-names></name><name><surname>Strauch</surname> <given-names>K</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Tonjes</surname> <given-names>A</given-names></name><name><surname>Trakalo</surname> <given-names>J</given-names></name><name><surname>Tremoli</surname> <given-names>E</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>Wennauer</surname> <given-names>R</given-names></name><name><surname>Wiltshire</surname> <given-names>S</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Dunham</surname> <given-names>I</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Pasquali</surname> <given-names>L</given-names></name><name><surname>Ferrer</surname> <given-names>J</given-names></name><name><surname>Loos</surname> <given-names>RJ</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>van Duijn</surname> <given-names>C</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Hu</surname> <given-names>FB</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Lakka</surname> <given-names>TA</given-names></name><name><surname>Rauramaa</surname> <given-names>R</given-names></name><name><surname>Stumvoll</surname> <given-names>M</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname> <given-names>SM</given-names></name><name><surname>Korpi-Hyövälti</surname> <given-names>E</given-names></name><name><surname>Saaristo</surname> <given-names>TE</given-names></name><name><surname>Saltevo</surname> <given-names>J</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Erbel</surname> <given-names>R</given-names></name><name><surname>Jöcke</surname> <given-names>KH</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Koistinen</surname> <given-names>H</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Njølstad</surname> <given-names>I</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>de Faire</surname> <given-names>U</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Illig</surname> <given-names>T</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Sladek</surname> <given-names>R</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Nilsson</surname> <given-names>PM</given-names></name><name><surname>Groop</surname> <given-names>LC</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>O'Callaghan</surname> <given-names>CA</given-names></name><name><surname>Gloyn</surname> <given-names>AL</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1415</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1038/ng.3437</pub-id><pub-id pub-id-type="pmid">26551672</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Nammo</surname> <given-names>T</given-names></name><name><surname>Pasquali</surname> <given-names>L</given-names></name><name><surname>Simon</surname> <given-names>JM</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Fogarty</surname> <given-names>MP</given-names></name><name><surname>Panhuis</surname> <given-names>TM</given-names></name><name><surname>Mieczkowski</surname> <given-names>P</given-names></name><name><surname>Secchi</surname> <given-names>A</given-names></name><name><surname>Bosco</surname> <given-names>D</given-names></name><name><surname>Berney</surname> <given-names>T</given-names></name><name><surname>Montanya</surname> <given-names>E</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Lieb</surname> <given-names>JD</given-names></name><name><surname>Ferrer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A map of open chromatin in human pancreatic islets</article-title><source>Nature Genetics</source><volume>42</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/ng.530</pub-id><pub-id pub-id-type="pmid">20118932</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname> <given-names>CE</given-names></name><name><surname>Bailey</surname> <given-names>TL</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FIMO: scanning for occurrences of a given motif</article-title><source>Bioinformatics</source><volume>27</volume><fpage>1017</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr064</pub-id><pub-id pub-id-type="pmid">21330290</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>S</given-names></name><name><surname>Diep</surname> <given-names>D</given-names></name><name><surname>Plongthongkum</surname> <given-names>N</given-names></name><name><surname>Fung</surname> <given-names>HL</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA</article-title><source>Nature Genetics</source><volume>49</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1038/ng.3805</pub-id><pub-id pub-id-type="pmid">28263317</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Arcelus</surname> <given-names>M</given-names></name><name><surname>Lappalainen</surname> <given-names>T</given-names></name><name><surname>Montgomery</surname> <given-names>SB</given-names></name><name><surname>Buil</surname> <given-names>A</given-names></name><name><surname>Ongen</surname> <given-names>H</given-names></name><name><surname>Yurovsky</surname> <given-names>A</given-names></name><name><surname>Bryois</surname> <given-names>J</given-names></name><name><surname>Giger</surname> <given-names>T</given-names></name><name><surname>Romano</surname> <given-names>L</given-names></name><name><surname>Planchon</surname> <given-names>A</given-names></name><name><surname>Falconnet</surname> <given-names>E</given-names></name><name><surname>Bielser</surname> <given-names>D</given-names></name><name><surname>Gagnebin</surname> <given-names>M</given-names></name><name><surname>Padioleau</surname> <given-names>I</given-names></name><name><surname>Borel</surname> <given-names>C</given-names></name><name><surname>Letourneau</surname> <given-names>A</given-names></name><name><surname>Makrythanasis</surname> <given-names>P</given-names></name><name><surname>Guipponi</surname> <given-names>M</given-names></name><name><surname>Gehrig</surname> <given-names>C</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Passive and active DNA methylation and the interplay with genetic variation in gene regulation</article-title><source>eLife</source><volume>2</volume><elocation-id>e00523</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.00523</pub-id><pub-id pub-id-type="pmid">23755361</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannon</surname> <given-names>E</given-names></name><name><surname>Spiers</surname> <given-names>H</given-names></name><name><surname>Viana</surname> <given-names>J</given-names></name><name><surname>Pidsley</surname> <given-names>R</given-names></name><name><surname>Burrage</surname> <given-names>J</given-names></name><name><surname>Murphy</surname> <given-names>TM</given-names></name><name><surname>Troakes</surname> <given-names>C</given-names></name><name><surname>Turecki</surname> <given-names>G</given-names></name><name><surname>O'Donovan</surname> <given-names>MC</given-names></name><name><surname>Schalkwyk</surname> <given-names>LC</given-names></name><name><surname>Bray</surname> <given-names>NJ</given-names></name><name><surname>Mill</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/nn.4182</pub-id><pub-id pub-id-type="pmid">26619357</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname> <given-names>D</given-names></name><name><surname>Hughes</surname> <given-names>JR</given-names></name><name><surname>Babbs</surname> <given-names>C</given-names></name><name><surname>Davies</surname> <given-names>JOJ</given-names></name><name><surname>Graham</surname> <given-names>BJ</given-names></name><name><surname>Hanssen</surname> <given-names>L</given-names></name><name><surname>Kassouf</surname> <given-names>MT</given-names></name><name><surname>Marieke Oudelaar</surname> <given-names>AM</given-names></name><name><surname>Sharpe</surname> <given-names>JA</given-names></name><name><surname>Suciu</surname> <given-names>MC</given-names></name><name><surname>Telenius</surname> <given-names>J</given-names></name><name><surname>Williams</surname> <given-names>R</given-names></name><name><surname>Rode</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>PS</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name><name><surname>Sloane-Stanley</surname> <given-names>JA</given-names></name><name><surname>Ayyub</surname> <given-names>H</given-names></name><name><surname>Butler</surname> <given-names>S</given-names></name><name><surname>Sauka-Spengler</surname> <given-names>T</given-names></name><name><surname>Gibbons</surname> <given-names>RJ</given-names></name><name><surname>Smith</surname> <given-names>AJH</given-names></name><name><surname>Wood</surname> <given-names>WG</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic dissection of the α-globin super-enhancer in vivo</article-title><source>Nature Genetics</source><volume>48</volume><fpage>895</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1038/ng.3605</pub-id><pub-id pub-id-type="pmid">27376235</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodson</surname> <given-names>DJ</given-names></name><name><surname>Mitchell</surname> <given-names>RK</given-names></name><name><surname>Marselli</surname> <given-names>L</given-names></name><name><surname>Pullen</surname> <given-names>TJ</given-names></name><name><surname>Gimeno Brias</surname> <given-names>S</given-names></name><name><surname>Semplici</surname> <given-names>F</given-names></name><name><surname>Everett</surname> <given-names>KL</given-names></name><name><surname>Cooper</surname> <given-names>DM</given-names></name><name><surname>Bugliani</surname> <given-names>M</given-names></name><name><surname>Marchetti</surname> <given-names>P</given-names></name><name><surname>Lavallard</surname> <given-names>V</given-names></name><name><surname>Bosco</surname> <given-names>D</given-names></name><name><surname>Piemonti</surname> <given-names>L</given-names></name><name><surname>Johnson</surname> <given-names>PR</given-names></name><name><surname>Hughes</surname> <given-names>SJ</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>WH</given-names></name><name><surname>Shapiro</surname> <given-names>AM</given-names></name><name><surname>Rutter</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ADCY5 couples glucose to insulin secretion in human islets</article-title><source>Diabetes</source><volume>63</volume><fpage>3009</fpage><lpage>3021</lpage><pub-id pub-id-type="doi">10.2337/db13-1607</pub-id><pub-id pub-id-type="pmid">24740569</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horikoshi</surname> <given-names>M</given-names></name><name><surname>Magi</surname> <given-names>R</given-names></name><name><surname>van de Bunt</surname> <given-names>M</given-names></name><name><surname>Surakka</surname> <given-names>I</given-names></name><name><surname>Sarin</surname> <given-names>AP</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Marullo</surname> <given-names>L</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Hagg</surname> <given-names>S</given-names></name><name><surname>Hottenga</surname> <given-names>JJ</given-names></name><name><surname>Ladenvall</surname> <given-names>C</given-names></name><name><surname>Ried</surname> <given-names>JS</given-names></name><name><surname>Winkler</surname> <given-names>TW</given-names></name><name><surname>Willems</surname> <given-names>SM</given-names></name><name><surname>Pervjakova</surname> <given-names>N</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Beekman</surname> <given-names>M</given-names></name><name><surname>Nelson</surname> <given-names>CP</given-names></name><name><surname>Willenborg</surname> <given-names>C</given-names></name><name><surname>Wiltshire</surname> <given-names>S</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Fernandez</surname> <given-names>J</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Magnusson</surname> <given-names>PK</given-names></name><name><surname>Willemsen</surname> <given-names>G</given-names></name><name><surname>Milaneschi</surname> <given-names>Y</given-names></name><name><surname>Robertson</surname> <given-names>NR</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Bennett</surname> <given-names>AJ</given-names></name><name><surname>Lehtimӓki</surname> <given-names>T</given-names></name><name><surname>Viikari</surname> <given-names>JS</given-names></name><name><surname>Rung</surname> <given-names>J</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Perola</surname> <given-names>M</given-names></name><name><surname>Heid</surname> <given-names>IM</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Hypponen</surname> <given-names>E</given-names></name><name><surname>Isaacs</surname> <given-names>A</given-names></name><name><surname>van Leeuwen</surname> <given-names>EM</given-names></name><name><surname>Karssen</surname> <given-names>LC</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Houwing-Duistermaat</surname> <given-names>JJ</given-names></name><name><surname>de Craen</surname> <given-names>AJ</given-names></name><name><surname>Deelen</surname> <given-names>J</given-names></name><name><surname>Havulinna</surname> <given-names>AS</given-names></name><name><surname>Blades</surname> <given-names>M</given-names></name><name><surname>Hengstenberg</surname> <given-names>C</given-names></name><name><surname>Erdmann</surname> <given-names>J</given-names></name><name><surname>Schunkert</surname> <given-names>H</given-names></name><name><surname>Kaprio</surname> <given-names>J</given-names></name><name><surname>Tobin</surname> <given-names>MD</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Slagboom</surname> <given-names>PE</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Jula</surname> <given-names>A</given-names></name><name><surname>Groop</surname> <given-names>L</given-names></name><name><surname>Raitakari</surname> <given-names>OT</given-names></name><name><surname>Power</surname> <given-names>C</given-names></name><name><surname>Penninx</surname> <given-names>BW</given-names></name><name><surname>de Geus</surname> <given-names>E</given-names></name><name><surname>Smit</surname> <given-names>JH</given-names></name><name><surname>Boomsma</surname> <given-names>DI</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><collab>ENGAGE Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005230</pub-id><pub-id pub-id-type="pmid">26132169</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>WE</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Rabinovic</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title><source>Biostatistics</source><volume>8</volume><fpage>118</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/kxj037</pub-id><pub-id pub-id-type="pmid">16632515</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>N</given-names></name><name><surname>Loh</surname> <given-names>M</given-names></name><name><surname>Takeuchi</surname> <given-names>F</given-names></name><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Kelly</surname> <given-names>TN</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Lehne</surname> <given-names>B</given-names></name><name><surname>Leach</surname> <given-names>IM</given-names></name><name><surname>Drong</surname> <given-names>AW</given-names></name><name><surname>Abbott</surname> <given-names>J</given-names></name><name><surname>Wahl</surname> <given-names>S</given-names></name><name><surname>Tan</surname> <given-names>ST</given-names></name><name><surname>Scott</surname> <given-names>WR</given-names></name><name><surname>Campanella</surname> <given-names>G</given-names></name><name><surname>Chadeau-Hyam</surname> <given-names>M</given-names></name><name><surname>Afzal</surname> <given-names>U</given-names></name><name><surname>Ahluwalia</surname> <given-names>TS</given-names></name><name><surname>Bonder</surname> <given-names>MJ</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Dehghan</surname> <given-names>A</given-names></name><name><surname>Edwards</surname> <given-names>TL</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Go</surname> <given-names>MJ</given-names></name><name><surname>Harris</surname> <given-names>SE</given-names></name><name><surname>Hartiala</surname> <given-names>J</given-names></name><name><surname>Kasela</surname> <given-names>S</given-names></name><name><surname>Kasturiratne</surname> <given-names>A</given-names></name><name><surname>Khor</surname> <given-names>CC</given-names></name><name><surname>Kleber</surname> <given-names>ME</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Yu Mok</surname> <given-names>Z</given-names></name><name><surname>Nakatochi</surname> <given-names>M</given-names></name><name><surname>Sapari</surname> <given-names>NS</given-names></name><name><surname>Saxena</surname> <given-names>R</given-names></name><name><surname>Stewart</surname> <given-names>AFR</given-names></name><name><surname>Stolk</surname> <given-names>L</given-names></name><name><surname>Tabara</surname> <given-names>Y</given-names></name><name><surname>Teh</surname> <given-names>AL</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>JY</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Aits</surname> <given-names>I</given-names></name><name><surname>Da Silva Couto Alves</surname> <given-names>A</given-names></name><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Dorajoo</surname> <given-names>R</given-names></name><name><surname>Hopewell</surname> <given-names>JC</given-names></name><name><surname>Kim</surname> <given-names>YK</given-names></name><name><surname>Koivula</surname> <given-names>RW</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lyytikäinen</surname> <given-names>LP</given-names></name><name><surname>Nguyen</surname> <given-names>QN</given-names></name><name><surname>Pereira</surname> <given-names>MA</given-names></name><name><surname>Postmus</surname> <given-names>I</given-names></name><name><surname>Raitakari</surname> <given-names>OT</given-names></name><name><surname>Bryan</surname> <given-names>MS</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Sorice</surname> <given-names>R</given-names></name><name><surname>Tragante</surname> <given-names>V</given-names></name><name><surname>Traglia</surname> <given-names>M</given-names></name><name><surname>White</surname> <given-names>J</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Adair</surname> <given-names>LS</given-names></name><name><surname>Ahmed</surname> <given-names>A</given-names></name><name><surname>Akiyama</surname> <given-names>K</given-names></name><name><surname>Asif</surname> <given-names>R</given-names></name><name><surname>Aung</surname> <given-names>T</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Bjonnes</surname> <given-names>A</given-names></name><name><surname>Braun</surname> <given-names>TR</given-names></name><name><surname>Cai</surname> <given-names>H</given-names></name><name><surname>Chang</surname> <given-names>LC</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Cheng</surname> <given-names>CY</given-names></name><name><surname>Chong</surname> <given-names>YS</given-names></name><name><surname>Collins</surname> <given-names>R</given-names></name><name><surname>Courtney</surname> <given-names>R</given-names></name><name><surname>Davies</surname> <given-names>G</given-names></name><name><surname>Delgado</surname> <given-names>G</given-names></name><name><surname>Do</surname> <given-names>LD</given-names></name><name><surname>Doevendans</surname> <given-names>PA</given-names></name><name><surname>Gansevoort</surname> <given-names>RT</given-names></name><name><surname>Gao</surname> <given-names>YT</given-names></name><name><surname>Grammer</surname> <given-names>TB</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Grewal</surname> <given-names>J</given-names></name><name><surname>Gu</surname> <given-names>D</given-names></name><name><surname>Wander</surname> <given-names>GS</given-names></name><name><surname>Hartikainen</surname> <given-names>AL</given-names></name><name><surname>Hazen</surname> <given-names>SL</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Heng</surname> <given-names>CK</given-names></name><name><surname>Hixson</surname> <given-names>JE</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Hsu</surname> <given-names>C</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Husemoen</surname> <given-names>LLN</given-names></name><name><surname>Hwang</surname> <given-names>JY</given-names></name><name><surname>Ichihara</surname> <given-names>S</given-names></name><name><surname>Igase</surname> <given-names>M</given-names></name><name><surname>Isono</surname> <given-names>M</given-names></name><name><surname>Justesen</surname> <given-names>JM</given-names></name><name><surname>Katsuya</surname> <given-names>T</given-names></name><name><surname>Kibriya</surname> <given-names>MG</given-names></name><name><surname>Kim</surname> <given-names>YJ</given-names></name><name><surname>Kishimoto</surname> <given-names>M</given-names></name><name><surname>Koh</surname> <given-names>WP</given-names></name><name><surname>Kohara</surname> <given-names>K</given-names></name><name><surname>Kumari</surname> <given-names>M</given-names></name><name><surname>Kwek</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>NR</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Liao</surname> <given-names>J</given-names></name><name><surname>Lieb</surname> <given-names>W</given-names></name><name><surname>Liewald</surname> <given-names>DCM</given-names></name><name><surname>Matsubara</surname> <given-names>T</given-names></name><name><surname>Matsushita</surname> <given-names>Y</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Milani</surname> <given-names>L</given-names></name><name><surname>Mills</surname> <given-names>R</given-names></name><name><surname>Mononen</surname> <given-names>N</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Nabika</surname> <given-names>T</given-names></name><name><surname>Nakashima</surname> <given-names>E</given-names></name><name><surname>Ng</surname> <given-names>HK</given-names></name><name><surname>Nikus</surname> <given-names>K</given-names></name><name><surname>Nutile</surname> <given-names>T</given-names></name><name><surname>Ohkubo</surname> <given-names>T</given-names></name><name><surname>Ohnaka</surname> <given-names>K</given-names></name><name><surname>Parish</surname> <given-names>S</given-names></name><name><surname>Paternoster</surname> <given-names>L</given-names></name><name><surname>Peng</surname> <given-names>H</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Pham</surname> <given-names>ST</given-names></name><name><surname>Pinidiyapathirage</surname> <given-names>MJ</given-names></name><name><surname>Rahman</surname> <given-names>M</given-names></name><name><surname>Rakugi</surname> <given-names>H</given-names></name><name><surname>Rolandsson</surname> <given-names>O</given-names></name><name><surname>Ann Rozario</surname> <given-names>M</given-names></name><name><surname>Ruggiero</surname> <given-names>D</given-names></name><name><surname>Sala</surname> <given-names>CF</given-names></name><name><surname>Sarju</surname> <given-names>R</given-names></name><name><surname>Shimokawa</surname> <given-names>K</given-names></name><name><surname>Snieder</surname> <given-names>H</given-names></name><name><surname>Sparsø</surname> <given-names>T</given-names></name><name><surname>Spiering</surname> <given-names>W</given-names></name><name><surname>Starr</surname> <given-names>JM</given-names></name><name><surname>Stott</surname> <given-names>DJ</given-names></name><name><surname>Stram</surname> <given-names>DO</given-names></name><name><surname>Sugiyama</surname> <given-names>T</given-names></name><name><surname>Szymczak</surname> <given-names>S</given-names></name><name><surname>Tang</surname> <given-names>WHW</given-names></name><name><surname>Tong</surname> <given-names>L</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>Turjanmaa</surname> <given-names>V</given-names></name><name><surname>Ueshima</surname> <given-names>H</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Umemura</surname> <given-names>S</given-names></name><name><surname>Vaarasmaki</surname> <given-names>M</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>van Gilst</surname> <given-names>WH</given-names></name><name><surname>van Veldhuisen</surname> <given-names>DJ</given-names></name><name><surname>Viikari</surname> <given-names>JS</given-names></name><name><surname>Waldenberger</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>R</given-names></name><name><surname>Wong</surname> <given-names>TY</given-names></name><name><surname>Xiang</surname> <given-names>YB</given-names></name><name><surname>Yamaguchi</surname> <given-names>S</given-names></name><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Young</surname> <given-names>RD</given-names></name><name><surname>Young</surname> <given-names>TL</given-names></name><name><surname>Yuan</surname> <given-names>JM</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Asselbergs</surname> <given-names>FW</given-names></name><name><surname>Ciullo</surname> <given-names>M</given-names></name><name><surname>Clarke</surname> <given-names>R</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name><name><surname>Franks</surname> <given-names>PW</given-names></name><name><surname>Franks</surname> <given-names>S</given-names></name><name><surname>Friedlander</surname> <given-names>Y</given-names></name><name><surname>Gross</surname> <given-names>MD</given-names></name><name><surname>Guo</surname> <given-names>Z</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Jarvelin</surname> <given-names>MR</given-names></name><name><surname>Jørgensen</surname> <given-names>T</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>Kähönen</surname> <given-names>M</given-names></name><name><surname>Kajio</surname> <given-names>H</given-names></name><name><surname>Kivimaki</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>JY</given-names></name><name><surname>Lehtimäki</surname> <given-names>T</given-names></name><name><surname>Linneberg</surname> <given-names>A</given-names></name><name><surname>Miki</surname> <given-names>T</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Sørensen</surname> <given-names>TIA</given-names></name><name><surname>Takayanagi</surname> <given-names>R</given-names></name><name><surname>Toniolo</surname> <given-names>D</given-names></name><name><surname>Ahsan</surname> <given-names>H</given-names></name><name><surname>Allayee</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>YT</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Deary</surname> <given-names>IJ</given-names></name><name><surname>Franco</surname> <given-names>OH</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Heijman</surname> <given-names>BT</given-names></name><name><surname>Holbrook</surname> <given-names>JD</given-names></name><name><surname>Isaacs</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>BJ</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>März</surname> <given-names>W</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Sanghera</surname> <given-names>DK</given-names></name><name><surname>Shu</surname> <given-names>XO</given-names></name><name><surname>van Meurs</surname> <given-names>JBJ</given-names></name><name><surname>Vithana</surname> <given-names>E</given-names></name><name><surname>Wickremasinghe</surname> <given-names>AR</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Wolffenbuttel</surname> <given-names>BHW</given-names></name><name><surname>Yokota</surname> <given-names>M</given-names></name><name><surname>Zheng</surname> <given-names>W</given-names></name><name><surname>Zhu</surname> <given-names>D</given-names></name><name><surname>Vineis</surname> <given-names>P</given-names></name><name><surname>Kyrtopoulos</surname> <given-names>SA</given-names></name><name><surname>Kleinjans</surname> <given-names>JCS</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Soong</surname> <given-names>R</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Scott</surname> <given-names>J</given-names></name><name><surname>Teo</surname> <given-names>YY</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Elliott</surname> <given-names>P</given-names></name><name><surname>Tai</surname> <given-names>ES</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><collab>BIOS-consortium</collab><collab>CARDIo GRAMplusCD</collab><collab>LifeLines Cohort Study</collab><collab>InterAct Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1282</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1038/ng.3405</pub-id><pub-id pub-id-type="pmid">26390057</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname> <given-names>WJ</given-names></name><name><surname>Sugnet</surname> <given-names>CW</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Roskin</surname> <given-names>KM</given-names></name><name><surname>Pringle</surname> <given-names>TH</given-names></name><name><surname>Zahler</surname> <given-names>AM</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The human genome browser at UCSC</article-title><source>Genome Research</source><volume>12</volume><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1101/gr.229102</pub-id><pub-id pub-id-type="pmid">12045153</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname> <given-names>F</given-names></name><name><surname>Andrews</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications</article-title><source>Bioinformatics</source><volume>27</volume><fpage>1571</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr167</pub-id><pub-id pub-id-type="pmid">21493656</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Meuleman</surname> <given-names>W</given-names></name><name><surname>Ernst</surname> <given-names>J</given-names></name><name><surname>Bilenky</surname> <given-names>M</given-names></name><name><surname>Yen</surname> <given-names>A</given-names></name><name><surname>Heravi-Moussavi</surname> <given-names>A</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ziller</surname> <given-names>MJ</given-names></name><name><surname>Amin</surname> <given-names>V</given-names></name><name><surname>Whitaker</surname> <given-names>JW</given-names></name><name><surname>Schultz</surname> <given-names>MD</given-names></name><name><surname>Ward</surname> <given-names>LD</given-names></name><name><surname>Sarkar</surname> <given-names>A</given-names></name><name><surname>Quon</surname> <given-names>G</given-names></name><name><surname>Sandstrom</surname> <given-names>RS</given-names></name><name><surname>Eaton</surname> <given-names>ML</given-names></name><name><surname>Wu</surname> <given-names>YC</given-names></name><name><surname>Pfenning</surname> <given-names>AR</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Claussnitzer</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Coarfa</surname> <given-names>C</given-names></name><name><surname>Harris</surname> <given-names>RA</given-names></name><name><surname>Shoresh</surname> <given-names>N</given-names></name><name><surname>Epstein</surname> <given-names>CB</given-names></name><name><surname>Gjoneska</surname> <given-names>E</given-names></name><name><surname>Leung</surname> <given-names>D</given-names></name><name><surname>Xie</surname> <given-names>W</given-names></name><name><surname>Hawkins</surname> <given-names>RD</given-names></name><name><surname>Lister</surname> <given-names>R</given-names></name><name><surname>Hong</surname> <given-names>C</given-names></name><name><surname>Gascard</surname> <given-names>P</given-names></name><name><surname>Mungall</surname> <given-names>AJ</given-names></name><name><surname>Moore</surname> <given-names>R</given-names></name><name><surname>Chuah</surname> <given-names>E</given-names></name><name><surname>Tam</surname> <given-names>A</given-names></name><name><surname>Canfield</surname> <given-names>TK</given-names></name><name><surname>Hansen</surname> <given-names>RS</given-names></name><name><surname>Kaul</surname> <given-names>R</given-names></name><name><surname>Sabo</surname> <given-names>PJ</given-names></name><name><surname>Bansal</surname> <given-names>MS</given-names></name><name><surname>Carles</surname> <given-names>A</given-names></name><name><surname>Dixon</surname> <given-names>JR</given-names></name><name><surname>Farh</surname> <given-names>KH</given-names></name><name><surname>Feizi</surname> <given-names>S</given-names></name><name><surname>Karlic</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>AR</given-names></name><name><surname>Kulkarni</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Lowdon</surname> <given-names>R</given-names></name><name><surname>Elliott</surname> <given-names>G</given-names></name><name><surname>Mercer</surname> <given-names>TR</given-names></name><name><surname>Neph</surname> <given-names>SJ</given-names></name><name><surname>Onuchic</surname> <given-names>V</given-names></name><name><surname>Polak</surname> <given-names>P</given-names></name><name><surname>Rajagopal</surname> <given-names>N</given-names></name><name><surname>Ray</surname> <given-names>P</given-names></name><name><surname>Sallari</surname> <given-names>RC</given-names></name><name><surname>Siebenthall</surname> <given-names>KT</given-names></name><name><surname>Sinnott-Armstrong</surname> <given-names>NA</given-names></name><name><surname>Stevens</surname> <given-names>M</given-names></name><name><surname>Thurman</surname> <given-names>RE</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Beaudet</surname> <given-names>AE</given-names></name><name><surname>Boyer</surname> <given-names>LA</given-names></name><name><surname>De Jager</surname> <given-names>PL</given-names></name><name><surname>Farnham</surname> <given-names>PJ</given-names></name><name><surname>Fisher</surname> <given-names>SJ</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name><name><surname>Jones</surname> <given-names>SJ</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Marra</surname> <given-names>MA</given-names></name><name><surname>McManus</surname> <given-names>MT</given-names></name><name><surname>Sunyaev</surname> <given-names>S</given-names></name><name><surname>Thomson</surname> <given-names>JA</given-names></name><name><surname>Tlsty</surname> <given-names>TD</given-names></name><name><surname>Tsai</surname> <given-names>LH</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Waterland</surname> <given-names>RA</given-names></name><name><surname>Zhang</surname> <given-names>MQ</given-names></name><name><surname>Chadwick</surname> <given-names>LH</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name><name><surname>Costello</surname> <given-names>JF</given-names></name><name><surname>Ecker</surname> <given-names>JR</given-names></name><name><surname>Hirst</surname> <given-names>M</given-names></name><name><surname>Meissner</surname> <given-names>A</given-names></name><name><surname>Milosavljevic</surname> <given-names>A</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><collab>Roadmap Epigenomics Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Integrative analysis of 111 reference human epigenomes</article-title><source>Nature</source><volume>518</volume><fpage>317</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nature14248</pub-id><pub-id pub-id-type="pmid">25693563</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Pop</surname> <given-names>M</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title><source>Genome Biology</source><volume>10</volume><elocation-id>R25</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><pub-id pub-id-type="pmid">19261174</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Leek</surname> <given-names>JT</given-names></name><name><surname>Johnson</surname> <given-names>WE</given-names></name><name><surname>Parker</surname> <given-names>HS</given-names></name><name><surname>Jaffe</surname> <given-names>AE</given-names></name><name><surname>Storey</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><source>Sva: Surrogate Variable Analysis</source><version designator="3.8.0">R package version 3.8.0</version></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Handsaker</surname> <given-names>B</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Ruan</surname> <given-names>J</given-names></name><name><surname>Homer</surname> <given-names>N</given-names></name><name><surname>Marth</surname> <given-names>G</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The sequence alignment/map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindblad-Toh</surname> <given-names>K</given-names></name><name><surname>Garber</surname> <given-names>M</given-names></name><name><surname>Zuk</surname> <given-names>O</given-names></name><name><surname>Lin</surname> <given-names>MF</given-names></name><name><surname>Parker</surname> <given-names>BJ</given-names></name><name><surname>Washietl</surname> <given-names>S</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Ernst</surname> <given-names>J</given-names></name><name><surname>Jordan</surname> <given-names>G</given-names></name><name><surname>Mauceli</surname> <given-names>E</given-names></name><name><surname>Ward</surname> <given-names>LD</given-names></name><name><surname>Lowe</surname> <given-names>CB</given-names></name><name><surname>Holloway</surname> <given-names>AK</given-names></name><name><surname>Clamp</surname> <given-names>M</given-names></name><name><surname>Gnerre</surname> <given-names>S</given-names></name><name><surname>Alföldi</surname> <given-names>J</given-names></name><name><surname>Beal</surname> <given-names>K</given-names></name><name><surname>Chang</surname> <given-names>J</given-names></name><name><surname>Clawson</surname> <given-names>H</given-names></name><name><surname>Cuff</surname> <given-names>J</given-names></name><name><surname>Di Palma</surname> <given-names>F</given-names></name><name><surname>Fitzgerald</surname> <given-names>S</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Hubisz</surname> <given-names>MJ</given-names></name><name><surname>Jaffe</surname> <given-names>DB</given-names></name><name><surname>Jungreis</surname> <given-names>I</given-names></name><name><surname>Kent</surname> <given-names>WJ</given-names></name><name><surname>Kostka</surname> <given-names>D</given-names></name><name><surname>Lara</surname> <given-names>M</given-names></name><name><surname>Martins</surname> <given-names>AL</given-names></name><name><surname>Massingham</surname> <given-names>T</given-names></name><name><surname>Moltke</surname> <given-names>I</given-names></name><name><surname>Raney</surname> <given-names>BJ</given-names></name><name><surname>Rasmussen</surname> <given-names>MD</given-names></name><name><surname>Robinson</surname> <given-names>J</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name><name><surname>Vilella</surname> <given-names>AJ</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Zody</surname> <given-names>MC</given-names></name><name><surname>Baldwin</surname> <given-names>J</given-names></name><name><surname>Bloom</surname> <given-names>T</given-names></name><name><surname>Chin</surname> <given-names>CW</given-names></name><name><surname>Heiman</surname> <given-names>D</given-names></name><name><surname>Nicol</surname> <given-names>R</given-names></name><name><surname>Nusbaum</surname> <given-names>C</given-names></name><name><surname>Young</surname> <given-names>S</given-names></name><name><surname>Wilkinson</surname> <given-names>J</given-names></name><name><surname>Worley</surname> <given-names>KC</given-names></name><name><surname>Kovar</surname> <given-names>CL</given-names></name><name><surname>Muzny</surname> <given-names>DM</given-names></name><name><surname>Gibbs</surname> <given-names>RA</given-names></name><name><surname>Cree</surname> <given-names>A</given-names></name><name><surname>Dihn</surname> <given-names>HH</given-names></name><name><surname>Fowler</surname> <given-names>G</given-names></name><name><surname>Jhangiani</surname> <given-names>S</given-names></name><name><surname>Joshi</surname> <given-names>V</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>LR</given-names></name><name><surname>Nazareth</surname> <given-names>LV</given-names></name><name><surname>Okwuonu</surname> <given-names>G</given-names></name><name><surname>Santibanez</surname> <given-names>J</given-names></name><name><surname>Warren</surname> <given-names>WC</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name><name><surname>Weinstock</surname> <given-names>GM</given-names></name><name><surname>Wilson</surname> <given-names>RK</given-names></name><name><surname>Delehaunty</surname> <given-names>K</given-names></name><name><surname>Dooling</surname> <given-names>D</given-names></name><name><surname>Fronik</surname> <given-names>C</given-names></name><name><surname>Fulton</surname> <given-names>L</given-names></name><name><surname>Fulton</surname> <given-names>B</given-names></name><name><surname>Graves</surname> <given-names>T</given-names></name><name><surname>Minx</surname> <given-names>P</given-names></name><name><surname>Sodergren</surname> <given-names>E</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Margulies</surname> <given-names>EH</given-names></name><name><surname>Herrero</surname> <given-names>J</given-names></name><name><surname>Green</surname> <given-names>ED</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name><name><surname>Siepel</surname> <given-names>A</given-names></name><name><surname>Goldman</surname> <given-names>N</given-names></name><name><surname>Pollard</surname> <given-names>KS</given-names></name><name><surname>Pedersen</surname> <given-names>JS</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><collab>Broad Institute Sequencing Platform and Whole Genome Assembly Team</collab><collab>Baylor College of Medicine Human Genome Sequencing Center Sequencing Team</collab><collab>Genome Institute at Washington University</collab></person-group><year iso-8601-date="2011">2011</year><article-title>A high-resolution map of human evolutionary constraint using 29 mammals</article-title><source>Nature</source><volume>478</volume><fpage>476</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1038/nature10530</pub-id><pub-id pub-id-type="pmid">21993624</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname> <given-names>R</given-names></name><name><surname>Gemma</surname> <given-names>C</given-names></name><name><surname>Beyan</surname> <given-names>H</given-names></name><name><surname>Hawa</surname> <given-names>MI</given-names></name><name><surname>Bazeos</surname> <given-names>A</given-names></name><name><surname>Leslie</surname> <given-names>RD</given-names></name><name><surname>Montpetit</surname> <given-names>A</given-names></name><name><surname>Rakyan</surname> <given-names>VK</given-names></name><name><surname>Ramagopalan</surname> <given-names>SV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies</article-title><source>Epigenetics</source><volume>8</volume><fpage>445</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.4161/epi.24362</pub-id><pub-id pub-id-type="pmid">23538714</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magoč</surname> <given-names>T</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FLASH: fast length adjustment of short reads to improve genome assemblies</article-title><source>Bioinformatics</source><volume>27</volume><fpage>2957</fpage><lpage>2963</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr507</pub-id><pub-id pub-id-type="pmid">21903629</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Go</surname> <given-names>MJ</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Below</surname> <given-names>JE</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Horikoshi</surname> <given-names>M</given-names></name><name><surname>Johnson</surname> <given-names>AD</given-names></name><name><surname>Ng</surname> <given-names>MC</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Adair</surname> <given-names>LS</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Atalay</surname> <given-names>M</given-names></name><name><surname>Aung</surname> <given-names>T</given-names></name><name><surname>Baldassarre</surname> <given-names>D</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Bao</surname> <given-names>Y</given-names></name><name><surname>Barnett</surname> <given-names>AH</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Basit</surname> <given-names>A</given-names></name><name><surname>Been</surname> <given-names>LF</given-names></name><name><surname>Beilby</surname> <given-names>J</given-names></name><name><surname>Bell</surname> <given-names>GI</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Burtt</surname> <given-names>N</given-names></name><name><surname>Cai</surname> <given-names>Q</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Carey</surname> <given-names>J</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Caulfield</surname> <given-names>M</given-names></name><name><surname>Chan</surname> <given-names>JC</given-names></name><name><surname>Chang</surname> <given-names>LC</given-names></name><name><surname>Chang</surname> <given-names>TJ</given-names></name><name><surname>Chang</surname> <given-names>YC</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>YT</given-names></name><name><surname>Chia</surname> <given-names>KS</given-names></name><name><surname>Chidambaram</surname> <given-names>M</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Cho</surname> <given-names>NH</given-names></name><name><surname>Cho</surname> <given-names>YM</given-names></name><name><surname>Chuang</surname> <given-names>LM</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Cornelis</surname> <given-names>MC</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Crenshaw</surname> <given-names>AT</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Das</surname> <given-names>D</given-names></name><name><surname>de Faire</surname> <given-names>U</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Dimas</surname> <given-names>AS</given-names></name><name><surname>Dina</surname> <given-names>C</given-names></name><name><surname>Doney</surname> <given-names>AS</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Dorkhan</surname> <given-names>M</given-names></name><name><surname>van Duijn</surname> <given-names>C</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Elliott</surname> <given-names>P</given-names></name><name><surname>Emilsson</surname> <given-names>V</given-names></name><name><surname>Erbel</surname> <given-names>R</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Escobedo</surname> <given-names>J</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Eury</surname> <given-names>E</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Fontanillas</surname> <given-names>P</given-names></name><name><surname>Forouhi</surname> <given-names>NG</given-names></name><name><surname>Forsen</surname> <given-names>T</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Fraser</surname> <given-names>RM</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Frossard</surname> <given-names>P</given-names></name><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Gertow</surname> <given-names>K</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Gigante</surname> <given-names>B</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Grant</surname> <given-names>GB</given-names></name><name><surname>Grrop</surname> <given-names>LC</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Grundberg</surname> <given-names>E</given-names></name><name><surname>Guiducci</surname> <given-names>C</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Han</surname> <given-names>BG</given-names></name><name><surname>Hara</surname> <given-names>K</given-names></name><name><surname>Hassanali</surname> <given-names>N</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Hedman</surname> <given-names>AK</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Holmen</surname> <given-names>OL</given-names></name><name><surname>Hovingh</surname> <given-names>K</given-names></name><name><surname>Hreidarsson</surname> <given-names>AB</given-names></name><name><surname>Hu</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>FB</given-names></name><name><surname>Hui</surname> <given-names>J</given-names></name><name><surname>Humphries</surname> <given-names>SE</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Hydrie</surname> <given-names>ZI</given-names></name><name><surname>Ikegami</surname> <given-names>H</given-names></name><name><surname>Illig</surname> <given-names>T</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Islam</surname> <given-names>M</given-names></name><name><surname>Isomaa</surname> <given-names>B</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Jafar</surname> <given-names>T</given-names></name><name><surname>James</surname> <given-names>A</given-names></name><name><surname>Jia</surname> <given-names>W</given-names></name><name><surname>Jöckel</surname> <given-names>KH</given-names></name><name><surname>Jonsson</surname> <given-names>A</given-names></name><name><surname>Jowett</surname> <given-names>JB</given-names></name><name><surname>Kadowaki</surname> <given-names>T</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>N</given-names></name><name><surname>Katulanda</surname> <given-names>P</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname> <given-names>KM</given-names></name><name><surname>Kelly</surname> <given-names>AM</given-names></name><name><surname>Khan</surname> <given-names>H</given-names></name><name><surname>Khaw</surname> <given-names>KT</given-names></name><name><surname>Khor</surname> <given-names>CC</given-names></name><name><surname>Kim</surname> <given-names>HL</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>YJ</given-names></name><name><surname>Kinnunen</surname> <given-names>L</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Korpi-Hyövälti</surname> <given-names>E</given-names></name><name><surname>Kowlessur</surname> <given-names>S</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Kravic</surname> <given-names>J</given-names></name><name><surname>Kristensen</surname> <given-names>MM</given-names></name><name><surname>Krithika</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Kumate</surname> <given-names>J</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Kwak</surname> <given-names>SH</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Lagou</surname> <given-names>V</given-names></name><name><surname>Lakka</surname> <given-names>TA</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Lawrence</surname> <given-names>R</given-names></name><name><surname>Leander</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Lee</surname> <given-names>NR</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Liang</surname> <given-names>J</given-names></name><name><surname>Liju</surname> <given-names>S</given-names></name><name><surname>Lim</surname> <given-names>WY</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Lindholm</surname> <given-names>E</given-names></name><name><surname>Liu</surname> <given-names>CT</given-names></name><name><surname>Liu</surname> <given-names>JJ</given-names></name><name><surname>Lobbens</surname> <given-names>S</given-names></name><name><surname>Long</surname> <given-names>J</given-names></name><name><surname>Loos</surname> <given-names>RJ</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Ma</surname> <given-names>RC</given-names></name><name><surname>Maeda</surname> <given-names>S</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Männisto</surname> <given-names>S</given-names></name><name><surname>Matthews</surname> <given-names>DR</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Meyer</surname> <given-names>J</given-names></name><name><surname>Mirza</surname> <given-names>G</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>Mohan</surname> <given-names>V</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Mühleisen</surname> <given-names>TW</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Musk</surname> <given-names>B</given-names></name><name><surname>Nakamura</surname> <given-names>J</given-names></name><name><surname>Nakashima</surname> <given-names>E</given-names></name><name><surname>Navarro</surname> <given-names>P</given-names></name><name><surname>Ng</surname> <given-names>PK</given-names></name><name><surname>Nica</surname> <given-names>AC</given-names></name><name><surname>Nilsson</surname> <given-names>PM</given-names></name><name><surname>Njølstad</surname> <given-names>I</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Ohnaka</surname> <given-names>K</given-names></name><name><surname>Ong</surname> <given-names>TH</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Park</surname> <given-names>KS</given-names></name><name><surname>Parkin</surname> <given-names>M</given-names></name><name><surname>Pechlivanis</surname> <given-names>S</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Pinidiyapathirage</surname> <given-names>JM</given-names></name><name><surname>Platou</surname> <given-names>CG</given-names></name><name><surname>Potter</surname> <given-names>S</given-names></name><name><surname>Price</surname> <given-names>JF</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Radha</surname> <given-names>V</given-names></name><name><surname>Rallidis</surname> <given-names>L</given-names></name><name><surname>Rasheed</surname> <given-names>A</given-names></name><name><surname>Rathman</surname> <given-names>W</given-names></name><name><surname>Rauramaa</surname> <given-names>R</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Rees</surname> <given-names>SD</given-names></name><name><surname>Rehnberg</surname> <given-names>E</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Rossin</surname> <given-names>EJ</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>Saaristo</surname> <given-names>TE</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Saltevo</surname> <given-names>J</given-names></name><name><surname>Samuel</surname> <given-names>M</given-names></name><name><surname>Sanghera</surname> <given-names>DK</given-names></name><name><surname>Saramies</surname> <given-names>J</given-names></name><name><surname>Scott</surname> <given-names>J</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Segrè</surname> <given-names>AV</given-names></name><name><surname>Sehmi</surname> <given-names>J</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Shah</surname> <given-names>N</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Shera</surname> <given-names>AS</given-names></name><name><surname>Shu</surname> <given-names>XO</given-names></name><name><surname>Shuldiner</surname> <given-names>AR</given-names></name><name><surname>Sigurđsson</surname> <given-names>G</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>Silveira</surname> <given-names>A</given-names></name><name><surname>Sim</surname> <given-names>X</given-names></name><name><surname>Sivapalaratnam</surname> <given-names>S</given-names></name><name><surname>Small</surname> <given-names>KS</given-names></name><name><surname>So</surname> <given-names>WY</given-names></name><name><surname>Stančáková</surname> <given-names>A</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Steinbach</surname> <given-names>G</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Stirrups</surname> <given-names>K</given-names></name><name><surname>Strawbridge</surname> <given-names>RJ</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Suo</surname> <given-names>C</given-names></name><name><surname>Syvänen</surname> <given-names>AC</given-names></name><name><surname>Takayanagi</surname> <given-names>R</given-names></name><name><surname>Takeuchi</surname> <given-names>F</given-names></name><name><surname>Tay</surname> <given-names>WT</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Trakalo</surname> <given-names>J</given-names></name><name><surname>Tremoli</surname> <given-names>E</given-names></name><name><surname>Trip</surname> <given-names>MD</given-names></name><name><surname>Tsai</surname> <given-names>FJ</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Valladares-Salgado</surname> <given-names>A</given-names></name><name><surname>Vedantam</surname> <given-names>S</given-names></name><name><surname>Veglia</surname> <given-names>F</given-names></name><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Wennauer</surname> <given-names>R</given-names></name><name><surname>Wickremasinghe</surname> <given-names>AR</given-names></name><name><surname>Wilsgaard</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Wiltshire</surname> <given-names>S</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Wong</surname> <given-names>TY</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Wu</surname> <given-names>JY</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name><name><surname>Yamauchi</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Yokota</surname> <given-names>M</given-names></name><name><surname>Young</surname> <given-names>R</given-names></name><name><surname>Zabaneh</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>R</given-names></name><name><surname>Zheng</surname> <given-names>W</given-names></name><name><surname>Zimmet</surname> <given-names>PZ</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Bowden</surname> <given-names>DW</given-names></name><name><surname>Cho</surname> <given-names>YS</given-names></name><name><surname>Cox</surname> <given-names>NJ</given-names></name><name><surname>Cruz</surname> <given-names>M</given-names></name><name><surname>Hanis</surname> <given-names>CL</given-names></name><name><surname>Kooner</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>JY</given-names></name><name><surname>Seielstad</surname> <given-names>M</given-names></name><name><surname>Teo</surname> <given-names>YY</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Parra</surname> <given-names>EJ</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Tai</surname> <given-names>ES</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab><collab>Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium</collab><collab>South Asian Type 2 Diabetes (SAT2D) Consortium</collab><collab>Mexican American Type 2 Diabetes (MAT2D) Consortium</collab><collab>Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility</article-title><source>Nature Genetics</source><volume>46</volume><fpage>234</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/ng.2897</pub-id><pub-id pub-id-type="pmid">24509480</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname> <given-names>JB</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name><name><surname>Byrnes</surname> <given-names>J</given-names></name><name><surname>Vukcevic</surname> <given-names>D</given-names></name><name><surname>Palin</surname> <given-names>K</given-names></name><name><surname>Su</surname> <given-names>Z</given-names></name><name><surname>Howson</surname> <given-names>JM</given-names></name><name><surname>Auton</surname> <given-names>A</given-names></name><name><surname>Myers</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>A</given-names></name><name><surname>Pirinen</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>MA</given-names></name><name><surname>Burton</surname> <given-names>PR</given-names></name><name><surname>Caulfield</surname> <given-names>MJ</given-names></name><name><surname>Compston</surname> <given-names>A</given-names></name><name><surname>Farrall</surname> <given-names>M</given-names></name><name><surname>Hall</surname> <given-names>AS</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Hill</surname> <given-names>AV</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Pembrey</surname> <given-names>M</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><name><surname>Stratton</surname> <given-names>MR</given-names></name><name><surname>Worthington</surname> <given-names>J</given-names></name><name><surname>Craddock</surname> <given-names>N</given-names></name><name><surname>Hurles</surname> <given-names>M</given-names></name><name><surname>Ouwehand</surname> <given-names>W</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Rahman</surname> <given-names>N</given-names></name><name><surname>Duncanson</surname> <given-names>A</given-names></name><name><surname>Todd</surname> <given-names>JA</given-names></name><name><surname>Kwiatkowski</surname> <given-names>DP</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Gough</surname> <given-names>SC</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><collab>Wellcome Trust Case Control Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Bayesian refinement of association signals for 14 loci in 3 common diseases</article-title><source>Nature Genetics</source><volume>44</volume><fpage>1294</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1038/ng.2435</pub-id><pub-id pub-id-type="pmid">23104008</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname> <given-names>JS</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Weinhold</surname> <given-names>N</given-names></name><name><surname>Försti</surname> <given-names>A</given-names></name><name><surname>Ali</surname> <given-names>M</given-names></name><name><surname>van Duin</surname> <given-names>M</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Johnson</surname> <given-names>DC</given-names></name><name><surname>Chen</surname> <given-names>B</given-names></name><name><surname>Halvarsson</surname> <given-names>BM</given-names></name><name><surname>Gudbjartsson</surname> <given-names>DF</given-names></name><name><surname>Kuiper</surname> <given-names>R</given-names></name><name><surname>Stephens</surname> <given-names>OW</given-names></name><name><surname>Bertsch</surname> <given-names>U</given-names></name><name><surname>Broderick</surname> <given-names>P</given-names></name><name><surname>Campo</surname> <given-names>C</given-names></name><name><surname>Einsele</surname> <given-names>H</given-names></name><name><surname>Gregory</surname> <given-names>WA</given-names></name><name><surname>Gullberg</surname> <given-names>U</given-names></name><name><surname>Henrion</surname> <given-names>M</given-names></name><name><surname>Hillengass</surname> <given-names>J</given-names></name><name><surname>Hoffmann</surname> <given-names>P</given-names></name><name><surname>Jackson</surname> <given-names>GH</given-names></name><name><surname>Johnsson</surname> <given-names>E</given-names></name><name><surname>Jöud</surname> <given-names>M</given-names></name><name><surname>Kristinsson</surname> <given-names>SY</given-names></name><name><surname>Lenhoff</surname> <given-names>S</given-names></name><name><surname>Lenive</surname> <given-names>O</given-names></name><name><surname>Mellqvist</surname> <given-names>UH</given-names></name><name><surname>Migliorini</surname> <given-names>G</given-names></name><name><surname>Nahi</surname> <given-names>H</given-names></name><name><surname>Nelander</surname> <given-names>S</given-names></name><name><surname>Nickel</surname> <given-names>J</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Rafnar</surname> <given-names>T</given-names></name><name><surname>Ross</surname> <given-names>FM</given-names></name><name><surname>da Silva Filho</surname> <given-names>MI</given-names></name><name><surname>Swaminathan</surname> <given-names>B</given-names></name><name><surname>Thomsen</surname> <given-names>H</given-names></name><name><surname>Turesson</surname> <given-names>I</given-names></name><name><surname>Vangsted</surname> <given-names>A</given-names></name><name><surname>Vogel</surname> <given-names>U</given-names></name><name><surname>Waage</surname> <given-names>A</given-names></name><name><surname>Walker</surname> <given-names>BA</given-names></name><name><surname>Wihlborg</surname> <given-names>AK</given-names></name><name><surname>Broyl</surname> <given-names>A</given-names></name><name><surname>Davies</surname> <given-names>FE</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Langer</surname> <given-names>C</given-names></name><name><surname>Hansson</surname> <given-names>M</given-names></name><name><surname>Kaiser</surname> <given-names>M</given-names></name><name><surname>Sonneveld</surname> <given-names>P</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Morgan</surname> <given-names>GJ</given-names></name><name><surname>Goldschmidt</surname> <given-names>H</given-names></name><name><surname>Hemminki</surname> <given-names>K</given-names></name><name><surname>Nilsson</surname> <given-names>B</given-names></name><name><surname>Houlston</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-wide association study identifies multiple susceptibility loci for multiple myeloma</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12050</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12050</pub-id><pub-id pub-id-type="pmid">27363682</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morán</surname> <given-names>I</given-names></name><name><surname>Akerman</surname> <given-names>I</given-names></name><name><surname>van de Bunt</surname> <given-names>M</given-names></name><name><surname>Xie</surname> <given-names>R</given-names></name><name><surname>Benazra</surname> <given-names>M</given-names></name><name><surname>Nammo</surname> <given-names>T</given-names></name><name><surname>Arnes</surname> <given-names>L</given-names></name><name><surname>Nakić</surname> <given-names>N</given-names></name><name><surname>García-Hurtado</surname> <given-names>J</given-names></name><name><surname>Rodríguez-Seguí</surname> <given-names>S</given-names></name><name><surname>Pasquali</surname> <given-names>L</given-names></name><name><surname>Sauty-Colace</surname> <given-names>C</given-names></name><name><surname>Beucher</surname> <given-names>A</given-names></name><name><surname>Scharfmann</surname> <given-names>R</given-names></name><name><surname>van Arensbergen</surname> <given-names>J</given-names></name><name><surname>Johnson</surname> <given-names>PR</given-names></name><name><surname>Berry</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Harkins</surname> <given-names>T</given-names></name><name><surname>Gmyr</surname> <given-names>V</given-names></name><name><surname>Pattou</surname> <given-names>F</given-names></name><name><surname>Kerr-Conte</surname> <given-names>J</given-names></name><name><surname>Piemonti</surname> <given-names>L</given-names></name><name><surname>Berney</surname> <given-names>T</given-names></name><name><surname>Hanley</surname> <given-names>N</given-names></name><name><surname>Gloyn</surname> <given-names>AL</given-names></name><name><surname>Sussel</surname> <given-names>L</given-names></name><name><surname>Langman</surname> <given-names>L</given-names></name><name><surname>Brayman</surname> <given-names>KL</given-names></name><name><surname>Sander</surname> <given-names>M</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Ravassard</surname> <given-names>P</given-names></name><name><surname>Ferrer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>435</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.08.010</pub-id><pub-id pub-id-type="pmid">23040067</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Segrè</surname> <given-names>AV</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Strawbridge</surname> <given-names>RJ</given-names></name><name><surname>Khan</surname> <given-names>H</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Dina</surname> <given-names>C</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Fraser</surname> <given-names>RM</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Lagou</surname> <given-names>V</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Pechlivanis</surname> <given-names>S</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Wiltshire</surname> <given-names>S</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Kinnunen</surname> <given-names>L</given-names></name><name><surname>Rossin</surname> <given-names>EJ</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>AD</given-names></name><name><surname>Dimas</surname> <given-names>AS</given-names></name><name><surname>Loos</surname> <given-names>RJ</given-names></name><name><surname>Vedantam</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>CT</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Cornelis</surname> <given-names>MC</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Fischer</surname> <given-names>K</given-names></name><name><surname>Fontanillas</surname> <given-names>P</given-names></name><name><surname>Holmen</surname> <given-names>OL</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Lawrence</surname> <given-names>R</given-names></name><name><surname>Meyer</surname> <given-names>J</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Platou</surname> <given-names>CG</given-names></name><name><surname>Potter</surname> <given-names>S</given-names></name><name><surname>Rehnberg</surname> <given-names>E</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Sivapalaratnam</surname> <given-names>S</given-names></name><name><surname>Stančáková</surname> <given-names>A</given-names></name><name><surname>Stirrups</surname> <given-names>K</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Atalay</surname> <given-names>M</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Burtt</surname> <given-names>N</given-names></name><name><surname>Carey</surname> <given-names>J</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Crenshaw</surname> <given-names>AT</given-names></name><name><surname>Doney</surname> <given-names>AS</given-names></name><name><surname>Dorkhan</surname> <given-names>M</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Emilsson</surname> <given-names>V</given-names></name><name><surname>Eury</surname> <given-names>E</given-names></name><name><surname>Forsen</surname> <given-names>T</given-names></name><name><surname>Gertow</surname> <given-names>K</given-names></name><name><surname>Gigante</surname> <given-names>B</given-names></name><name><surname>Grant</surname> <given-names>GB</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Guiducci</surname> <given-names>C</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Hreidarsson</surname> <given-names>AB</given-names></name><name><surname>Hui</surname> <given-names>J</given-names></name><name><surname>James</surname> <given-names>A</given-names></name><name><surname>Jonsson</surname> <given-names>A</given-names></name><name><surname>Rathmann</surname> <given-names>W</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Kravic</surname> <given-names>J</given-names></name><name><surname>Krjutškov</surname> <given-names>K</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Leander</surname> <given-names>K</given-names></name><name><surname>Lindholm</surname> <given-names>E</given-names></name><name><surname>Lobbens</surname> <given-names>S</given-names></name><name><surname>Männistö</surname> <given-names>S</given-names></name><name><surname>Mirza</surname> <given-names>G</given-names></name><name><surname>Mühleisen</surname> <given-names>TW</given-names></name><name><surname>Musk</surname> <given-names>B</given-names></name><name><surname>Parkin</surname> <given-names>M</given-names></name><name><surname>Rallidis</surname> <given-names>L</given-names></name><name><surname>Saramies</surname> <given-names>J</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Sigurðsson</surname> <given-names>G</given-names></name><name><surname>Silveira</surname> <given-names>A</given-names></name><name><surname>Steinbach</surname> <given-names>G</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Trakalo</surname> <given-names>J</given-names></name><name><surname>Veglia</surname> <given-names>F</given-names></name><name><surname>Wennauer</surname> <given-names>R</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Zabaneh</surname> <given-names>D</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>van Duijn</surname> <given-names>C</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Trip</surname> <given-names>MD</given-names></name><name><surname>Forouhi</surname> <given-names>NG</given-names></name><name><surname>Syvänen</surname> <given-names>AC</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>Isomaa</surname> <given-names>B</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><collab>Wellcome Trust Case Control Consortium</collab><collab>Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators</collab><collab>Genetic Investigation of ANthropometric Traits (GIANT) Consortium</collab><collab>Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium</collab><collab>South Asian Type 2 Diabetes (SAT2D) Consortium</collab><name><surname>Shuldiner</surname> <given-names>AR</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Wilsgaard</surname> <given-names>T</given-names></name><name><surname>Beilby</surname> <given-names>J</given-names></name><name><surname>Hovingh</surname> <given-names>K</given-names></name><name><surname>Price</surname> <given-names>JF</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Rauramaa</surname> <given-names>R</given-names></name><name><surname>Lakka</surname> <given-names>TA</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Njølstad</surname> <given-names>I</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Khaw</surname> <given-names>KT</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname> <given-names>SM</given-names></name><name><surname>Saaristo</surname> <given-names>TE</given-names></name><name><surname>Korpi-Hyövälti</surname> <given-names>E</given-names></name><name><surname>Saltevo</surname> <given-names>J</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Baldassarre</surname> <given-names>D</given-names></name><name><surname>Tremoli</surname> <given-names>E</given-names></name><name><surname>Humphries</surname> <given-names>SE</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Erbel</surname> <given-names>R</given-names></name><name><surname>Jöckel</surname> <given-names>KH</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Illig</surname> <given-names>T</given-names></name><name><surname>de Faire</surname> <given-names>U</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Nilsson</surname> <given-names>PM</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Groop</surname> <given-names>LC</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Hu</surname> <given-names>F</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes</article-title><source>Nature Genetics</source><volume>44</volume><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/ng.2383</pub-id><pub-id pub-id-type="pmid">22885922</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname> <given-names>AH</given-names></name><name><surname>Volkov</surname> <given-names>P</given-names></name><name><surname>Bacos</surname> <given-names>K</given-names></name><name><surname>Dayeh</surname> <given-names>T</given-names></name><name><surname>Hall</surname> <given-names>E</given-names></name><name><surname>Nilsson</surname> <given-names>EA</given-names></name><name><surname>Ladenvall</surname> <given-names>C</given-names></name><name><surname>Rönn</surname> <given-names>T</given-names></name><name><surname>Ling</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004735</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004735</pub-id><pub-id pub-id-type="pmid">25375650</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname> <given-names>SC</given-names></name><name><surname>Stitzel</surname> <given-names>ML</given-names></name><name><surname>Taylor</surname> <given-names>DL</given-names></name><name><surname>Orozco</surname> <given-names>JM</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Akiyama</surname> <given-names>JA</given-names></name><name><surname>van Bueren</surname> <given-names>KL</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Narisu</surname> <given-names>N</given-names></name><name><surname>Black</surname> <given-names>BL</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><collab>NISC Comparative Sequencing Program</collab><collab>National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program Authors</collab><collab>NISC Comparative Sequencing Program Authors</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants</article-title><source>PNAS</source><volume>110</volume><fpage>17921</fpage><lpage>17926</lpage><pub-id pub-id-type="doi">10.1073/pnas.1317023110</pub-id><pub-id pub-id-type="pmid">24127591</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasquali</surname> <given-names>L</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Rodríguez-Seguí</surname> <given-names>SA</given-names></name><name><surname>Mularoni</surname> <given-names>L</given-names></name><name><surname>Miguel-Escalada</surname> <given-names>I</given-names></name><name><surname>Akerman</surname> <given-names>İ</given-names></name><name><surname>Tena</surname> <given-names>JJ</given-names></name><name><surname>Morán</surname> <given-names>I</given-names></name><name><surname>Gómez-Marín</surname> <given-names>C</given-names></name><name><surname>van de Bunt</surname> <given-names>M</given-names></name><name><surname>Ponsa-Cobas</surname> <given-names>J</given-names></name><name><surname>Castro</surname> <given-names>N</given-names></name><name><surname>Nammo</surname> <given-names>T</given-names></name><name><surname>Cebola</surname> <given-names>I</given-names></name><name><surname>García-Hurtado</surname> <given-names>J</given-names></name><name><surname>Maestro</surname> <given-names>MA</given-names></name><name><surname>Pattou</surname> <given-names>F</given-names></name><name><surname>Piemonti</surname> <given-names>L</given-names></name><name><surname>Berney</surname> <given-names>T</given-names></name><name><surname>Gloyn</surname> <given-names>AL</given-names></name><name><surname>Ravassard</surname> <given-names>P</given-names></name><name><surname>Skarmeta</surname> <given-names>JLG</given-names></name><name><surname>Müller</surname> <given-names>F</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Ferrer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants</article-title><source>Nature Genetics</source><volume>46</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1038/ng.2870</pub-id><pub-id pub-id-type="pmid">24413736</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickrell</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Joint analysis of functional genomic data and genome-wide association studies of 18 human traits</article-title><source>The American Journal of Human Genetics</source><volume>94</volume><fpage>559</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.004</pub-id><pub-id pub-id-type="pmid">24702953</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruim</surname> <given-names>RJ</given-names></name><name><surname>Welch</surname> <given-names>RP</given-names></name><name><surname>Sanna</surname> <given-names>S</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Gliedt</surname> <given-names>TP</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Willer</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>LocusZoom: regional visualization of genome-wide association scan results</article-title><source>Bioinformatics</source><volume>26</volume><fpage>2336</fpage><lpage>2337</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq419</pub-id><pub-id pub-id-type="pmid">20634204</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>BEDTools: The Swiss-Army Tool for Genome Feature Analysis</article-title><source>Current Protocols in Bioinformatics</source><volume>47</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1002/0471250953.bi1112s47</pub-id><pub-id pub-id-type="pmid">25199790</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2011">2011</year><data-title>A language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravassard</surname> <given-names>P</given-names></name><name><surname>Hazhouz</surname> <given-names>Y</given-names></name><name><surname>Pechberty</surname> <given-names>S</given-names></name><name><surname>Bricout-Neveu</surname> <given-names>E</given-names></name><name><surname>Armanet</surname> <given-names>M</given-names></name><name><surname>Czernichow</surname> <given-names>P</given-names></name><name><surname>Scharfmann</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>3589</fpage><lpage>3597</lpage><pub-id pub-id-type="doi">10.1172/JCI58447</pub-id><pub-id pub-id-type="pmid">21865645</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname> <given-names>TS</given-names></name><name><surname>Cannon</surname> <given-names>ME</given-names></name><name><surname>Vadlamudi</surname> <given-names>S</given-names></name><name><surname>Buchkovich</surname> <given-names>ML</given-names></name><name><surname>Wolford</surname> <given-names>BN</given-names></name><name><surname>Welch</surname> <given-names>RP</given-names></name><name><surname>Morken</surname> <given-names>MA</given-names></name><name><surname>Kwon</surname> <given-names>GJ</given-names></name><name><surname>Varshney</surname> <given-names>A</given-names></name><name><surname>Kursawe</surname> <given-names>R</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Parker</surname> <given-names>SCJ</given-names></name><name><surname>Stitzel</surname> <given-names>ML</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><collab>National Institutes of Health Intramural Sequencing Center (NISC) Comparative Sequencing Program</collab></person-group><year iso-8601-date="2017">2017</year><article-title>A Type 2 diabetes-associated functional regulatory variant in a pancreatic islet enhancer at the ADCY5 Locus</article-title><source>Diabetes</source><volume>66</volume><fpage>2521</fpage><lpage>2530</lpage><pub-id pub-id-type="doi">10.2337/db17-0464</pub-id><pub-id pub-id-type="pmid">28684635</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Marullo</surname> <given-names>L</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Kaakinen</surname> <given-names>M</given-names></name><name><surname>Pervjakova</surname> <given-names>N</given-names></name><name><surname>Pers</surname> <given-names>TH</given-names></name><name><surname>Johnson</surname> <given-names>AD</given-names></name><name><surname>Eicher</surname> <given-names>JD</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>C</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Van Zuydam</surname> <given-names>NR</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Ried</surname> <given-names>JS</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Karssen</surname> <given-names>LC</given-names></name><name><surname>van Leeuwen</surname> <given-names>EM</given-names></name><name><surname>Willems</surname> <given-names>SM</given-names></name><name><surname>Fuchsberger</surname> <given-names>C</given-names></name><name><surname>Kwan</surname> <given-names>P</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>Chanda</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Dina</surname> <given-names>C</given-names></name><name><surname>Thuillier</surname> <given-names>D</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Sparso</surname> <given-names>T</given-names></name><name><surname>Kestler</surname> <given-names>HA</given-names></name><name><surname>Chheda</surname> <given-names>H</given-names></name><name><surname>Eisele</surname> <given-names>L</given-names></name><name><surname>Gustafsson</surname> <given-names>S</given-names></name><name><surname>Frånberg</surname> <given-names>M</given-names></name><name><surname>Strawbridge</surname> <given-names>RJ</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Hreidarsson</surname> <given-names>AB</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Sigurðsson</surname> <given-names>G</given-names></name><name><surname>Kerrison</surname> <given-names>ND</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Liang</surname> <given-names>L</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>CT</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>Isomaa</surname> <given-names>B</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Have</surname> <given-names>CT</given-names></name><name><surname>Jørgensen</surname> <given-names>ME</given-names></name><name><surname>Jørgensen</surname> <given-names>T</given-names></name><name><surname>Linneberg</surname> <given-names>A</given-names></name><name><surname>Cornelis</surname> <given-names>MC</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Perry</surname> <given-names>JRB</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Tajes-Fernandes</surname> <given-names>J</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Koistinen</surname> <given-names>HA</given-names></name><name><surname>Kinnunen</surname> <given-names>L</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Mühleisen</surname> <given-names>TW</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Pechlivanis</surname> <given-names>S</given-names></name><name><surname>Baldassarre</surname> <given-names>D</given-names></name><name><surname>Gertow</surname> <given-names>K</given-names></name><name><surname>Humphries</surname> <given-names>SE</given-names></name><name><surname>Tremoli</surname> <given-names>E</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Meyer</surname> <given-names>J</given-names></name><name><surname>Steinbach</surname> <given-names>G</given-names></name><name><surname>Wennauer</surname> <given-names>R</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Mӓnnistö</surname> <given-names>S</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Eury</surname> <given-names>E</given-names></name><name><surname>Lobbens</surname> <given-names>S</given-names></name><name><surname>Gigante</surname> <given-names>B</given-names></name><name><surname>Leander</surname> <given-names>K</given-names></name><name><surname>McLeod</surname> <given-names>O</given-names></name><name><surname>Bottinger</surname> <given-names>EP</given-names></name><name><surname>Gottesman</surname> <given-names>O</given-names></name><name><surname>Ruderfer</surname> <given-names>D</given-names></name><name><surname>Blüher</surname> <given-names>M</given-names></name><name><surname>Kovacs</surname> <given-names>P</given-names></name><name><surname>Tonjes</surname> <given-names>A</given-names></name><name><surname>Maruthur</surname> <given-names>NM</given-names></name><name><surname>Scapoli</surname> <given-names>C</given-names></name><name><surname>Erbel</surname> <given-names>R</given-names></name><name><surname>Jöckel</surname> <given-names>KH</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>de Faire</surname> <given-names>U</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Stumvoll</surname> <given-names>M</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Lannfelt</surname> <given-names>L</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Loos</surname> <given-names>RJF</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Boeing</surname> <given-names>H</given-names></name><name><surname>Franks</surname> <given-names>PW</given-names></name><name><surname>Barricarte Gurrea</surname> <given-names>A</given-names></name><name><surname>Palli</surname> <given-names>D</given-names></name><name><surname>van der Schouw</surname> <given-names>YT</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Groop</surname> <given-names>LC</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Strauch</surname> <given-names>K</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Palmer</surname> <given-names>CNA</given-names></name><name><surname>Hu</surname> <given-names>FB</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>An expanded genome-wide association study of Type 2 diabetes in europeans</article-title><source>Diabetes</source><volume>66</volume><fpage>2888</fpage><lpage>2902</lpage><pub-id pub-id-type="doi">10.2337/db16-1253</pub-id><pub-id pub-id-type="pmid">28566273</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadler</surname> <given-names>MB</given-names></name><name><surname>Murr</surname> <given-names>R</given-names></name><name><surname>Burger</surname> <given-names>L</given-names></name><name><surname>Ivanek</surname> <given-names>R</given-names></name><name><surname>Lienert</surname> <given-names>F</given-names></name><name><surname>Schöler</surname> <given-names>A</given-names></name><name><surname>van Nimwegen</surname> <given-names>E</given-names></name><name><surname>Wirbelauer</surname> <given-names>C</given-names></name><name><surname>Oakeley</surname> <given-names>EJ</given-names></name><name><surname>Gaidatzis</surname> <given-names>D</given-names></name><name><surname>Tiwari</surname> <given-names>VK</given-names></name><name><surname>Schübeler</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>DNA-binding factors shape the mouse methylome at distal regulatory regions</article-title><source>Nature</source><volume>480</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nature10716</pub-id><pub-id pub-id-type="pmid">22170606</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Bunt</surname> <given-names>M</given-names></name><name><surname>Manning Fox</surname> <given-names>JE</given-names></name><name><surname>Dai</surname> <given-names>X</given-names></name><name><surname>Barrett</surname> <given-names>A</given-names></name><name><surname>Grey</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Bennett</surname> <given-names>AJ</given-names></name><name><surname>Johnson</surname> <given-names>PR</given-names></name><name><surname>Rajotte</surname> <given-names>RV</given-names></name><name><surname>Gaulton</surname> <given-names>KJ</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name><name><surname>MacDonald</surname> <given-names>PE</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Gloyn</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcript expression data from human islets links regulatory signals from genome-wide association studies for Type 2 diabetes and glycemic traits to their downstream effectors</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005694</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005694</pub-id><pub-id pub-id-type="pmid">26624892</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Geijn</surname> <given-names>B</given-names></name><name><surname>McVicker</surname> <given-names>G</given-names></name><name><surname>Gilad</surname> <given-names>Y</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>WASP: allele-specific software for robust molecular quantitative trait locus discovery</article-title><source>Nature Methods</source><volume>12</volume><fpage>1061</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3582</pub-id><pub-id pub-id-type="pmid">26366987</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname> <given-names>A</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Welch</surname> <given-names>RP</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Narisu</surname> <given-names>N</given-names></name><name><surname>Albanus</surname> <given-names>RD</given-names></name><name><surname>Orchard</surname> <given-names>P</given-names></name><name><surname>Wolford</surname> <given-names>BN</given-names></name><name><surname>Kursawe</surname> <given-names>R</given-names></name><name><surname>Vadlamudi</surname> <given-names>S</given-names></name><name><surname>Cannon</surname> <given-names>ME</given-names></name><name><surname>Didion</surname> <given-names>JP</given-names></name><name><surname>Hensley</surname> <given-names>J</given-names></name><name><surname>Kirilusha</surname> <given-names>A</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Taylor</surname> <given-names>DL</given-names></name><name><surname>Watanabe</surname> <given-names>R</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Parker</surname> <given-names>SC</given-names></name><name><surname>Stitzel</surname> <given-names>ML</given-names></name><collab>NISC Comparative Sequencing Program</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic regulatory signatures underlying islet gene expression and type 2 diabetes</article-title><source>PNAS</source><volume>114</volume><fpage>2301</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621192114</pub-id><pub-id pub-id-type="pmid">28193859</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventham</surname> <given-names>NT</given-names></name><name><surname>Kennedy</surname> <given-names>NA</given-names></name><name><surname>Adams</surname> <given-names>AT</given-names></name><name><surname>Kalla</surname> <given-names>R</given-names></name><name><surname>Heath</surname> <given-names>S</given-names></name><name><surname>O'Leary</surname> <given-names>KR</given-names></name><name><surname>Drummond</surname> <given-names>H</given-names></name><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Gut</surname> <given-names>IG</given-names></name><name><surname>Nimmo</surname> <given-names>ER</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><collab>IBD BIOM consortium</collab><collab>IBD CHARACTER consortium</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>13507</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms13507</pub-id><pub-id pub-id-type="pmid">27886173</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Dina</surname> <given-names>C</given-names></name><name><surname>Welch</surname> <given-names>RP</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Huth</surname> <given-names>C</given-names></name><name><surname>Aulchenko</surname> <given-names>YS</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>McCulloch</surname> <given-names>LJ</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Amin</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Willer</surname> <given-names>CJ</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Hofmann</surname> <given-names>OM</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Segrè</surname> <given-names>AV</given-names></name><name><surname>van Hoek</surname> <given-names>M</given-names></name><name><surname>Navarro</surname> <given-names>P</given-names></name><name><surname>Ardlie</surname> <given-names>K</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Bennett</surname> <given-names>AJ</given-names></name><name><surname>Blagieva</surname> <given-names>R</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Bengtsson Boström</surname> <given-names>K</given-names></name><name><surname>Bravenboer</surname> <given-names>B</given-names></name><name><surname>Bumpstead</surname> <given-names>S</given-names></name><name><surname>Burtt</surname> <given-names>NP</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Cornelis</surname> <given-names>M</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Crawford</surname> <given-names>G</given-names></name><name><surname>Doney</surname> <given-names>AS</given-names></name><name><surname>Elliott</surname> <given-names>KS</given-names></name><name><surname>Elliott</surname> <given-names>AL</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Fox</surname> <given-names>CS</given-names></name><name><surname>Franklin</surname> <given-names>CS</given-names></name><name><surname>Ganser</surname> <given-names>M</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Green</surname> <given-names>T</given-names></name><name><surname>Griffin</surname> <given-names>S</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Guiducci</surname> <given-names>C</given-names></name><name><surname>Hadjadj</surname> <given-names>S</given-names></name><name><surname>Hassanali</surname> <given-names>N</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Isomaa</surname> <given-names>B</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Johnson</surname> <given-names>PR</given-names></name><name><surname>Jørgensen</surname> <given-names>T</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Lauritzen</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Lieverse</surname> <given-names>A</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Marre</surname> <given-names>M</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Midthjell</surname> <given-names>K</given-names></name><name><surname>Morken</surname> <given-names>MA</given-names></name><name><surname>Narisu</surname> <given-names>N</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Payne</surname> <given-names>F</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Petersen</surname> <given-names>AK</given-names></name><name><surname>Platou</surname> <given-names>C</given-names></name><name><surname>Proença</surname> <given-names>C</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Rathmann</surname> <given-names>W</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Robertson</surname> <given-names>NR</given-names></name><name><surname>Rocheleau</surname> <given-names>G</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Sampson</surname> <given-names>MJ</given-names></name><name><surname>Saxena</surname> <given-names>R</given-names></name><name><surname>Shields</surname> <given-names>BM</given-names></name><name><surname>Shrader</surname> <given-names>P</given-names></name><name><surname>Sigurdsson</surname> <given-names>G</given-names></name><name><surname>Sparsø</surname> <given-names>T</given-names></name><name><surname>Strassburger</surname> <given-names>K</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Swift</surname> <given-names>AJ</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Tichet</surname> <given-names>J</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>van Haeften</surname> <given-names>TW</given-names></name><name><surname>van Herpt</surname> <given-names>T</given-names></name><name><surname>van Vliet-Ostaptchouk</surname> <given-names>JV</given-names></name><name><surname>Walters</surname> <given-names>GB</given-names></name><name><surname>Weedon</surname> <given-names>MN</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Witteman</surname> <given-names>J</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Gloyn</surname> <given-names>AL</given-names></name><name><surname>Gyllensten</surname> <given-names>U</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Hide</surname> <given-names>WA</given-names></name><name><surname>Hitman</surname> <given-names>GA</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Pramstaller</surname> <given-names>PP</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>Stein</surname> <given-names>LD</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Uitterlinden</surname> <given-names>A</given-names></name><name><surname>Walker</surname> <given-names>M</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Watanabe</surname> <given-names>RM</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Hu</surname> <given-names>FB</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Wichmann</surname> <given-names>HE</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Groop</surname> <given-names>L</given-names></name><name><surname>Sladek</surname> <given-names>R</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Illig</surname> <given-names>T</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><collab>MAGIC investigators</collab><collab>GIANT Consortium</collab></person-group><year iso-8601-date="2010">2010</year><article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis</article-title><source>Nature Genetics</source><volume>42</volume><fpage>579</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/ng.609</pub-id><pub-id pub-id-type="pmid">20581827</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkov</surname> <given-names>P</given-names></name><name><surname>Bacos</surname> <given-names>K</given-names></name><name><surname>Ofori</surname> <given-names>JK</given-names></name><name><surname>Esguerra</surname> <given-names>JL</given-names></name><name><surname>Eliasson</surname> <given-names>L</given-names></name><name><surname>Rönn</surname> <given-names>T</given-names></name><name><surname>Ling</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Whole-Genome bisulfite sequencing of human pancreatic islets reveals novel differentially methylated regions in Type 2 diabetes pathogenesis</article-title><source>Diabetes</source><volume>66</volume><fpage>1074</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.2337/db16-0996</pub-id><pub-id pub-id-type="pmid">28052964</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tucker</surname> <given-names>NR</given-names></name><name><surname>Rizki</surname> <given-names>G</given-names></name><name><surname>Mills</surname> <given-names>R</given-names></name><name><surname>Krijger</surname> <given-names>PH</given-names></name><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>Subramanian</surname> <given-names>V</given-names></name><name><surname>Bartell</surname> <given-names>E</given-names></name><name><surname>Nguyen</surname> <given-names>XX</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name><name><surname>Leyton-Mange</surname> <given-names>J</given-names></name><name><surname>Dolmatova</surname> <given-names>EV</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>de Laat</surname> <given-names>W</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Milan</surname> <given-names>DJ</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Boyer</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures</article-title><source>eLife</source><volume>5</volume><elocation-id>e10557</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10557</pub-id><pub-id pub-id-type="pmid">27162171</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-loc>New York</publisher-loc><publisher-name>Springer-Verlag</publisher-name></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Jonsson</surname> <given-names>A</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Wang</surname> <given-names>N</given-names></name><name><surname>van Leewen</surname> <given-names>N</given-names></name><name><surname>Palmer</surname> <given-names>ND</given-names></name><name><surname>Kobes</surname> <given-names>S</given-names></name><name><surname>Deelen</surname> <given-names>J</given-names></name><name><surname>Boquete-Vilarino</surname> <given-names>L</given-names></name><name><surname>Paananen</surname> <given-names>J</given-names></name><name><surname>Stančáková</surname> <given-names>A</given-names></name><name><surname>Boomsma</surname> <given-names>DI</given-names></name><name><surname>de Geus</surname> <given-names>EJC</given-names></name><name><surname>Eekhoff</surname> <given-names>EMW</given-names></name><name><surname>Fritsche</surname> <given-names>A</given-names></name><name><surname>Kramer</surname> <given-names>M</given-names></name><name><surname>Nijpels</surname> <given-names>G</given-names></name><name><surname>Simonis-Bik</surname> <given-names>A</given-names></name><name><surname>van Haeften</surname> <given-names>TW</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Banasik</surname> <given-names>K</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Pearson</surname> <given-names>ER</given-names></name><name><surname>Natali</surname> <given-names>A</given-names></name><name><surname>Mari</surname> <given-names>A</given-names></name><name><surname>Buchanan</surname> <given-names>TA</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Xiang</surname> <given-names>AH</given-names></name><name><surname>Gjesing</surname> <given-names>AP</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Eiberg</surname> <given-names>H</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Chen</surname> <given-names>YD</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Norris</surname> <given-names>JM</given-names></name><name><surname>Smith</surname> <given-names>U</given-names></name><name><surname>Wagenknecht</surname> <given-names>LE</given-names></name><name><surname>Baier</surname> <given-names>L</given-names></name><name><surname>Bowden</surname> <given-names>DW</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Walker</surname> <given-names>M</given-names></name><name><surname>Watanabe</surname> <given-names>RM</given-names></name><name><surname>'t Hart</surname> <given-names>LM</given-names></name><name><surname>Hanson</surname> <given-names>RL</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><collab>Diabetes Research on Patient Stratification (DIRECT)</collab></person-group><year iso-8601-date="2017">2017</year><article-title>A Genome-Wide association study of IVGTT-Based measures of first-phase insulin secretion refines the underlying physiology of Type 2 diabetes variants</article-title><source>Diabetes</source><volume>66</volume><fpage>2296</fpage><lpage>2309</lpage><pub-id pub-id-type="doi">10.2337/db16-1452</pub-id><pub-id pub-id-type="pmid">28490609</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Spector</surname> <given-names>TD</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Bell</surname> <given-names>JT</given-names></name><name><surname>Engelhardt</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0581-9</pub-id><pub-id pub-id-type="pmid">25616342</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.31977.046</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Nobrega</surname><given-names>Marcelo</given-names></name><role>Reviewing Editor</role><aff id="aff10"><institution>University of Chicago</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Aviv Regev as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The reviewers of your manuscript found that the publication of a comprehensive epigenomic map of human islets is of broad interest and a timely resource for the community. The study has significant strengths, including the important observation of the far superior performance of WGBS compared to even the more recent, expanded 800K methylation array in comprehensively annotating methylation sites across the genome. Another significant strength highlighted by all reviewers is the integration of this dataset with other functional annotations and genetic fine mapping for T2D-associted loci, readily identifying a subset of variants that are putatively causal of the associations, and laying out a general analytical strategy that can be used by others, beyond those with immediate interest in T2D genetics. Overall, the reviewers found that this study significantly contributes to the effort of generating comprehensive functional annotations of a tissue of great medical and biological importance and thus far not properly characterized yet.</p><p>Below is a summary of essential points to be addressed:</p><p>1) The data presented starting in <xref ref-type="fig" rid="fig2">Figure 2B</xref> and shown throughout the manuscript suggest that virtually all enrichments are significant using FDR (masked by reporting only &quot;FDR &lt; 0.05&quot; in main text). A more appropriate representation would either be quantitative (size proportional to log10p) or using a more stringent (Bonferroni) correction. The enrichments shown could be depicted in a more quantitative manner.</p><p>2) Causal GWAS variants can be enriched in regions with other functional annotations, such as coding regions or regions with strong evolutionary conservation. Such regions have not been considered here. The authors chose to reweight their PPAs solely using chromatin data, but this would down-weight causal variants with other functional annotations in the same region.</p><p>3) How much have the segmentations from the HMM improved with the additional data generated (without using GWAS enrichment as the benchmark)? It appears as though FGWAS enrichments for the actual annotations themselves (shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>) are just as good, if not better, than the HMM analysis (could also look at simple non-HMM two-annotation enrichments). Another way to look at this in the authors' framework would be to compare the median # of credible set SNPs (and top PPA) using only these annotations for FGWAS.</p><p>4) Both the Bayes Factor and FGWAS approaches rely on the assumption that at most one SNP in each region is causal, which may not always be true. This limitation should be discussed.</p><p>5) The addition of the Capture-C data in <xref ref-type="fig" rid="fig5">Figure 5C</xref> does not appear to help resolve rs11708067 as the likely causal variant as a several LD variants are similarly (by eye) overlapping fragments of high Capture-C density. Could this be quantified?</p><p>6) Given the known advantages of Stratified LD Score Regression (Finucane et al., 2015) over FGWAS to uncover true enrichments, have the authors considered using this approach?</p><p>7) What proportion of the narrow sense heritability is captured by the PPA variants?</p><p>8) The nomenclature used to define individual loci emerging from GWAS has followed the historical approach of using the closest gene to the associated SNPs. It has recently been recognized that this is often an imprecise approximation, as pointed out by reviewer 1. While there is no expectation that the authors would come up with a solution to this nomenclature conundrum, it was felt that the authors might address this issue on the paper, highlighting that the gene names associated with each locus may not accurately reflect the gene target of the association.</p><p>9) It was also noted that, despite the depth and complexity of the analysis carried out in this work, key data are missing which would greatly enhance the value of this report. An example is provided by <xref ref-type="fig" rid="fig4">Figure 4D</xref>: why not present a table giving the identified variants at each of the loci (or at least the top half?) with their causal probability? Presumably TCF7L2 refers to rs7903146? This should be clarified (as for the other loci included). It would also be nice to provide eQTL data for this and a few other chosen loci.</p><p>10) Finally, we would suggest that the authors consider bringing up the possibility that the association signal of several of the GWAS loci analyzed, including the ones highlighted in this work (see comment 5, above), might result not from the phenotypic impact of a single causal variant, but rather by the combined effects of multiple variants within the associated haplotype. This is certainly a topic that will become more obvious as we perform more detailed and high throughput computational and experimental analysis of GWAS loci, and it would be important for this work to come out already pondering about this possibility.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.31977.047</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Below is a summary of essential points to be addressed:</p><p>1) The data presented starting in <xref ref-type="fig" rid="fig2">Figure 2B</xref> and shown throughout the manuscript suggest that virtually all enrichments are significant using FDR (masked by reporting only &quot;FDR &lt; 0.05&quot; in main text). A more appropriate representation would either be quantitative (size proportional to log10p) or using a more stringent (Bonferroni) correction. The enrichments shown could be depicted in a more quantitative manner.</p></disp-quote><p>Since, in the original analysis, only 1000 permutations had been performed, the lowest empirical P-value (0.001) did not lend itself to Bonferroni correction for the number of tests performed. Given the reviewers’ comment, we have increased the number of permutations to 100k to be able to estimate a more accurate empirical P-value and then applied a Bonferroni correction. This had no relevant impact on the findings since the empirical P-values calculated for most annotations were still less than 1/100,000 (equating to a minimum Bonferroni corrected P-value of 0.00032). All annotations that were significant using an FDR &lt;0.05 remained significant using the Bonferroni correction (adjusted P&lt;0.05) and the newly calculated enrichment estimates were in the same range as the original ones.</p><p>As requested we also represented the P-values more appropriately by providing the P-values in <xref ref-type="fig" rid="fig2">Figure 2B</xref> and the associated figure legend. In addition, we added <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref> that has been changed to show both the enrichment (x-axis) and associated –log10 Bonferroni adjusted P-value (y-axis) for a more quantitative presentation of the enrichment.</p><p>We updated the results in section 2.2 and modified the Materials and methods section 4.9.1 as well as <xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>.</p><disp-quote content-type="editor-comment"><p>2) Causal GWAS variants can be enriched in regions with other functional annotations, such as coding regions or regions with strong evolutionary conservation. Such regions have not been considered here. The authors chose to reweight their PPAs solely using chromatin data, but this would down-weight causal variants with other functional annotations in the same region.</p></disp-quote><p>We agree with the reviewers’ comments that it is important to include a wide range of functional annotations. In fact, and contrary to the reviewer comments, we had already included coding regions in the original FGWAS analysis.</p><p>In response to the reviewers’ suggestion, we have now repeated the analyses adding in conserved region annotation. We used conserved sequence annotations from Lindblad-Toh et al., 2011 and updated the results of the paper accordingly.</p><p>Consistent with previous observations (e.g. Finucane et al., 2015) we found that conserved sequence was significantly enriched for T2D association in the single-state analysis. However, in the joint model, conserved sequence annotation was <italic>not</italic> retained presumably because the signal arising from conserved sequence was adequately captured by the chromatin state and coding annotations. Therefore, the addition of conserved sequence annotation does not change the major findings and conclusions.</p><p>To include the updated analysis results the manuscript has been revised as follows: We included the updated results in <xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, Figure 3—figure supplement2 as well as <xref ref-type="table" rid="table1">Table 1</xref>–<xref ref-type="table" rid="table2">2</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>–<xref ref-type="supplementary-material" rid="fig3sdata3">3</xref>. In addition, we updated the results described in the main text (in particular, section 2.3 Refining islet enhancer function using methylation and open chromatin data).</p><disp-quote content-type="editor-comment"><p>3) How much have the segmentations from the HMM improved with the additional data generated (without using GWAS enrichment as the benchmark)? It appears as though FGWAS enrichments for the actual annotations themselves (shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>) are just as good, if not better, than the HMM analysis (could also look at simple non-HMM two-annotation enrichments). Another way to look at this in the authors' framework would be to compare the median # of credible set SNPs (and top PPA) using only these annotations for FGWAS.</p></disp-quote><p>While high levels of enrichment do not necessarily reflect high levels of sensitivity across a large number of GWAS loci, we agree that this is an interesting question. To compare the effect of different annotations to the baseline model, we have generated the requested metrics (median number and distribution of 99% credible set SNPs and median top variant PPA and top variant PPA distributions) for the following datasets as suggested:</p><p>- ChIP-only</p><p>- ChIP+Meth</p><p>- ChIP+ATAC</p><p>- ChIP+ATAC+Meth</p><p>- ATAC-only</p><p>- LMR-only</p><p>As shown in the new <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> (see below for additional information), we found that ATAC-seq on its own (ATAC-only) or in combination with ChIP-seq data (ChIP+ATAC), leads to a notable reduction in 99% credible set size and an increase in top variant PPA compared to the baseline ChIP-only model.</p><p>In contrast, DNA methylation did not improve fine-mapping resolution: DNA methylation on its own (LMR-only) or in combination with ChIP-seq data, actually led to a <italic>reduction</italic> in top variant PPA compared to the baseline ChIP-only model. Credible set size <italic>increased</italic> when only DNA methylation (LMR-only) was included in the FGWAS fine-mapping analysis.</p><p>Despite the opposing effects of ATAC-seq and DNA methylation, the combination of ChIP-seq, ATAC-seq and DNA methylation (ChIP+ATAC+Meth) also performed well. The ChIP+ATAC+Meth model showed the best results in terms of median credible set size, identified a higher number of significant segments/loci and was almost identical in performance to the ChIP+ATAC dataset in terms of median maximum variant PPA.</p><p>Overall these results indicate that the chromatin accessibility data provided by ATAC-Seq (either in its own or in combination with islet ChIP-seq annotations) has the most value for refining fine-mapping and homing in on likely causal variants at T2D GWAS loci.</p><p>These results are highly consistent with our original analysis described in section 2.3, which showed that the effect of open chromatin on genetic T2D risk predominates over the effects of DNA methylation. The additional results are shown in the new and updated <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, Supplementary <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> and referred to in the main text:</p><p>“We also expanded the FGWAS PPA analysis to investigate open chromatin and DNA methylation effects on fine-mapping and found that the reduction in 99% credible set size and increase in maximum variant PPA was driven predominantly by open chromatin (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This demonstrates that the inclusion of open chromatin maps helps to improve prioritisation of causal variants at many T2D GWAS loci.”</p><disp-quote content-type="editor-comment"><p>4) Both the Bayes Factor and FGWAS approaches rely on the assumption that at most one SNP in each region is causal, which may not always be true. This limitation should be discussed.</p></disp-quote><p>We agree with the reviewer. We have been working to implement additional analyses steps to circumvent this limitation. Specifically, we have been testing an adaptation to FGWAS that allows us to analyse regions with multiple signals, after conditional decomposition. This is something we hope to deploy in future analyses, but it is not yet ready for inclusion in this paper. Meantime, and in line with reviewers’ comment 10, we have included the following paragraph in the Discussion highlighting this limitation of FGWAS and how future studies could address this:</p><p>“Although we provide highly detailed functional fine-mapping of T2D genetic variants to uncover causal variants, the FGWAS approach applied in this study is limited in its ability to determine the effect of multiple variants at individual loci. […] Analysis methods that combine functional fine-mapping with conditional analysis and consider LD and haplotype patterns are likely to provide a more complete overview of the causal interactions at T2D GWAS loci.”</p><disp-quote content-type="editor-comment"><p>5) The addition of the Capture-C data in <xref ref-type="fig" rid="fig5">Figure 5C</xref> does not appear to help resolve rs11708067 as the likely causal variant as a several LD variants are similarly (by eye) overlapping fragments of high Capture-C density. Could this be quantified?</p></disp-quote><p>This is correct. In our experience using Capture-C, it is typical that promoter “baits” capture multiple (enhancer) sequences in the adjacent region. This is not unexpected given the strong correlation of functional activity within adjacent sequence (as reflected in TAD structure for example). We agree, therefore, that it is generally not possible to use capture-C in isolation to definitively resolve the mechanistic interactions at a GWAS signal. At the <italic>ADCY5</italic> locus, the capture-C data we present demonstrate physical approximation between rs11708067 and the <italic>ADCY5</italic> promoter in an appropriate cell type: this provides additional evidence (to be considered in tandem with other complementary data) to support their relationship. At <italic>ADCY5</italic>, we are able to push the interpretation a little further in terms of resolving the causal variant because rs11708067 is the sole variant in the enhancer region that shows this physical approximation to the promoter.</p><p>To support more rigorous assessments of Capture-C data, we have been implementing a method for quantitative detection of Capture-C peaks which takes into account the background distribution of interaction “noise”. We have quantified the evidence for interaction for a total of 12 fragments across the <italic>ADCY5</italic> region which contain rs11708067 or other close T2D-associated proxies. In this analysis, only two fragments (one of which contains rs11708067) are called as “peaks” on the basis of significant read number over background.</p><p>These updated results are shown in the newly added <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref> and in the main text as shown below:</p><p>“To resolve the significance of the interaction between the restriction fragment encompassing rs11708067 and the ADCY5 promoter, we used the programme peakC (de Wit and Geeven et al., 2017) (https://github.com/deWitLab/peakC) to evaluate the interactions of 12 fragments covering the lead SNP rs11708067 and 15 SNPs in high LD (r2 &gt; 0.8) across a region of 47kb. […] These SNPs fall into a region that did not show evidence of open chromatin.”</p><p>In addition, we also added the following paragraph to the Materials and methods section to include the additional analysis:</p><p>“Significant chromatin interactions were determined from a rank-sum test implemented in the program peakC (de Wit and Geeven et al., 2017)(https://github.com/deWitLab/peakC). […] We applied the Benjamini-Hochberg correction to control the false discovery rate for the set of p-values corresponding to each restriction fragment within the 47kb region at the ADCY5 locus.”</p><disp-quote content-type="editor-comment"><p>6) Given the known advantages of Stratified LD Score Regression (Finucane et al., 2015) over FGWAS to uncover true enrichments, have the authors considered using this approach?</p></disp-quote><p>We agree with the authors that Stratified LD Score Regression could be a valuable method to run on our dataset, in particular, since it can include multiple causal signals at a locus. However, after considering the use of multiple methods (Garfield, Stratified LD Score regression, FGWAS) we ultimately decided to use FGWAS for the following reasons:</p><p>- The FGWAS framework provides a stringent and straightforward way to determine a maximum likelihood model with multiple annotations using both forward and reverse mode selection.</p><p>- The framework provides a simple way of calculating updated posterior probabilities based on the enrichment priors of the best maximum likelihood annotation model. Importantly, the joint maximum likelihood model provides relative enrichment estimates for each category that allow us to up-weight the PPA of variants overlapping a given annotation in a proportional way dependent on the annotation.</p><p>- FGWAS is not dependent on reference datasets for LD-scores and can use all variants tested in the 1000G imputed DIAGRAM dataset including low frequency and rare variants.</p><p>- The observed enrichment patterns (highest enrichment for active enhancer states) are highly consistent with previous studies (e.g. Parker et al., 2013, Pasquali et al., 2014 and Gaulton et al., 2015).</p><p>We will continue to review these different approaches and will seek to implement other methods – such as LD score regression – in future work.</p><disp-quote content-type="editor-comment"><p>7) What proportion of the narrow sense heritability is captured by the PPA variants?</p></disp-quote><p>We have estimated the narrow sense heritability for T2D using UK Biobank data from ~350k individuals. To avoid inflation of the heritability estimates by variants in high LD, we restricted the analysis to the (single) top PPA variant for each of the 52 segments that were significantly associated with T2D genome-wide. The narrow sense heritability for T2D was estimated at 1.8%. To provide a reference point, we also estimated that all currently published T2D GWAS variants (Scott et al., 2017, Mahajan et al., 2014, Morris et al., 2012, Voight et al., 2010) explain 5.7% of variation in T2D risk. We have also used the top associated FG variants at 20 genome-wide significant segments to calculate narrow sense heritability estimates for FG, using Oxford BioBank data from 3.6k individuals. The narrow sense heritability for FG was estimated at 1.9%.</p><disp-quote content-type="editor-comment"><p>8) The nomenclature used to define individual loci emerging from GWAS has followed the historical approach of using the closest gene to the associated SNPs. It has recently been recognized that this is often an imprecise approximation, as pointed out by reviewer 1. While there is no expectation that the authors would come up with a solution to this nomenclature conundrum, it was felt that the authors might address this issue on the paper, highlighting that the gene names associated with each locus may not accurately reflect the gene target of the association.</p></disp-quote><p>We agree! We have added the following sentence:</p><p>“(Of note, in line with traditional GWAS nomenclature, locus names were defined based on proximity between the lead variant and the closest gene and does not, of itself, indicate any causal role for the gene in T2D susceptibility).”</p><disp-quote content-type="editor-comment"><p>9) It was also noted that, despite the depth and complexity of the analysis carried out in this work, key data are missing which would greatly enhance the value of this report. An example is provided by <xref ref-type="fig" rid="fig4">Figure 4D</xref>: why not present a table giving the identified variants at each of the loci (or at least the top half?) with their causal probability? Presumably TCF7L2 refers to rs7903146? This should be clarified (as for the other loci included). It would also be nice to provide eQTL data for this and a few other chosen loci.</p></disp-quote><p>- As requested we have created an additional table (<xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>) that provides information for all 190 variants from <xref ref-type="fig" rid="fig4">Figure 4D</xref> which overlap one of the annotations included in the FGWAS joint-model.</p><p>- Per variant, the following T2D/FGWAS information is provided: rsID; FGWAS PPA; T2D GWAS P-value; FGWAS segment number; T2D locus name; tested for allelic imbalance (Yes/No).</p><p>- If available, the following eQTL information (from Varshney et al., 2017) is also provided:</p><p>eQTL allele1 (effector), eQTL allele 2, eQTL q-value, eQTL effect and eQTL gene</p><disp-quote content-type="editor-comment"><p>10) Finally, we would suggest that the authors consider bringing up the possibility that the association signal of several of the GWAS loci analyzed, including the ones highlighted in this work (see comment 5, above), might result not from the phenotypic impact of a single causal variant, but rather by the combined effects of multiple variants within the associated haplotype. This is certainly a topic that will become more obvious as we perform more detailed and high throughput computational and experimental analysis of GWAS loci, and it would be important for this work to come out already pondering about this possibility.</p></disp-quote><p>In line with the reviewers’ comment 4 about the limitation of FGWAS to assume only single causal variants, we have added a paragraph in the Discussion describing the potential impact of multiple signals per locus and interacting causal variants on the phenotype and how this could be addressed. The part of the paragraph that highlights these effects is shown below:</p><p>“Specifically, FGWAS relies on the assumption of a single causal variant within each region, which may not necessarily be true for all loci. […] Analysis methods that combine functional fine-mapping with conditional analysis and consider LD and haplotype patterns are likely to provide a more complete overview of the causal interactions at T2D GWAS loci.”</p></body></sub-article></article>